#gileadnews: We signed voluntary licensing agreements to support potential future access to our investigational antiviral for Ebola Bundibugyo virus disease. Read more: gilead.inc/4t6DoQL
Gilead Sciences
Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy. More on Wikipedia
-
Gilead Sciences
@GileadSciences
-
Gilead Sciences
@GileadSciences
#gileadnews: HIV research to be presented at #hivglasgow2026.
Read more: gilead.inc/4iBJzXZ
For Business and Industry Media -
Gilead Sciences
@GileadSciences
#gileadnews: We will present new data in primary biliary cholangitis (PBC) at The Liver Meeting® 2026, supporting progress towards a better future for people living with PBC. Read more: gilead.inc/4kAbg64
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#kitenews: We'll be presenting new data at #ash26 with @GileadSciences to illustrate progress across our pipeline and portfolio. Read more: gilead.inc/3WJl4AQ
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, Gilead announced third quarter 2026 results, including 16% year-over-year growth in our base business, our strongest growth in more than a decade. Read more, including important cautionary statements about forward-looking information: gilead.inc/4ixD1Ka
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, we announced an agreement to acquire an investigational oral peptide IL-23 receptor inhibitor program. Learn more: gilead.inc/4yFW5vM
-
Gilead Sciences
@GileadSciences
#gileadnews: We will present new clinical and real-world evidence across primary biliary cholangitis (PBC) and chronic hepatitis delta virus (HDV) infection at The Liver Meeting® 2026. Read more: gilead.inc/4sfaxJj
-
Gilead Sciences
@GileadSciences
#gileadnews: At #idweek2026, we will share new data across #hiv treatment and prevention, along with emerging antiviral research such as early results from our investigational program for recurrent genital herpes.
Read more: gilead.inc/3UzpyJC -
Gilead Sciences
@GileadSciences
Our new research published in @Nature points to a more selective way to harness IL-10, long a challenge for drug developers, that suggests a potential new treatment approach for inflammatory bowel disease.
Read the publication: www.nature.com/articles/s41586-026-11176-1 -
Gilead Sciences
@GileadSciences
#gileadnews: We’ve expanded the scope of our six royalty-free voluntary licensing agreements for our twice-yearly HIV prevention medicine to include an investigational once-yearly formulation. Read more: gilead.inc/4AhPLMT
-
Gilead Sciences
@GileadSciences
#gileadnews: This milestone reflects our commitment to engaging with global stakeholders, including partners like PAHO, to help countries move quickly from scientific innovation to real-world access to HIV prevention. Read more: gilead.inc/4dBBSiI
-
Gilead Sciences reposted
Devex
@devex
Scientific advances are transforming the HIV response, but trusted local leadership remains essential.
Anne Aslett and Daniel O’Day highlight how RADIAN, a partnership between @ejaf and @GileadSciences, supports community-led organizations.
Read more: dvx.cm/2b58ew -
Gilead Sciences
@GileadSciences
We’re honored to receive the 2026 ACS Heroes of Chemistry Award at #acsfall2026 – reflecting years of antiviral chemistry and our commitment to advancing science that benefits patients. Learn more about our R&D approach: gilead.inc/4hVJ4JJ
-
Gilead Sciences
@GileadSciences
#gileadnews: The U.S. FDA approves first and only single-tablet regimen for the treatment of HIV in adults who are virologically suppressed, including those on complex multi-tablet regimens. Learn more: gilead.inc/4qGK5Yd
-
Gilead Sciences
@GileadSciences
#gileadnews: The European Commission (EC) expands role of our treatment for first-line metastatic triple-negative breast cancer (mTNBC), establishing it as the first and only antibody-drug conjugate for first-line treatment across PD-(L)1 status. gilead.inc/3UPN2Kc
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, Gilead announced second quarter 2026 results, including 10% year-over-year growth in our base business.
Read more, including important cautionary statements about forward-looking information, here: gilead.inc/4pYNaCM -
Gilead Sciences
@GileadSciences
#gileadnews: We received a #chmp positive opinion for our combination regimen in PD-(L)1-positive first-line metastatic triple-negative breast cancer. If approved, patients with PD-(L)1 positive mTNBC will have a new treatment option in Europe. gilead.inc/4vIE7XN
-
Gilead Sciences
@GileadSciences
#gileadnews: At #aids2026, we will present new HIV research across prevention, treatment and cure, including long-term data for our twice-yearly HIV prevention medicine. Learn more: gilead.inc/4b7qZnH
-
Gilead Sciences
@GileadSciences
#gileadnews: At #aids2026, in collaboration with @Merck, we’re presenting new data from our Phase 3 trials evaluating an investigational long-acting oral treatment for adults with virologically suppressed HIV.
Read the full press release here: gilead.inc/3TfiSiP -
Gilead Sciences reposted
STAT Brand Studio
@statbrandstudio
Driven by a deep heritage in science, @GileadSciences and @KitePharma are establishing their leadership in oncology.
Dietmar Berger, Chief Medical Officer of Gilead, shares his perspective on how advances in science, technology and collaboration are shaping their vision for the future of cancer care: www.statnews.com/sponsor/2026/07/20/changing-whats-possib…This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#inthenews: We're supporting a new clinical trial evaluating an investigational antiviral as a preventative treatment for Ebola Bundibugyo virus disease. The study aims to determine whether treatment after exposure can help prevent Ebola infection.
More: gilead.inc/4yoyW1V -
Gilead Sciences
@GileadSciences
#inthenews: Following FDA approval of our treatment for first-line metastatic triple-negative breast cancer (mTNBC), watch coverage highlighting the impact for patients facing one of the most aggressive cancers: gilead.inc/4f5PGSN
-
Gilead Sciences reposted
STAT Brand Studio
@statbrandstudio
How can innovation in oncology become more meaningful for patients? Dr. Mika Kakefuda Derynck of @GileadSciences and Dr. Gallia Levy of @KitePharma discuss advances in ADCs, CAR T-cell therapies and what it will take to bring these innovations to more people living with cancer.
-
Gilead Sciences
@GileadSciences
#inthenews: Yesterday, we received FDA approval for our treatment for first-line metastatic triple-negative breast cancer (mTNBC). Read recent coverage highlighting the impact of this approval and our commitment to driving innovation in cancer care: gilead.inc/4aliqp2
-
Gilead Sciences
@GileadSciences
#gileadnews: U.S. FDA approves our treatment for first-line metastatic triple-negative breast cancer, marking a new backbone therapy for people who previously had few options. Read more on this much-needed treatment option for the mTNBC community: gilead.inc/4eZCm3k
-
Gilead Sciences
@GileadSciences
#gileadnews: The European Commission (EC) approves our treatment for first-line metastatic triple-negative breast cancer for patients who are not candidates for PD-(L)1 inhibitors. Read how this marks a much-needed advance for the mTNBC community: gilead.inc/3QEIe8W
-
Gilead Sciences reposted
STAT Brand Studio
@statbrandstudio
Cancer care is becoming increasingly personalized.
At STAT@ASCO, @GileadSciences CMO Dietmar Berger discussed how advances in cell therapy, antibody-drug conjugates, and other targeted approaches are helping researchers pursue new ways to treat cancer and improve outcomes for patients. -
Gilead Sciences
@GileadSciences
#gileadnews: The U.S. FDA has accepted our filing for our investigational once-weekly oral option for the prevention of HIV as pre-exposure prophylaxis (PrEP). If approved, this formulation could be the first once-weekly oral PrEP option. Read more: gilead.inc/4oxl5BJ
-
Gilead Sciences
@GileadSciences
#gileadnews: We are donating antiviral medication to the Government of Uganda to support Ebola response efforts.
Additional supplies are being readied to support the regional outbreak response. gilead.inc/4ekgtKD -
Gilead Sciences
@GileadSciences
Science has transformed the fight against HIV/AIDS, but there’s more work ahead. Today, the National AIDS Memorial and the Gilead Foundation announced a 3-year, nearly $3M commitment to preserve HIV history and support future community leaders. Learn more: gilead.inc/4v7D3xk
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, in collaboration with @Merck, we announced positive topline results from a Phase 3 study evaluating an investigational long-acting oral HIV treatment. Read the full press release here: gilead.inc/4xfl21p
-
Gilead Sciences
@GileadSciences
#gileadnews: Update on our Phase 3 EVOKE-03 study in first-line PD-L1 ≥50% metastatic non-small cell lung cancer: gilead.inc/4g7kVPd
-
Gilead Sciences
@GileadSciences
Because of the leadership of the @GovernmentZA and the @GlobalFund, access to long-acting HIV prevention medication is accelerating. This effort underscores the power of global partnership to help drive progress toward ending HIV as a public health threat. gilead.inc/4atLiv4
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, we completed our acquisition of Ouro Medicines to advance T cell engager therapies for autoimmune diseases. This builds on our long-term strategy to focus on developing transformative medicines that address significant unmet need. gilead.inc/3Q5CpAZ
-
Gilead Sciences
@GileadSciences
We held a high-level meeting with the WHO on the sidelines of the 79th World Health Assembly to announce the five-year renewal of our collaboration to accelerate progress toward eliminating visceral leishmaniasis (VL), also known as kala-azar. www.gilead.com/news/news-details/2026/gilead-sciences-and…
-
Gilead Sciences
@GileadSciences
#gileadnews: We’ve announced new Phase 3 data looking at ALP normalization in a patient population less extensively studied in primary biliary cholangitis (PBC): www.gilead.com/news/news-details/2026/gileads-livdelzi-se…
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, Gilead presented new data in primary biliary cholangitis (PBC) at #easl2026, further advancing scientific innovation with the aim to drive positive change for people living with PBC. Read more: www.gilead.com/news/news-details/2026/gilead-to-present-n…
-
Gilead Sciences
@GileadSciences
#gileadnews: The U.S. FDA has granted accelerated approval for our treatment for adults living with chronic hepatitis delta virus (HDV), making it the first and only treatment option in the United States. Read more www.gilead.com/news/news-details/2026/fda-grants-accelera…
-
Gilead Sciences
@GileadSciences
#gileadnews: We received a #chmp positive opinion for our treatment in first line metastatic triple-negative breast cancer (mTNBC) for patients not candidates for PD-(L)1 inhibitors. gilead.inc/3RTSfz8
-
Gilead Sciences
@GileadSciences
#gileadnews: With @KitePharma, we will be presenting data highlighting advances in our antibody-drug conjugate and cell therapy programs at #asco26 and #eha2026. Read more on our progress in developing treatment options for people living with cancer: gilead.inc/4tIivd3
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, we completed our acquisition of Tubulis, further strengthening our oncology portfolio with a next‑generation ADC platform and clinical‑stage programs with broad potential across multiple tumor types. Learn more: gilead.inc/3RCuZpf
Learn more: -
Gilead Sciences
@GileadSciences
#gileadnews: Today, we released our first quarter 2026 financial results. gilead.inc/4w7cJEi #earnings
-
Gilead Sciences
@GileadSciences
#gileadnews: The U.S. FDA has granted priority review of our NDA for an investigational once daily HIV treatment regimen. If approved, this single tablet regimen could expand treatment options for virologically suppressed adults living with HIV. Read more: gilead.inc/3Qz8RvH
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, we completed our acquisition of Arcellx, which strengthens our oncology portfolio and the long-term potential of an investigational cell therapy for multiple myeloma. Read more: gilead.inc/48rJHVO
-
Gilead Sciences
@GileadSciences
At Stanford Drug Discovery Symposium, our EVP of Research Flavius Martin takes part in a panel to share how Gilead and @KitePharma are targeting biological mechanisms behind cancer and inflammatory disease.
Watch live on 4/28 at 11:10 a.m. PT: med.stanford.edu/cvi/events/sdds2026-stanford-drug-discov… -
Gilead Sciences
@GileadSciences
This Earth Day, we’re recognizing the people behind our commitment to sustainable health. That work recently earned us TRUE Gold Zero Waste certification at our Foster City headquarter campus. Learn more: www.gilead.com/responsibility/esg
-
Gilead Sciences
@GileadSciences
Since setting our corporate strategy in 2019, we’ve been building toward a bold, long‑term vision for Gilead. Read our 2025 Responsible Business and Impact Report to see how the past year marked accelerated momentum toward our 2030 ambitions. www.gilead.com/responsibility/esg
-
Gilead Sciences
@GileadSciences
As the oncology research community gathers at #aacr26 this week, Jackson Egen and Priti Hegde sat down with @statnews to discuss how Gilead and @KitePharma are working to reach more patients, across more types of cancer.
-
Gilead Sciences
@GileadSciences
Cancer rarely stays the same, especially in how it resists treatment. That’s why our research teams are at #aacr26, to advance transformative therapies that can stay ahead of it. See what our leaders are watching this week.
-
Gilead Sciences
@GileadSciences
#gileadnews: @USForeignAssist and the @GlobalFund will further invest in our HIV prevention medication to expand access for up to 1 million more people, bringing the total commitment up to 3 million people in high-incidence, resource limited countries. gilead.inc/41BSQY3
-
Gilead Sciences
@GileadSciences
The needs of people living with HIV propel our research teams at Gilead. Learn how we are putting people at the center of developing new therapies as we strive to offer options for all those living with the virus. www.gilead.com/stories/Gilead-Commitment-to-Bridging-the-…
-
Gilead Sciences
@GileadSciences
#gileadnews: We’ve entered into an agreement to acquire Tubulis further strengthening Gilead’s leadership in oncology with a next‑generation ADC platform and clinical‑stage programs with broad potential across multiple tumor types. Learn more: www.gilead.com/news/news-details/2026/gilead-to-acquire-t…
-
Gilead Sciences
@GileadSciences
Hear from Gilead's Stacey Ma as she explains how nearly two decades of high-stakes problem-solving, cutting edge science and cross-functional teamwork helped pave the way for a new approach to HIV prevention medication development. gilead.inc/3PKwaSB
-
Gilead Sciences
@GileadSciences
#gileadnews: We have entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager therapies for autoimmune diseases.
Read more: www.gilead.com/news/news-details/2026/gilead-sciences-to-… -
Gilead Sciences
@GileadSciences
We’re honored to share that Gilead has been recognized by Ethisphere as one of the 2026 World’s Most Ethical Companies®
This designation reflects ongoing work to embed ethics and integrity as a core principle in how we operate and make decisions. #worldsmostethicalcompanies -
Gilead Sciences
@GileadSciences
At Gilead, we always put patients first – that’s why our clinical research team pursued a more challenging crossover clinical trial for those living with metastatic triple-negative breast cancer (mTNBC) – the most aggressive form. Read more on www.gilead.com/stories/Putting-Patients-First-in-Metastat…
-
Gilead Sciences
@GileadSciences
#gileadnews: Our Phase 3 ASCENT-04 results have since been updated in the @NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) as a Category 1 preferred regimen for certain people living with metastatic #tnbc. gilead.inc/418N1Rs
Gilead Sciences
@GileadSciences
#gileadnews: @NEJM publishes our Phase 3 ASCENT-04 results supporting a potential new standard of care in first-line metastatic triple-negative breast cancer. We’re committed to bringing more treatments to people living with metastatic #tnbc. gilead.inc/4r7cFRL
-
Gilead Sciences
@GileadSciences
This UK Mother’s Day, we’re raising awareness of primary biliary cholangitis (#pbc), a chronic, autoimmune, liver condition.
Hear how this PBC ambassador navigates motherhood alongside PBC, and her advice for others on a similar path. #mothersday -
Gilead Sciences
@GileadSciences
Conversations shaping the future of healthcare are happening at #sxsw, and we’re excited to be part of them in Austin. We’re fostering dialogue on amplifying #hiv prevention through music, pop culture and community.
-
Gilead Sciences
@GileadSciences
Early scientific insights, at-risk manufacturing decisions months and years before FDA-approval and coordinated partnerships helped ensure our twice-yearly injectable medication for HIV prevention could reach patients as soon as science and approvals aligned.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Reflecting on the Gilead Foundation’s Giving Together efforts in 2025, we’re proud of the meaningful impact we made in the communities we serve. Today, as we look ahead, we’re excited to build on this momentum — and to make an even greater impact in 2026.
-
Gilead Sciences
@GileadSciences
We’re proud to share that the Gilead Foundation has awarded $12 million to 33 organizations to strengthen knowledge, care navigation and access to services for communities disproportionately affected by HIV as part of our CHW Initiative. Learn more: gilead.inc/4kZ7scI
-
Gilead Sciences
@GileadSciences
#gileadnews Presented at #croi2026 and published in @TheLancet, new research explores an investigational #hiv treatment regimens that could expand choice, enabling people who are seeking new treatment options to sustain virologic suppression. gilead.inc/4s5ZQHJ
-
Gilead Sciences
@GileadSciences
The San Francisco Business Times named Daniel O’Day, Chairman and CEO, to its Newsmakers 100 list. Gilead congratulates all the SFBT Newsmakers leaders who are shaping the Bay Area through impact and vision. gilead.inc/4kOLrxe
-
Gilead Sciences
@GileadSciences
#gileadnews: We reached an agreement to acquire @arcellx, supporting an investigational cell therapy for multiple myeloma. FDA acceptance of the BLA marks an important milestone. Read more: gilead.inc/4qMWh8x
-
Gilead Sciences
@GileadSciences
We create possibilities when great minds, cutting-edge technology and bold vision converge. Our investments in AI, biotech partnerships and next-gen facilities are building tomorrow's medicine blueprint right here in America.
gilead.inc/462F0AE -
Gilead Sciences
@GileadSciences
TIME has named our Chairman and CEO, Daniel O’Day to its 2026 TIME100 Health list of Titans — “the people most influential in the world of health right now.”
time.com/collections/time100-health-2026/7362475/daniel-o… -
Gilead Sciences
@GileadSciences
#gileadnews: Today, we released our fourth quarter and full year financial results. www.gilead.com/news/news-details/2026/gilead-sciences-ann… #earnings
-
Gilead Sciences
@GileadSciences
Join us this Tuesday, February 10 at 4:30 PM ET to hear business updates and insights from Gilead leadership on our fourth quarter and full year financial results. Sign up here: investors.gilead.com/overview/default.aspx
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#kitenews: The @US_FDA approved a label update for our CAR T-cell therapy, which removed the Limitations of Use in relapsed or refractory primary central nervous system lymphoma based on safety data. www.kitepharma.com/news/press-releases/2026/2/fda-approve…
-
Gilead Sciences
@GileadSciences
The future of medicine is being built in state-of-the-art facilities in America. Our NTDC, NRC and new biologics building represent where we're creating possibilities for therapies that will tackle tomorrow's health challenges. gilead.inc/46ykDLH
-
Gilead Sciences
@GileadSciences
Every patient’s journey is unique, and their powerful stories inspire our commitment to advancing cancer care with science that meets people where they are. This #worldcancerday, we remain committed to science that changes what cancer treatment can mean for those living with it.
-
Gilead Sciences
@GileadSciences
Gilead’s Choose U ambassadors in Italy share their experiences living with HIV to help others in the community. Learn more about the services and support they provide is making a difference throughout the country. gilead.inc/4kjJ99k
-
Gilead Sciences
@GileadSciences
#gileadnews: @NEJM publishes our Phase 3 ASCENT-04 results supporting a potential new standard of care in first-line metastatic triple-negative breast cancer. We’re committed to bringing more treatments to people living with metastatic #tnbc. gilead.inc/4r7cFRL
-
Gilead Sciences
@GileadSciences
Today, we’re honoring Dr. Martin Luther King Jr.’s enduring legacy. Dr. King’s work continues to inspire our commitment to advancing health equity and reducing barriers to care in our pursuit of a healthier world for all people. #mlkday2026
-
Gilead Sciences
@GileadSciences
In an era of rapid scientific advancement and ongoing global health challenges, we’re taking a forward-looking approach to innovation – guided by our long-term plan to advance 10 potential transformative therapies by 2030. Read more in @endpts. #jpm2026 gilead.inc/4sF7n1s
-
Gilead Sciences
@GileadSciences
Check out the latest from Daniel O'Day at #jpm26 discussing Gilead’s strategic transformation delivering real, measurable progress for long-term sustainable growth. gilead.inc/4qlaZEh
-
Gilead Sciences
@GileadSciences
The momentum that drives progress starts here. At #jpm26 this year, we’re excited to explore what’s possible next.
-
Gilead Sciences
@GileadSciences
We shared with @statnews how, since 2019, ten potential breakthrough therapies by 2030 could transform patient care worldwide. Learn more how we are aiming to ensure breakthroughs reach patients everywhere: gilead.inc/3Ncx7Sv #jpm2026
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, Gilead and the U.S. government reach an agreement to lower costs of medicines for Americans. gilead.inc/3YCiVEJ
-
Gilead Sciences
@GileadSciences
Cue the highlights: standout moments, innovative science and meaningful progress across Gilead and @KitePharma in 2025. From major global achievements to everyday team accomplishments, this work helped define who we are, where we’re going and how far we still want to go.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
One of our reimagined buildings has been named the Winner of the 2025 Lab Building and Projects Award for Excellence in Energy Efficiency by @i2sl_. This reflects our commitment to creating facilities that are as forward-thinking as the science and manufacturing happening inside.
-
Gilead Sciences
@GileadSciences
#gileadnews: We’ve announced positive topline results from a Phase 3 HIV trial assessing the potential of an investigational single-tablet regimen to expand current treatment options. Read more: gilead.inc/48V6SXZ
-
Gilead Sciences
@GileadSciences
#gileadnews: Gilead Foundation has committed more than $3M in new grants to 23 nationwide programs to address critical gaps in education, care delivery and support services for people affected by metastatic breast cancer (mBC).
Read more: gilead.inc/3MsmDhu -
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#kitenews: We're presenting a new pooled analysis highlighting safety & efficacy data and observed quality of life benefits of our treatment in R/R large B-cell lymphoma at #ash25. Learn how this may help further establish a new standard of care: www.kitepharma.com/news/press-releases/2025/12/yescarta-d…
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#kitenews: Early Phase 1 clinical findings presented at #ash25 suggest our bicistronic cell therapies may have the potential to transform care for people with R/R B-cell lymphoma. Read more: www.kitepharma.com/news/press-releases/2025/12/kites-next…
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#kitenews: New pivotal Phase 2 data presented at #ash25 with @Arcellx may help redefine care and offer hope for people with relapsed or refractory multiple myeloma. Learn more about the results: www.kitepharma.com/news/press-releases/2025/12/kite-annou…
-
Gilead Sciences
@GileadSciences
Imagine being invited to a dinner where you're asked to wear red formal attire & share conversations about sexual health and #hiv. Learn about Gilead’s seat at this table and our commitment to community-driven solutions and our health equity mission. gilead.inc/4poYtTM
-
Gilead Sciences
@GileadSciences
As part of Gilead and @KitePharma's ongoing commitment to taking back possibility for people living with cancer, Olivier Nolan-Stevaux shares his perspective on the future of cancer care.
-
Gilead Sciences
@GileadSciences
On #idpd, we celebrate the contributions of individuals with disabilities and reaffirm our commitment to accessibility and equal opportunity. Our #disabilityinclusion employee resource group continues to advance this work to foster belonging for all. gilead.inc/4rPnRUm
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, Gilead Sciences announced it has provided 1,200 vials of its antiviral therapy to the Ministry of Health of Ethiopia to help aid the country’s first outbreak of Marburg Virus Disease (MVD). gilead.inc/48tTQ3s
-
Gilead Sciences
@GileadSciences
We are honored to be recognized with the 2025 Action Award from U.S. Business Action to End HIV. This award celebrates our work to raise #hiv visibility, end stigma, support employees, strengthen communities, advocate for change and fund progress.
-
Gilead Sciences
@GileadSciences
98% of our R&D infrastructure is U.S.-based—and that matters. From our Bay Area HQ to sites nationwide, we’re fostering collaboration that turns innovation into life-changing therapies. American ingenuity, creating possibilities worldwide. #creatingpossibleinamerica
-
Gilead Sciences
@GileadSciences
#gileadnews: The Gilead Foundation announced its commitment of over $3 million in grants to expand access to food in communities across the U.S., including organizations addressing food insecurity – where Gilead employees live and work. Read more: gilead.inc/480zHDd
-
Gilead Sciences
@GileadSciences
From receiving a diagnosis to reflecting on a treatment experience, hear how advocates take back possibility in the face of cancer. #gcam
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Science and style join forces to give lab coats a makeover. Learn how this collab involving scientists and fashion designers is helping break #hiv stigma. gilead.inc/4iiAm6l
-
Gilead Sciences
@GileadSciences
Hope isn't just a word—it's a powerful force found in the #lungcancer community. Central to our work at Gilead is listening to advocate voices, like Danielle Hicks from @GO2forLungCancr, to guide how we transform the way cancer is treated, during #lcam and beyond.
-
Gilead Sciences
@GileadSciences
Time takes on a new meaning for people living with cancer. Brian Weist reaffirms the importance of working with urgency to accelerate innovative treatments.
At Gilead and @KitePharma, we’re guided by a shared commitment to address the greatest gaps in care. -
Gilead Sciences
@GileadSciences
#gileadnews: Gilead joined partners in delivering the first shipments of our twice-yearly HIV prevention option to Eswatini & Zambia, an important milestone in our shared efforts to accelerate progress toward ending the HIV epidemic in sub-Saharan Africa. gilead.inc/47NB7AW
-
Gilead Sciences
@GileadSciences
We are driving the future of America’s biopharma innovation. Our $32 billion commitment to U.S. manufacturing is an investment in the next generation of scientists, communities and R&D.
Read more on @thehill gilead.inc/4iep4Ac
#creatingpossibleinamerica #americaninnovation -
Gilead Sciences
@GileadSciences
We left #abclisbon last week with critical perspectives from advocates and healthcare providers on the importance of treatment innovation for more aggressive cancers, like metastatic triple-negative breast cancer. Hear what drives hope and progress for the #mbc community. #abc8
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
What does it take to turn invisible symptoms into visible art? @LoveMondoTrasho shares creative outfits inspired by real people living with PBC.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: We’ve announced positive topline results from a Phase 3 HIV research trial evaluating an investigational novel treatment combination with the potential to expand options. Read more: gilead.inc/43vLiaB
-
Gilead Sciences
@GileadSciences
As both Associate General Counsel and a veteran, Mark Hurvitz brings leadership, discipline and purpose to @KitePharma’s manufacturing and quality teams. Hear how he applies lessons from his military service to advance innovation at Kite. #veteransday
-
Gilead Sciences
@GileadSciences
‘Emotionally, living with hepatitis C made me feel really small for a long time. It was this quiet shame.’ Steffy P shares what’s BehinD the SilenCe to break down the stigma around hepatitis that can prevent individuals from receiving support. Learn more: behind-the-silence.com
-
Gilead Sciences
@GileadSciences
#gileadnews: Update on our Phase 3 ASCENT-07 study in HR+/HER2- metastatic #breastcancer gilead.inc/3JyGk6j
-
Gilead Sciences
@GileadSciences
#gileadnews: At #tlm, we’re presenting new interim, long-term data in primary biliary cholangitis (PBC). Learn about our ongoing commitment to addressing the unmet needs of people living with PBC: gilead.inc/3LNj05i
-
Gilead Sciences
@GileadSciences
Listen as advocates share why they dedicate their lives to speaking up for others living with cancer.
Advocacy is especially critical for people living with metastatic #breastcancer, who often face significant unmet needs.This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Gilead’s U.S. team is 10.5K strong—and growing. Behind every number is a person creating possibilities, chasing breakthroughs, solving puzzles and bringing hope. These aren’t just careers—they’re paths to change. Learn more: gilead.inc/47CAN6A.
-
Gilead Sciences
@GileadSciences
We are committed to transforming the treatment landscape for people living with metastatic TNBC. Last month at #esmo25, we asked attendees to explain why it is so important that we continue to bring innovation to this community. Hear their answers.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Gilead’s Research Scholars Program supports emerging researchers around the world to advance scientific knowledge in areas of high unmet medical need. This year, the program introduces its first cohort for primary biliary cholangitis. Learn more. gilead.inc/4oUjCVd
-
Gilead Sciences
@GileadSciences
That’s a wrap on #communityvision2025.
Two insightful days featuring 30+ expert speakers in #hiv and #oncology to show how cross-sector collaboration, people-centered care and shared momentum work to positively impact #healthequity. -
Gilead Sciences
@GileadSciences
In collaboration with 50+ oncology organizations, we’re dedicated to creating new possibilities for people living with cancer. Together, we're improving access to supportive oncology care and health literacy resources.
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#kitenews: At #ash25, we’re sharing data across our portfolio and pipeline of CAR T-cell therapies, including from the pivotal iMMagine-1 Phase 2 study in multiple myeloma. Read how we’re aiming to transform blood cancer care with @GileadSciences: www.kitepharma.com/news/press-releases/2025/11/gilead-and…
-
Gilead Sciences
@GileadSciences
#gileadnews: Today we released our third quarter financial results. gilead.inc/3WwqJqM #earnings
-
Gilead Sciences
@GileadSciences
This week is #communityvision2025 🌍
160 advocates from 130+ orgs in the #hiv & #cancer communities will unite to share insights, challenges and solutions.
We cannot wait to connect, collaborate and share learnings.💪✨ -
Gilead Sciences
@GileadSciences
At #esmo25, we reinforced our commitment to advancing cancer treatment and delivering innovation with purpose.
Watch what patients, advocates and Gilead team members said about what it means to take back possibility in the face of cancer.This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
$43 billion in projected U.S. economic impact. Every dollar we invest creates new possibilities: high-quality jobs, breakthrough science, stronger communities. Because building a healthier world starts with building stronger foundations at home: gilead.inc/47oNLVm
-
Gilead Sciences
@GileadSciences
#gileadnews: We’ll present new findings in primary biliary cholangitis and viral hepatitis at #tlm25. This reflects our continued dedication to improving the lives of people affected by liver disease. Read more: gilead.inc/4huOPMk
-
Gilead Sciences
@GileadSciences
Our vision is bold: to change the future of cancer care. Kasia’s determination is just one inspiring example embodying how we’re disrupting cancer and redefining what’s possible.
-
Gilead Sciences
@GileadSciences
#gileadnews: At #idweek2025 Gilead will showcase new data from our antiviral research & development portfolio. Learn about our ongoing commitment to addressing the evolving needs of people and communities affected by HIV, hepatitis and respiratory viruses: gilead.inc/42KZtIG
-
Gilead Sciences
@GileadSciences
#gileadnews: At #esmo25, we're sharing positive Phase 3 ASCENT-03 data, also in @NEJM. With this second Phase 3 study, our ADC has the potential to be a backbone standard of care option for all 1L metastatic #tnbc patients, regardless of PD-L1 status. gilead.inc/43q4AxW
-
Gilead Sciences
@GileadSciences
Women in Europe, particularly migrants, face unique challenges with #hiv. Meet the women at #eacs2025 who are breaking the stigma, disclosing their status, and advocating for others. Hear their stories. gilead.inc/3KTwfRK
-
Gilead Sciences
@GileadSciences
At #esmo25, we’re showing progress in our commitment to transform how cancer is treated with new data. Together with @KitePharma, we’re innovating to reach people living with cancer earlier with novel therapies to build a better future for this community.
-
Gilead Sciences
@GileadSciences
We’re looking forward to joining the HIV community at #eacs2025. We’ll share insights on long-term treatment outcomes, expanding prevention choices and meaningful partnerships. Together, we're driving progress to help end the global HIV epidemic.
-
Gilead Sciences
@GileadSciences
#gileadnews: We look forward to showcasing our dedication to person-centered innovation in HIV research and the impact of global collaboration on advancing health equity at #eacs2025. Read more: gilead.inc/3KSGuWk
-
Gilead Sciences
@GileadSciences
#creatingpossible: We're committing $32 billion to U.S. innovation through 2030. This is an investment in creating possibilities for patients worldwide, rooted right here at home. When U.S. innovation leads, global health follows. #gileadinvestment
-
Gilead Sciences
@GileadSciences
What do we wish everyone knew about metastatic breast cancer? That scientific innovation is critical, and care for MBC goes beyond treatment to help meet the vast needs of patients.
#bcam #mbcdayThis media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: This #esmo25, we’re sharing Phase 3 ASCENT-03 & 04 results supporting a potential new standard of care in 1L metastatic #tnbc, new Phase 2 EDGE-Gastric data and more. See how we’re committed to broadening treatment options with @KitePharma: gilead.inc/46Qx3zn
-
Gilead Sciences
@GileadSciences
For #worldinclusionday, we asked Gilead employees to share how they #choosetoinclude. Their answers remind us that inclusion means listening deeply, uplifting voices and valuing differences as strengths. We’re committed to ensuring everyone feels a sense of belonging.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Our own Dietmar Berger sat down with @statbrandstudio to discuss how Gilead and @KitePharma are working to overcome challenges to better support outcomes for people living with cancer. Listen to the full conversation: gilead.inc/48pcHhS
-
Gilead Sciences
@GileadSciences
Our novel #hiv prevention medicine was named one of @TIME's Best Inventions of 2025. At Gilead, creating possible is never a finish line. This award honors decades of progress and fuels our commitment to what’s next as we work to help end the HIV epidemic.
-
Gilead Sciences
@GileadSciences
With a growing inflammation pipeline, learn how Gilead is aiming to address the unmet need of those suffering from autoimmune disorders such as lupus and rheumatoid arthritis. gilead.inc/3IYJb83
-
Gilead Sciences
@GileadSciences
Bhavna’s commitment to the community enables her team to innovate and transform how cancer is treated. Together with @KitePharma, we’re collaborating to address the greatest gaps in care.
-
Gilead Sciences
@GileadSciences
Triple-negative breast cancer is the most aggressive form of breast cancer, and unmet needs persist. Through relentless innovation, we’re helping to bring practice-changing treatments to those living with #tnbc sooner. Read more in @statbrandstudio: gilead.inc/3KsXJNT
-
Gilead Sciences
@GileadSciences
During #bcam and beyond, the Gilead Oncology Grant program supports organizations like the @elliefund, that provide financial and practical help for individuals with breast cancer. Read more. gilead.inc/4gNsiK1
-
Gilead Sciences
@GileadSciences
Gilead is strengthening our United States footprint to power the next era of discovery, job creation and public health preparedness — while continuing to invest globally to ensure patients everywhere benefit from our science.
-
Gilead Sciences
@GileadSciences
Gilead Foundation is committed to making a meaningful difference through community partnerships, grantee programs and more. Learn more about how the Foundation supports organizations that are positively impacting people living with breast cancer across the United States.
-
Gilead Sciences
@GileadSciences
The recent groundbreaking of our New Technical Development Center is part of our $32B investment in technology and R&D projects that will help create $43B in value to the U.S. economy through direct capital and jobs creation.
Learn more: gilead.inc/4mFtJvs -
Gilead Sciences
@GileadSciences
We've received the 2025 SMR Award for Drug Discovery for our latest #hiv prevention and treatment therapy. This breakthrough exemplifies our commitment to transformative science that has the potential to change the HIV landscape and make a profound difference in people's lives.
-
Gilead Sciences
@GileadSciences
STEM skills will be essential for 80% of jobs, yet the U.S. faces a projected shortfall of 1.4M workers by 2030.
That's why the Gilead Foundation is committing $6.5M to expand STEM education pathways for students in the Bay Area and beyond.
gilead.inc/3KlRsmX -
Gilead Sciences
@GileadSciences
We're honored to be named to the 2025 @FortuneMagazine #changetheworld List for our innovations in #hiv prevention. Thank you to every advocate, partner and team member working to end the HIV epidemic and building a healthier world for all people. #gileadlife
-
Gilead Sciences
@GileadSciences
#gileadnews: New partnerships with the @GatesFoundation, @heteroofficial, @CHAI_health, @UNITAID, @WitsRHI & @drreddys will help bring low-cost versions of our twice-yearly HIV prevention option to low- and lower-middle-income countries, if approved. gilead.inc/48twRHh
-
Gilead Sciences
@GileadSciences
“Nobody’s really spoken to me about my feelings around PBC.”
Meet Angela, who lives with primary biliary cholangitis (PBC). The hidden symptoms of PBC can impact someone’s physical and mental wellbeing. This #pbcawarenessmonth, Angela encourages others to seek support. -
Gilead Sciences
@GileadSciences
#gileadnews: @CDCgov has released new guidelines for our twice-yearly #hiv prevention medication. This is an important milestone as we strive to help transform HIV prevention in the U.S. More: gilead.inc/4pAcKxu
-
Gilead Sciences
@GileadSciences
On #worldpatientsafetyday, we’re joining patients, families, healthcare workers, communities, policymakers and the @WHO to reaffirm what patient safety means: protecting those most at risk and their right to safe and quality care from the start.
-
Gilead Sciences
@GileadSciences
For #hispanicheritagemonth, we celebrate how diverse journeys spark innovation. Fabian Gonzalez brings his roots and tech expertise to global auditing, offering powerful perspective that strengthens our work worldwide. #gileadlife
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Our new documentary shines a light on primary biliary cholangitis (PBC) – a progressive liver disease that often remains invisible to the outside world while profoundly affecting those who live with it. Watch here: gilead.inc/3K1JrmY #pbcawarenessmonth
-
Gilead Sciences
@GileadSciences
Breaking ground for breakthroughs! Our campus in Foster City is bustling. Learn more about our manufacturing investments that are a testament to our commitment to helping meet patients’ needs. gilead.inc/4mYDTs7
-
Gilead Sciences
@GileadSciences
Art can tell powerful stories. Go behind the scenes with @LoveMondoTrasho as he shares what “All the Feelings with PBC” means to him and why transforming invisible symptoms into visible art matters. Watch the full story: gilead.inc/4pkcJ0g
-
Gilead Sciences
@GileadSciences
When Celeste's lymphoma didn't respond to treatment, she was able to receive CAR T-cell therapy because her husband Ricky could serve as her caregiver — a crucial component of qualifying for CAR T. Watch Celeste and Ricky's story to learn more. gilead.inc/4goBdSg
-
Gilead Sciences
@GileadSciences
We’re proud to be named one of @FastCompany’s Best Workplaces for Innovators. At Gilead, inclusion sparks bold ideas and those ideas drive life-changing therapies. This honor celebrates our people as they embody Gilead's commitment to transformative science each day. #gileadlife
-
Gilead Sciences
@GileadSciences
For the sixth year in a row, Gilead has been named one of @Seramount's 100 Best Companies. This recognition reflects our inclusive workplace culture – where we invest in our people, prioritize collaboration and drive impact. #seramount100best
-
Gilead Sciences
@GileadSciences
At Gilead, we’re committed to helping patients live healthier lives. During #uscha, we’re launching the Choose U® campaign to share the personal experiences of those living with #hiv who are prioritizing wellness and self-care. Learn more. gilead.inc/4naKsaC
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, we announced an agreement with @StateDept and @PEPFAR to support the delivery of our long-acting #hiv prevention medication for up to two million people at no profit to us. Read more: gilead.inc/42hnPt1
-
Gilead Sciences
@GileadSciences
#gileadnews: We’re launching Choose U: a global campaign shaped by real voices and real journeys. Stay tuned as we share inspiring stories of resilience from people living with HIV. We remain committed to putting people first. Learn more: gilead.inc/465AqR8
-
Gilead Sciences
@GileadSciences
Progress starts with people, and lived experience guides our HIV work across generations. With aging as the focus of #uscha2025, we’re continuing our longstanding partnership with the community to help advance equity and reimagine what’s possible in prevention, care and research.
-
Gilead Sciences
@GileadSciences
We’re paving the way for the future pipeline in oncology and inflammation with a new state-of-the-art Research Center. Learn what makes the new labs so unique and how it’s part of Gilead’s bigger investment in U.S. manufacturing and R&D capabilities. gilead.inc/3UZtK1Z
This media couldn't be displayed. See it on the original post. -
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
This #bloodcancerawarenessmonth, we’re focused on where progress begins. Patient cells are the starting point — collected and engineered to attack cancer. Our science is the engine, turning those cells into medicine. The cure is our singular focus, every step of the way.
-
Gilead Sciences
@GileadSciences
#gileadnews: The @EU_Commission has authorized our long-acting HIV prevention medication, making it the first and only twice-yearly prevention option available in the EU. This is a major milestone across the region and in our work to help end the epidemic. gilead.inc/3HRjSEs
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#inthenews: We’ve entered into a definitive agreement to acquire Interius BioTherapeutics, a privately held biotechnology company developing in vivo CAR therapeutics. Read more: www.kitepharma.com/news/press-releases/2025/8/kite-to-acq…
-
Gilead Sciences
@GileadSciences
On Southern HIV/AIDS Awareness Day, we’re spotlighting Joyce’s perspective to bring attention to the unique challenges in the U.S. South. Beyond access, we’re helping to break down systematic barriers and working toward solutions to drive real progress in this region. #shaad
-
Gilead Sciences
@GileadSciences
This week, we opened our regional headquarters in Singapore, marking ten years of impact there and our next chapter of growth in Asia. This space reflects our commitment to grow with intention, expand access and strengthen our presence to meet the evolving needs of patients.
-
Gilead Sciences
@GileadSciences
For Olivier Nolan-Stevaux, nature offers unexpected insights into restoring balance — in the wild and in the lab. Discover how Gilead and @KitePharma are rethinking cancer treatment through a unique scientific framework inspired by harmony in nature. gilead.inc/4mIeHFI
-
Gilead Sciences
@GileadSciences
If we invest in data and partnerships that focus on the hardest-hit communities, it can provide a powerful tool to help us end the HIV epidemic. Gilead and @EmoryUniversity teamed up to create AIDSVu, a powerful online map driving HIV awareness and action. gilead.inc/3JaNOM4
-
Gilead Sciences
@GileadSciences
#gileadnews: Today we released our second quarter financial results. We had another very strong quarter of clinical, commercial and operational execution; and product sales increased by 4% year-over-year. gilead.inc/4oqoSR1 #earnings
-
Gilead Sciences
@GileadSciences
Progress demands more than a vision; it requires innovation built for impact. Our scientific focus remains on addressing the most urgent unmet needs, as we strive to create a healthier world for all people by delivering more than 10 transformative medicines by 2030.
-
Gilead Sciences
@GileadSciences
Linda-Gail Bekker has played a significant role in #hiv prevention efforts globally, and has championed the representation of underrepresented communities in research programs. Hear more from her on the importance of community in our collective work to end the epidemic. #ias2025
-
Gilead Sciences
@GileadSciences
Ending viral hepatitis as a public health threat by 2030 is possible, but stigma remains a key barrier to making this a reality. On #worldhepatitisday, Mardon’s story of living with hepatitis B and D motivates us to continue expanding awareness and bridging gaps in care.
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, we received positive opinions from the #chmp for our long-acting HIV prevention medication. If approved, it could be an important step toward expanding #hiv prevention options in Europe and beyond: gilead.inc/3ILympx
-
Gilead Sciences
@GileadSciences
A powerful Sunday at the @aidswalksf! Gilead employees joined the nearly 40-year tradition, supporting community organizations and raising funds for #hiv care. We are deeply honored to partner as we work together to help end the HIV epidemic for everyone, everywhere.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Women are leading efforts to help end #hiv by driving research, raising awareness and advocating for better health for all. Hear more from #ias2025 on the importance of their perspectives in innovation.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Progress demands more than a vision; it requires innovation built for impact. Our scientific focus addresses the most urgent unmet needs, as we strive to create a healthier world for all people by delivering more than 10 transformative medicines by 2030.
-
Gilead Sciences
@GileadSciences
In the U.S., 85% of people believe #hiv stigma still exists. On #zerohivstigmaday, we recognize the resilience of individuals like Morris who navigate life with HIV and advocate for change. At Gilead, we're focused on breaking down barriers to care.
-
Gilead Sciences
@GileadSciences
At #ias2025, we invited advocates to share the impact of community involvement in the #hiv landscape. Hear how, together, we’re helping shape the future of research and taking steps to end the epidemic.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Nearly 40% of people living with #hiv reported starting treatment more than 30 days post-diagnosis. To help bridge this gap, it’s imperative to heighten awareness of the benefits of rapid treatment initiation. Learn more about our research at #ias2025. gilead.inc/4nVbbsU
-
Gilead Sciences
@GileadSciences
At Gilead, our focus is on turning scientific innovation into real-world impact. Our recent agreement with The @GlobalFund will help expand access to our #hiv prevention medicine once approved in high-incidence, resource-limited countries. #ias2025
-
Gilead Sciences
@GileadSciences
Inclusion in #hiv research leads to better, more equitable outcomes. Yvette Raphael and Moupali Das share how they helped shape Gilead’s prevention trials by prioritizing the voices of young women and adolescent girls. #ias2025
-
Gilead Sciences
@GileadSciences
The results of our new global survey gather insights from people living with HIV – a diverse representation of multiple historically underrepresented communities. This spotlights our commitment to putting people at the center. gilead.inc/3TC9DpY #ias2025
-
Gilead Sciences
@GileadSciences
We’re proud to bring our people-first mission to #ias2025. We’re driving innovation to help end the #hiv epidemic for everyone, everywhere.
-
Gilead Sciences
@GileadSciences
#gileadnews: At #ias2025, we’re sharing new data on our long-acting HIV prevention medication, with new safety, efficacy and preference data across a broad range of populations, including pregnant and lactating women and young people. Read more: gilead.inc/4kzk5cV
-
Gilead Sciences
@GileadSciences
#gileadnews: The @WHO has released new guidelines on our long-acting #hiv prevention medication, as well as updated HIV testing protocols for long-acting HIV medications. Read more: gilead.inc/40MiDMX
-
Gilead Sciences
@GileadSciences
We’re committed to meeting the needs of people most affected by #hiv. Next week, we’ll be at #ias2025, highlighting the intentional inclusion of women in our HIV prevention trial program. Learn more about this work and about our UK Women & HIV campaign: gilead.inc/40AL4h9
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: Today, we announced an agreement with @GlobalFund to supply our long-acting #hiv prevention medication for up to two million people over three years in low- and lower-middle-income countries upon approval, at no profit to us. gilead.inc/44R1fsR
-
Gilead Sciences
@GileadSciences
As our Month of Service continued, Gilead employees sorted, prepared and distributed food at the @ACCFB, supporting its mission to end hunger in the county. We're proud to partner with organizations like this to continue making a positive impact in the communities we serve.
-
Gilead Sciences
@GileadSciences
We proudly joined the San Francisco Pride Parade last weekend, standing with the LGBTQ+ community and living our values of inclusion and respect. We showed up, we marched, we celebrated — and we’ll keep the spirit alive all year long. #gileadlife
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Proud to be named a leader in TIME100’s Most Influential Companies of 2025 — a recognition of our global work. From advancing innovative medicines to expanding access to our therapies, we’re committed to creating a healthier world for all. gilead.inc/3Gh40u7 #gileadlife
-
Gilead Sciences
@GileadSciences
Welcomed by @aids_memorial's CEO John Cunningham, Gilead employees rolled up their sleeves and got to work in San Francisco. The volunteer effort was part of our Month of Service, and it reflects our enduring commitment to communities affected by #hiv and AIDS.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
We're engineering a new era of innovation. As part of our $32 billion investment, we’re harnessing AI and automation to transform how medicines are discovered, manufactured and delivered. Read about our new standard for infrastructure and speed in @Axios: gilead.inc/4k8O5Mn
-
Gilead Sciences
@GileadSciences
At Gilead, we're focused on delivering transformative therapies in #hiv and pushing the boundaries of scientific innovation in our mission to help end the epidemic. Here's what it takes.
-
Gilead Sciences
@GileadSciences
We’ve been working to advance #hiv innovation for decades, and we’re committed to creating options that help address the diverse needs and preferences of people who need or want PrEP. Hear the perspectives from three HIV advocates on the value of HIV prevention.
-
Gilead Sciences
@GileadSciences
Since our researchers developed the first single-dose, daily HIV tablet in 2006, Gilead has been at the forefront of helping transform #hiv from a serious disease to one that can be effectively treated and prevented. Read more about our work: gilead.inc/4k2R60G.
-
Gilead Sciences
@GileadSciences
#gileadnews: In an open letter, Chairman and Chief Executive Officer Daniel O’Day discusses our just-approved #hiv prevention medication and its role in our fight to help end the epidemic: gilead.inc/3TuzsrI
-
Gilead Sciences
@GileadSciences
Congratulations to Gilead’s Tomas Cihlar who received the 2025 Warren Alpert Foundation Prize for his scientific leadership in the development of a novel HIV medication that has the potential to change the landscape in HIV prevention and treatment.
-
Gilead Sciences
@GileadSciences
Juneteenth, which commemorates the emancipation of the United States’ last enslaved African Americans, is a critical moment in our country’s history. As we honor this important day, Gilead’s Tashica Amirgholizadeh shares what the holiday means to her. #juneteenth
-
Gilead Sciences
@GileadSciences
#inthenews: Earlier today, we received FDA approval for our #hiv prevention medication. Read more on this milestone moment in our mission to help end the HIV epidemic: gilead.inc/4eaEiUO
-
Gilead Sciences
@GileadSciences
#inthenews: In light of our recent #hiv announcement, hear how community advocates feel about the importance of prevention.
-
Gilead Sciences
@GileadSciences
#gileadnews: The FDA has approved our injectable HIV-1 prevention medication, making it the first and only twice-yearly #hiv prevention option in the U.S. This approval is helping to usher in the future of prevention as we work to help end the epidemic. gilead.inc/4e9KI6B
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
We’re excited to share that our partner @Arcellx presented new data from the pivotal Phase 2 iMMagine-1 study in relapsed/refractory multiple myeloma at #eha2025 today.
-
Gilead Sciences
@GileadSciences
More than 100 volunteers packed 1,000 backpacks for local students with @Samaritan_House during our first Month of Service event. We’re committed to making a difference in the world through our work and our employees, who make a positive impact in the communities we serve.
-
Gilead Sciences
@GileadSciences
100+ Gilead employees. 2,800 total riders. 545 miles. 1 final ride. As a longtime partner, our team rode, volunteered and cheered at @AIDSLifeCycle — supporting an incredible community and the impactful work of the San Francisco AIDS Foundation and the @LALGBTCenter.
-
Gilead Sciences
@GileadSciences
Congratulations to Gilead's Moupali Das for being awarded the @aaas Mani L. Bhaumik Breakthrough of the Year Award. This recognizes the pivotal role she played as part of the team in designing the most diverse HIV prevention studies ever conducted.
-
Gilead Sciences
@GileadSciences
On #hltsad, we honor the strength and stories of those who have lived with #hiv for decades - including Kim Canady. Our work is rooted in partnership with the communities most affected by the epidemic to help ensure everyone lives healthier lives. gilead.inc/3ZReozc
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Yesterday kicked off our annual Month of Service in Foster City. With @Samaritan_House, nearly 100 Gilead volunteers assembled 1,000 backpacks filled with supplies for K–2nd grade students in the San Mateo School District. Watch the @kron4news coverage: gilead.inc/43IOU8B
-
Gilead Sciences
@GileadSciences
What would you tell your former self living with cancer? At #asco25, two advocates left powerful voicemails to their past selves – messages of reflection, resilience and the extraordinary fight to take back possibility in the face of cancer. Hear their inspiring stories.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
At Gilead and @KitePharma, we’re applying our combined expertise and learnings to advance next-generation cancer treatments. See how we’re working together to move cell therapy beyond blood cancer to address solid tumors. gilead.inc/4dIy91P #asco25
-
Gilead Sciences
@GileadSciences
We know that inclusion can drive innovation. As we mark the start of #pridemonth, Gary Ryan, a leader in our Pride Alliance employee resource group, shares how creating space for authenticity can strengthen teams and spark bold ideas. #gileadlife
This media couldn't be displayed. See it on the original post. -
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
We’re encouraged by early results of a @PennMedicine Phase 1 clinical study of CAR T-cell therapy in recurrent GBM in @NatureMedicine. As the potential of CAR T expands beyond blood cancers, so does the hope for new options for patients. #asco25
-
Gilead Sciences
@GileadSciences
#gileadnews: We're presenting late-breaking Phase 3 data in first-line metastatic triple-negative breast cancer at #asco25. These results underscore our commitment to transforming how cancer is treated. Learn more: gilead.inc/4kp5dhS
-
Gilead Sciences
@GileadSciences
We’ve built our oncology pipeline to address challenging-to-treat conditions and bring more hope to people with cancer. We’re excited to be at #asco25 with @KitePharma to showcase our bold approach to innovation and our work to reach patients earlier in their treatment journey.
-
Gilead Sciences
@GileadSciences
With the launch of #cartvision, we’re deepening our commitment to advancing cell therapy alongside @KitePharma by joining an international coalition to expand access to these innovative treatments.
Kite, a Gilead Company
@KitePharma
Today, we proudly join an international, multi-stakeholder coalition to launch #cartvision, which aims to double the number of eligible patients treated with CAR T-cell therapy by 2030. www.cartvision.com
-
Gilead Sciences
@GileadSciences
From new discoveries to reclaiming hope, we're driven by a collective goal - helping to bring more lite to people living with cancer. Ahead of #asco25, watch Gilead and @KitePharma leaders share what that
means to them.This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
At Gilead, we’re advancing new ways to help end the #hiv epidemic. In this episode of The Centrifuge Sessions, Magdeleine Hung, Director of Protein Therapeutics, shares insights on our pioneering work in HIV.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: We’re announcing topline results from our Phase 3 ASCENT-03 study in metastatic triple-negative breast cancer. This is a major milestone in the treatment of this aggressive and difficult-to-treat cancer, where progress has long been limited. gilead.inc/4kq3Xuy
-
Gilead Sciences
@GileadSciences
When Emma was diagnosed with #tnbc, she didn't let it define her. There are so many ways cancer steals possibility, but at Gilead, we’re helping take it back. We’ll continue working to transform how cancer is treated — and we look forward to sharing our research at #asco25.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
We’re more than halfway to our goal to deliver 10+ transformative medicines in cancer, HIV, COVID-19 and liver disease by 2030. We’ll continue to help drive progress through pioneering internal discovery and development efforts.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
We’re proud to share that “The Adventure Jar,” a children’s book supporting families impacted by #mbc, has received two 2025 Bronze Anvil Awards from @PRSA. Get a free copy: gilead.inc/4iZNRqd #anvilawards
-
Gilead Sciences
@GileadSciences
#gileadnews: With @KitePharma, we’re announcing the presentation of transformative cancer research at #asco25 and #eha2025. Read more: gilead.inc/3GQyiEa
-
Gilead Sciences
@GileadSciences
At Gilead, we’ve spent decades focusing on #hiv and pushing the boundaries of scientific innovation. The story of HIV prevention is one of persistence, progress and possibility – and we won’t stop until we reach our ultimate goal of ending the epidemic.
-
Gilead Sciences
@GileadSciences
For more than 35 years, Gilead has been at the forefront of tackling some of the world’s greatest public health challenges. We’re committed to delivering innovative therapies and working to improve the lives of patients around the world. #gileadlife
-
Gilead Sciences
@GileadSciences
Living with primary biliary cholangitis (PBC) can be an isolating experience due to often-invisible symptoms of the chronic liver disease. A new campaign launched by Gilead in partnership with @PBCFoundation and @FriendsofPBC is building awareness. gilead.inc/3GEKKqu #easl
-
Gilead Sciences
@GileadSciences
Today at @NYTimes Well Festival, leaders in health, science & policy gathered to share essential health news & guidance and to explore what it means to live healthier lives. The inaugural event included a panel led by Gilead’s Jared Baeten on the next chapter in HIV prevention.
-
Gilead Sciences
@GileadSciences
Where medicines are made matters. Gilead’s U.S. investments in R&D and manufacturing over the next five years will create approximately $43 billion in value to the U.S. economy through direct capital and jobs creation. gilead.inc/4jJEeND
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: We’re sharing our latest data from studies looking at investigational finite treatment options for adults with chronic hepatitis D at #easlcongress. This reflects our commitment to transform the lives of people with liver disease. Read more: gilead.inc/3Z4dNKc
-
Gilead Sciences
@GileadSciences
#gileadnews: We’re presenting new ASSURE data at #easlcongress that show results for people with primary biliary cholangitis (PBC) who had prior use of existing therapies. Read more: gilead.inc/43hE0Yd
-
Gilead Sciences
@GileadSciences
This weekend, we commemorated the opening of the Bay Area Young Survivors (BAYS) Breast Cancer Memorial Garden in Golden Gate Park — a place to honor the lives taken by #mbc. We’re dedicated to supporting BAYS and creating new possibilities for those living with cancer.
-
Gilead Sciences
@GileadSciences
Meet Gaurang Patel: Inspired by his scientist family, he's tackling advancing CAR T-cell therapy manufacturing innovation at @KitePharma to bring life-changing treatments to patients. We are proud to highlight his journey this #aanhpiheritagemonth.
-
Gilead Sciences
@GileadSciences
#gileadnews: We’ll share the latest data from our liver disease portfolio at #easlcongress, providing new insights for people with liver disease. Read more: gilead.inc/4jvY66N
-
Gilead Sciences
@GileadSciences
We’re helping transform what’s possible in #hiv treatment and prevention. We’re unwavering in our commitment to improving the lives of people worldwide and continuing our work to help end the HIV epidemic for everyone, everywhere.
-
Gilead Sciences
@GileadSciences
#gileadnews: Today we released our first quarter financial results. Our base business grew by 4% year-over-year, and our diverse pipeline continues to deliver across HIV, oncology and inflammation. gilead.inc/4m0nsLU #earnings
-
Gilead Sciences
@GileadSciences
We’re excited to join @KitePharma at #aacr25 to discuss how we’re transforming the way cancer is treated. Watch as leaders, Jackson Egen and Priti Hegde, share how we’re leveraging research across solid tumors and hematological malignancies to address the greatest gaps in care.
-
Gilead Sciences
@GileadSciences
At Gilead, we innovate for impact, which helps us drive scientific solutions forward, reach more people in more places and protect the planet we all share. Read our 2024 Responsible Business and Impact Report to see how we’re driving change. gilead.inc/3Eu4JHC #gileadlife
-
Gilead Sciences
@GileadSciences
Creating a healthier world for all starts with taking care of the one we all share. As one of America's Greenest Companies, we're always working to ensure our medicines are delivered in ways that safeguard the planet. #earthday
-
Gilead Sciences
@GileadSciences
We’re sharing topline results from our Phase 3 ASCENT-04 study for people living with metastatic triple-negative breast cancer. For individuals with #tnbc, these results potentially offer a new pathway that may redefine their treatment options. Read more: gilead.inc/42KdhSV
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
For #ecam2025, we’re joining @ECActionNetwork in their efforts to light up the sky in periwinkle for #esophagealcancer awareness. Our ribbon is a visible reflection of our commitment to advancing scientific innovation for people living with cancer. #periwinklepowerday2025
-
Gilead Sciences
@GileadSciences
Congratulations to Tomas Cihlar, Senior Vice President of Research, Virology, for being named to TIME's list of the 100 Most Influential People in the World. This honors nearly 20 years of #hiv research and development and the progress in helping end the epidemic. #time100
-
Gilead Sciences
@GileadSciences
At #bhps2025, we joined health leaders and advocates to discuss the future of HIV prevention and to drive meaningful action. By working with the communities most affected, we aim to ensure everyone receives the care and services they need to help end the #hiv epidemic.
-
Gilead Sciences
@GileadSciences
At Gilead, we set and achieve bold ambitions in our fight against the world’s most devastating diseases. See Phan, Vice President, Oncology Clinical Development, discusses how Gilead is working to deliver innovative therapies that offer new hope for patients.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
For the last 15 years, an online mapping tool called AIDSVu has helped communities better understand what #hiv looks like across the U.S. Watch to learn how it can help us get closer to our goal of ending the epidemic. gilead.inc/3GgOTjS
-
Gilead Sciences
@GileadSciences
We're focused on driving innovation in three therapeutic areas, and that includes investing in world-class science to change the way cancer is treated. Hear from @KitePharma's Samuel Haile on how we're working to deliver cell therapies that offer new hope for patients.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
We just marked a milestone in the construction of our state-of-the-art Research Center, which will help advance the most diverse pipeline in Gilead history. Within a year of breaking ground, we placed the last beam on the 182,000 square-foot-building. #milestonemoment #gileadlife
-
Gilead Sciences
@GileadSciences
Physician Anchalee Avihingsanon has spent nearly two decades treating people with both #hiv and hepatitis B. Read about her work to meet the unique needs associated with coinfections: gilead.inc/4kPB2ks #croi2025
-
Gilead Sciences
@GileadSciences
#gileadnews: At #croi2025, we’re presenting research data from across our innovative #hiv pipeline and treatment portfolio. Learn how we’re working to help end the epidemic through continuous scientific discovery: gilead.inc/3XMgvmZ
-
Gilead Sciences
@GileadSciences
#gileadnews: Today at #croi2025, we announced initial data about our investigational once-yearly medication for HIV prevention. This is part of our mission to continue to innovate new person-centered #hiv prevention options. Learn more: gilead.inc/3FlRjNP
-
Gilead Sciences
@GileadSciences
On #internationalwomensday, we’re celebrating the women at Gilead and @KitePharma who drive our work and advance our mission. Together, we’re building workplaces where everyone can make an impact, because that can help lead to a healthier world for all.
#accelerateaction -
Gilead Sciences
@GileadSciences
#croi2025 is right in our backyard - in a city that has played a major role in the decades-long efforts to help end the #hiv epidemic. We’ll be in San Francisco to collaborate with the scientific community and share new data from across our innovative HIV portfolio and pipeline.
-
Gilead Sciences
@GileadSciences
At Gilead, putting people first is central to all we do. That’s why we’re proud to be recognized by patient groups who work with us as “best” at ESG in a new report from UK-based PatientView.
-
Gilead Sciences
@GileadSciences
Gilead’s Research Scholars Program supports investigators around the world as they help transform scientific understanding, address knowledge gaps and drive medical breakthroughs. Watch the video to hear from three scholars working to advance cancer care: gilead.inc/4kCE1wK
-
Gilead Sciences
@GileadSciences
In recognition of #womenshistorymonth, our Identity + Innovation spotlight features Devi SenGupta. Hear how Devi's background has shaped her approach to developing new medicines and to bringing Gilead closer to a cure for HIV. #gileadlife
This media couldn't be displayed. See it on the original post. -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Triple-negative breast cancer (TNBC), which accounts for 10-15% of all breast cancer diagnoses, often comes with uncertainty. On #tnbcday, Lauren reminds us that there's hope, even in the hardest moments. See her story and others like hers: gilead.inc/3XnBuMC
-
Gilead Sciences
@GileadSciences
#gileadnews: Our Marketing Authorization Application and EU-Medicines for all application for our investigational #hiv prevention medicine have been validated by the European Medicines Agency. Read more: gilead.inc/3EOrgyL
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, the European Commission granted conditional marketing authorization for a new treatment for adults with primary biliary cholangitis (PBC). This provides an important new treatment option for people living with PBC in Europe. Read more: gilead.inc/4hJY8as
-
Gilead Sciences
@GileadSciences
“Anyone with lungs can have lung cancer. It’s time to remove the blame.”
Learn how the lessons of the HIV epidemic are being applied to help people living with lung cancer reduce the stigma they often face. gilead.inc/3EOhb4I -
Gilead Sciences
@GileadSciences
#gileadnews: The U.S. FDA has accepted the New Drug Applications for our investigational medicine for #hiv prevention. If approved, this medicine would be a first-in-class long-acting option for prevention. Read more: gilead.inc/4k5aew9
-
Gilead Sciences
@GileadSciences
Take a spin through Gilead’s latest in science and innovation in our new series, The Centrifuge Sessions. Today we speak with Barry Crittenden, Executive Director of Clinical Development, about making an impact in PBC, a rare autoimmune disease that affects the liver.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
We’ve been recognized by @Forbes as one of America's Best Large Employers 2025. We’re proud to foster a culture where employees are valued and empowered to make a positive impact on the communities we serve.
-
Gilead Sciences
@GileadSciences
#gileadnews: Today we released our fourth quarter and full year financial results. Our strong results underscore the positive momentum that we’re carrying into 2025: gilead.inc/42Skz8H #earnings
-
Gilead Sciences
@GileadSciences
We’re proud to once again be ranked in the top five of #americasmostjust companies in biopharma. The honor reflects our ongoing commitment to operate responsibly and empower our employees to help create a healthier world for all. #gileadforgood
-
Gilead Sciences
@GileadSciences
One of Gilead’s #hiv therapies is featured in Breakthrough, The Quest for Life-Changing Medicines – a newly released book that looks at medications that significantly impact patients around the world. Read more: gilead.inc/3Q2VMqX
-
Gilead Sciences
@GileadSciences
Cancer is never just a diagnosis. It’s a story defined by unique challenges, milestones and triumphs. This #worldcancerday, we’re reaffirming our commitment to help change the way cancer is treated by seeing the person behind the diagnosis. #unitedbyunique
-
Gilead Sciences
@GileadSciences
We believe our people are our greatest asset, and we’re launching a new series to spotlight some of them. This #blackhistorymonth, we’re highlighting Tashica Amirgholizadeh, whose unique journey to patent law led to her making a meaningful impact at Gilead. #gileadlife
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
It’s a wrap on #jpm25. Gilead leaders were in San Francisco, where they discussed the potential of our long-acting #hiv medication for prevention, the diversity of our portfolio, our work to deliver cutting-edge approaches across multiple diseases, and industry insights.
-
Gilead Sciences
@GileadSciences
At #jpm25, Chairman and Chief Executive Officer Daniel O'Day shared the progress we’ve made and how we’re beginning the year from a strong vantage point.
-
Gilead Sciences
@GileadSciences
We've received a 100% rating in the Human Rights Campaign Foundation’s Corporate Equality Index for the 8th year in a row. This reflects our commitment to fostering a diverse workforce and inclusive culture where everyone can bring their whole selves to work. #cei2025
-
Gilead Sciences
@GileadSciences
This has been a year of transformative progress and meaningful impact at Gilead. As 2024 comes to a close, we’re looking back on some of our exciting milestones and looking forward to helping make the world a healthier place for all people in 2025. #gileadlife
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
For the fourth year, we’ve been named to the Dow Jones Sustainability World Index as one of the most sustainable pharmaceutical companies, reflecting our commitment to environmental, social and governance (ESG) transparency. Read more: gilead.inc/3ZLVGIO
-
Gilead Sciences
@GileadSciences
#inthenews: The Global Fund and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) today announced a coordinated effort to provide affordable and equitable access to our investigational twice-yearly medication for #hiv prevention, if approved. gilead.inc/3DeZP00
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, the U.S. FDA granted Breakthrough Therapy Designation for our potential treatment for certain people with previously treated extensive-stage small cell #lungcancer. Read more: gilead.inc/3ZXMfHu
-
Gilead Sciences
@GileadSciences
Our culture of inclusion and diversity fuels innovation and allows us to connect with and uplift the communities we serve around the world. We’re honored that this commitment, which begins with our Board of Directors, has been recognized with a 2024 DE&I Award from the @NACD.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
At #sabcs24, we sparked a conversation about supportive care for those diagnosed with metastatic breast cancer. We left inspired to continue efforts to help create a healthier world where people living with cancer receive the support they deserve from diagnosis and beyond.
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, we received a positive opinion from the #chmp for a novel treatment for adults with #primarybiliarycholangitis. This is an important step in providing another treatment option for people living with PBC in Europe. Read more: gilead.inc/3OVyDG8
-
Gilead Sciences
@GileadSciences
We’re pleased to announce that Dietmar Berger has been named our new Chief Medical Officer. An internist, hematologist and oncologist with more than 25 years of experience in developing and delivering innovative medicines, he’ll assume his role on Jan. 2. gilead.inc/3ZPVjxN
-
Gilead Sciences
@GileadSciences
Our investigational medication for #hiv prevention was named the 2024 Breakthrough of the Year, an annual honor Science gives to important developments. This recognition underscores the importance of our groundbreaking research and our commitment to help end the HIV epidemic.
-
Gilead Sciences
@GileadSciences
People in migrant populations face legal, social and economic barriers to accessing HIV prevention and care. We’re announcing a $5+ million commitment with Charities Aid Foundation (@Caf) to help drive community-led solutions. gilead.inc/3Vl07bN #gileadforgood
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
Proud to share our latest data at #ash24, highlighting the impact of CAR T-cell therapy. Every data point represents a story of resilience and hope, driving us to keep innovating for people with blood cancers worldwide.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Shannon Hader is an author of a new report commissioned by Gilead that outlines strategies every nation must take to help end the #hiv epidemic. In recognition of #worldaidsday, learn about the four key areas countries need to focus on for success. gilead.inc/4dnAoG9
-
Gilead Sciences
@GileadSciences
For more than three decades, we’ve worked with community and research partners to help advance HIV treatment and prevention. This #worldaidsday, we honor those whose lives have been impacted by HIV and affirm our commitment to work together to help end the epidemic.
-
Gilead Sciences
@GileadSciences
#gileadnews: Today, we’re proud to announce that @NEJM has published the full results of our second Phase 3 clinical trial of our investigational medication for #hiv prevention. Read more: gilead.inc/49cVAOk
-
Gilead Sciences
@GileadSciences
Gilead has been at the forefront of the work to help end the #hiv epidemic for years. Watch here to see how: gilead.inc/3CKbDHr #worldaidsday
-
Gilead Sciences
@GileadSciences
As #worldaidsday approaches, we're reflecting on making progress together in #hiv. Last week, 140+ community leaders from 35+ countries gathered in Amsterdam to share best practices and connect on strategies to drive meaningful change in HIV. #makingprogresstogether
-
Gilead Sciences
@GileadSciences
In anticipation of #worldaidsday, Gilead Canada partnered with @CANFAR to raise awareness of #hiv, promote community action and break two Guinness World Records (@GWR). Together they made 11,000 ribbons and created the largest ever HIV awareness ribbon mosaic.
-
Gilead Sciences
@GileadSciences
Since 2008, Gilead's Research Scholars Program has supported early-career investigators to advance scientific knowledge in areas of unmet need. With the program's expansion to #primarybiliarycholangitis, there's opportunity to foster the next generation of PBC research. #tlm24
-
Gilead Sciences
@GileadSciences
#gileadnews: Interim Phase 3 ASSURE study results show key efficacy and safety outcomes for people with #primarybiliarycholangitis (PBC). Read more about the #tlm24 late-breaker here: gilead.inc/3YNMP8J
-
Gilead Sciences
@GileadSciences
Congratulations to Deborah Telman, EVP, Corporate Affairs and General Counsel. She has again been named to PRWeek’s Health Influencer 30 list for her continued commitment to health equity and for her support of work that benefits communities impacted by HIV and other diseases.
-
Gilead Sciences
@GileadSciences
#gileadnews: Data from our second Phase 3 clinical trial of our investigational preventative medication for #hiv were presented at #hivglasgow and will be published in @NEJM. We’re hopeful about what this potential medication could mean for HIV prevention. gilead.inc/4eyGdRw
-
Gilead Sciences
@GileadSciences
#gileadnews: Research data presented at #hivglasgow2024 across our HIV treatment portfolio and pipeline reflect a focus to #putpeoplefirst. Learn more about our efforts to help end the epidemic through scientific innovation: gilead.inc/3CxTNXW
-
Gilead Sciences
@GileadSciences
Veterans bring leadership and dedication to Gilead’s mission, helping to create a healthier world for all. Their unique experiences strengthen us at every level, and we’ll continue to proudly support and uplift those who served our country today and every day. #veteransday
-
Gilead Sciences
@GileadSciences
Gilead’s Moupali Das leads one of the most comprehensive and diverse clinical trial programs for an investigational #hiv prevention medication. Read why the trial prioritized women and girls and how it could help end the HIV epidemic. gilead.inc/3CfhBjt #hivglasgow2024
-
Gilead Sciences
@GileadSciences
#gileadnews: At #hivglasgow2024, we’ll share data from our research and development programs in HIV treatment and prevention, extending our leadership efforts toward ending the epidemic. gilead.inc/48G6Oeb
-
Gilead Sciences
@GileadSciences
#gileadnews: Today we shared our Q3 financial results. Learn more here: gilead.inc/3Yz7RIh #earnings
-
Gilead Sciences
@GileadSciences
Strengthening primary healthcare systems to improve education, screening and diagnosis is vital as we aim to help eliminate viral hepatitis. This is why we partner with local health facilities to reach those who would benefit. #liverawarenessmonth
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
We're prioritizing health equity for patients across the cancer care continuum. Our Gilead Oncology Grant supports 22 U.S. organizations with $3.15 million to provide resources for people affected by breast cancer. Learn more here: gilead.inc/3NM4Vmo
#gileadforgood -
Gilead Sciences
@GileadSciences
#gileadnews: We’ll share the latest data from our liver disease portfolio at #tlm24, underlining our commitment to improving the lives of people with liver disease and driving breakthroughs in treatment. Read more: gilead.inc/3BXYsT2
-
Gilead Sciences
@GileadSciences
#gileadnews: We're presenting our latest HIV treatment research data evaluating an investigational long-acting option at #idweek2024 in collaboration with @Merck. This highlights our commitment to help meet the diverse needs of people affected by HIV. gilead.inc/4dVDSQq
-
Gilead Sciences
@GileadSciences
Gilead collaborated with patient advocates to create "The Adventure Jar," a children's book supporting families facing metastatic #breastcancer. Discover how this resource helps the whole family navigate a cancer diagnosis. gilead.inc/484prs1
-
Gilead Sciences
@GileadSciences
Harm reduction services are crucial to reach people and communities most adversely affected by #hiv and #viralhepatitis. We're collaborating with stakeholders at #inhsu2024 to address the disparities impacting those who use drugs and support local health systems globally.
-
Gilead Sciences
@GileadSciences
#gileadnews: We’re presenting data from our antiviral portfolio and research pipeline at #idweek2024. This reflects our commitment to help address the evolving needs of people and communities affected by some of the most challenging viruses. gilead.inc/4eA24IZ
-
Gilead Sciences
@GileadSciences
#gileadnews: At #hivr4p2024 we announced data from our second Phase 3 clinical trial of our investigational medication for #hiv prevention. Results highlight the potential for the medication, if approved, among cisgender men and gender-diverse individuals. gilead.inc/47Xsty4
-
Gilead Sciences
@GileadSciences
#gileadnews: We’re donating our antiviral therapy to Rwanda for emergency use. The current #marburg outbreak there is one of the largest in history, and this donation continues our legacy of responding to devastating health crises around the world. gilead.inc/3BvPLio
-
Gilead Sciences
@GileadSciences
#gileadnews: We’ve signed non-exclusive, royalty-free voluntary licensing agreements to enable access to our investigational medication for #hiv prevention across 120 high-incidence, resource-limited countries, if approved. Learn more: gilead.inc/3Bw8AlB
-
Gilead Sciences
@GileadSciences
For more than 35 years, we’ve translated cutting-edge science into innovative solutions, advanced our commitment to achieve health equity and delivered life-changing medicines to people all over the world. Explore the newly redesigned website: www.gilead.com #gileadlife
-
Gilead Sciences
@GileadSciences
Authors of a new report, commissioned by Gilead, found that there are treatment and tools available to help end the HIV epidemic, but every country in the world – no matter rich or poor – has much more to do to make it happen. Learn why. gilead.inc/4dnAoG9
-
Gilead Sciences
@GileadSciences
During Gilead’s recent Science Day, we caught up with a few of our talented and passionate researchers. Get to know some of the people responsible for turning cutting-edge science into life-changing medicines for people around the world. #passthephonechallenge
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
We’re proud to have signed the Hispanic promise, reaffirming our commitment to the Hispanic community. This pledge is embedded in our talent development, recruitment practices and supplier diversity, helping us drive forward innovation. #hispanicheritagemonth
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
We're part of a greater ecosystem working to advance care for those in need, like Jaymie and Emma. #esmo24 is a pivotal moment for the global oncology community to accelerate research and reclaim possibilities in the face of cancer.
-
Gilead Sciences
@GileadSciences
Patients are at the heart of everything we do – and we’re focused on developing and delivering innovative therapies across virology, oncology and inflammatory diseases. Today for our annual Science Day, learn why our researchers are passionate about the work they do. #gileadlife
-
Gilead Sciences
@GileadSciences
#gileadnews: We’ve announced topline results from an interim analysis of our second Phase 3 clinical trial of our investigational medication for #hiv prevention. This continues to confirm the medication’s potential to help those who need or want PrEP. gilead.inc/3ZlTXLl
-
Gilead Sciences
@GileadSciences
Our dedication to driving innovation thrives because we foster a culture of inclusion and growth. Jyoti Mehra, Executive Vice President, Human Resources, shares how we’re investing in our people across the globe. gilead.inc/esg
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: Today, we've shared news about a strategic collaboration with Genesis Therapeutics, Inc. to discover and develop novel, small molecule therapies across multiple targets. Read more: gilead.inc/4dS9ya2
-
Gilead Sciences
@GileadSciences
Living with #primarybiliarycholangitis (PBC) can be challenging. As part of our work to address unmet needs, we’re providing resources and support that can help people navigating life with this disease.
Watch the video to learn more about PBC. #pbcday2024This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: We’re sharing research from our #lungcancer clinical development program at #wclc24, underscoring our commitment to improving care for people with lung cancer. Read more: gilead.inc/4ecTLSU
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
At Kite and @GileadSciences, we're dedicated to advancing research and expanding treatment options for people living with blood cancer. We’re proud to join our colleagues during #bloodcancerawarenessmonth, and all year, to raise awareness and stand with this resilient community.
-
Gilead Sciences
@GileadSciences
Six years ago, registered nurse Maria Morais was diagnosed with a rare autoimmune liver disease called primary biliary cholangitis (PBC). Here, she describes how her journey transformed her into a patient advocate and peer counselor for others living with rare liver disease.
-
Gilead Sciences
@GileadSciences
Gilead is one of 42 organizations recognized as a Leading Inclusion Index Company. We know creating a healthier world starts with embracing diversity and valuing every voice, and our inclusive policies and practices reflect this commitment. #seramountinclusionindex #gileadlife
-
Gilead Sciences
@GileadSciences
“The Adventure Jar” extends on our commitment to provide resources and support for families impacted by #mbc.
Gilead Oncology
@GileadOncology
Cancer can disrupt life for the whole family. “The Adventure Jar” was created with the metastatic breast cancer community to showcase the perspective of one family navigating the challenges of a diagnosis, while finding magic in time together. gilead.inc/3WPCtEl
-
Gilead Sciences
@GileadSciences
Transformative medicines have the greatest impact when they reach those who need them most. Johanna Mercier, Chief Commercial Officer, shares how Gilead works to remove barriers to care, improve health equity and increase access to life-changing therapies. #gileadforgood
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: The U.S. FDA granted accelerated approval for a new treatment for adults with primary biliary cholangitis (PBC). The treatment demonstrated significant and durable improvements in both liver disease markers and pruritus (chronic itchy skin). gilead.inc/4e1wN1h
-
Gilead Sciences
@GileadSciences
#gileadnews: Read the press release to learn more about our financial results from last quarter. gilead.inc/46GkIvL
-
Gilead Sciences
@GileadSciences
Summer Sitima, Gilead’s Commercial Operations Lead for South Africa, was motivated to pursue a medical career after losing her sister to HIV.
Read how she’s helping to reach young people in greatest risk and need in her region of the world. -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Instead of focusing on the challenges, Jaymie’s stage 4 lung cancer diagnosis inspired her to do things she had never done before. Her diagnosis was not the end of her story – only a new chapter. #worldlungcancerday
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
We're sponsoring the 30th anniversary of Until There’s A Cure® Night with the @SFGiants and @UntilOrg to raise awareness of HIV/AIDS in the Bay Area and beyond. Together, we can help end the epidemic.
SFGiants
@SFGiants
On July 31, 1994, the #sfgiants became the first-ever professional sports team to host an HIV/AIDS awareness game.
Tonight marks the 30th anniversary of "Until There's A Cure Night," a game dedicated to remembering those we've lost, committing to raising funds and leading in the fight for a cure.
@GileadSciences | @UntilOrg -
Gilead Sciences
@GileadSciences
For the third year in a row, we’ve been recognized as one of @Forbes #bestemployersforwomen. Women at Gilead are vital to our success — driving innovation and helping us further our mission to create a healthier world for all people.
-
Gilead Sciences
@GileadSciences
For nearly 240,000 Ukrainians living with HIV, the ongoing conflict has caused disruption to healthcare services resulting in limited access to testing and treatment. Community leaders Anastasia and Olga are working to provide HIV care with RADIAN support.
-
Gilead Sciences
@GileadSciences
This #worldhepatitisday, we’re committed to raising awareness on the importance of testing and early access to treatment. Together, with organizations like the @Hep_Alliance, we aim to help eliminate viral hepatitis as a public health threat by 2030.
-
Gilead Sciences
@GileadSciences
#primarybiliarycholangitis (PBC) is a rare, chronic autoimmune disease that damages the liver’s bile ducts. We’re committed to advancing transformative care for people with PBC.
-
Gilead Sciences
@GileadSciences
Early diagnosis is essential to combating the #hiv epidemic, which is why Gilead partners with numerous organizations around the world to help ensure people are being tested and treated, especially in resource-limited areas. Learn about one such project, in Germany.
#aids2024 -
Gilead Sciences
@GileadSciences
#gileadnews: Research data presented at #aids2024 across our broad and innovative HIV treatment portfolio and pipeline reflect a focus to #putpeoplefirst. Learn more about our efforts to help end the epidemic through scientific innovation: gilead.inc/4c13OJc
-
Gilead Sciences
@GileadSciences
Our person-centric approach in HIV research prioritizes long-term studies and real-world evidence and considers the intersection of efficacy, adherence and resistance in #hiv treatment. Watch to learn more.
#aids2024 | #putpeoplefirstThis media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: At #aids2024, we’re presenting the latest data from the PURPOSE 1 trial for our investigational medication for HIV prevention.
Learn more about our efforts as we move closer to ending the HIV epidemic: gilead.inc/4dclWB5 -
Gilead Sciences
@GileadSciences
Today, we’re announcing a further five-year $25 million commitment to RADIAN to address the HIV crisis in Eastern Europe and Central Asia. Together, we can help end the epidemic. gilead.inc/46hVHqo
@ejafThis media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
With HIV diagnosis rates at approximately 90%, HIV experts in Germany united through a Gilead initiative to bridge the final gap. Watch the full video: gilead.inc/3We4oh5
#aids2024 | #putpeoplefirst -
Gilead Sciences
@GileadSciences
Jared Baeten, SVP, Clinical Development, Virology, discusses the global response to the HIV epidemic with @newscientist, spotlighting the vital role of collaboration in driving scientific innovation and advancing health equity. gilead.inc/4f5UOp4
#aids2024 | #putpeoplefirst -
Gilead Sciences
@GileadSciences
For the fifth year, we’re on the @Seramount 100 Best Companies list for our inclusive workplace and culture. Investing in our people can inspire a healthier and happier workforce that drives collaboration and impact. #seramount100best
-
Gilead Sciences
@GileadSciences
#gileadnews: Read our announcement here. gilead.inc/3xRRpto
-
Gilead Sciences
@GileadSciences
#gileadnews: We’ll share data from our research and development programs and collaborations at #aids2024, underscoring our commitment to a person-centered approach to help advance progress toward ending the HIV epidemic. gilead.inc/3W4HGrE
-
Gilead Sciences
@GileadSciences
Last month marked Gilead's Month of Service, when employees around the world celebrated the power of giving back to local communities by providing meals, restoring habitats, assembling care packages and making other meaningful contributions.
-
Gilead Sciences
@GileadSciences
Gilead and @KitePharma received International and Regional Awards from the Association of Energy Engineers for outstanding contributions to the field of energy and sustainability. Our passion for creating a healthier world drives us to be responsible corporate citizens.
-
Gilead Sciences
@GileadSciences
Last week, Gilead executives joined other world leaders, CEOs, entrepreneurs and change agents at the 2024 @GBEF_ Business Summit at @essencefest to discuss the impact Gilead’s diverse Board has on communities with the greatest unmet needs.
-
Gilead Sciences
@GileadSciences
During #pridemonth, Gilead and @KitePharma employees, families and friends proudly participated in the @SFPride and WeHo Pride parades to celebrate the LGBTQ+ community, embodying our theme of “live, love, liberate” -- an anthem of equality and inclusion for all.
-
Gilead Sciences
@GileadSciences
This #nhtd, we’re working with community partners to address systemic barriers and expand access to #hiv testing to ensure it’s more accessible.
-
Gilead Sciences
@GileadSciences
The Gilead Foundation is announcing a funding opportunity through its new Healthcare Education, Access and Leadership (HEAL) initiative focused on developing a healthcare workforce that reflects the patient populations.
Learn more and apply: gilead.inc/3VyuxGY -
Gilead Sciences
@GileadSciences
#gileadnews: Yesterday, we shared results of a study on an investigational medication for #hiv prevention. Now, we’re announcing our approach to ensure access to that medication, if approved, in countries that represent the highest HIV burden in the world. gilead.inc/3VTChF5
-
Gilead Sciences
@GileadSciences
Gilead and @KitePharma employees hopped on their bikes to take part in #aidslifecycle. This 545-mile fundraising trek from the California coast to Los Angeles helps raise AIDS awareness and supports organizations providing HIV/AIDS medical care, testing and prevention services.
-
Gilead Sciences
@GileadSciences
#gileadnews: Today we announced topline results of an interim analysis from the most comprehensive and diverse #hiv prevention trial program ever conducted. This study builds on our commitment to help serve the needs of people who need or want PrEP. gilead.inc/3XzahaO
-
Gilead Sciences
@GileadSciences
Remi Murphy, a member of the Gilead Leadership Organization of Black Employees (GLOBE) Employee Resource Group, shares what #juneteenth means to her and the significance of Gilead’s annual flag raising. Hear her perspective about a day that symbolizes hope and progress.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
The risk of developing various types of #cancer is higher in Black people than white people. We're advancing equitable access in cancer care through our Toward Health Equity Oncology Grant™ with an aim to reduce disparities. #blackfamcan
Learn more: gilead.inc/3OTUpuh -
Gilead Sciences
@GileadSciences
We must work collectively to achieve the @UNAIDS' goal to end the #hiv epidemic by 2030. The new 'Going the Extra Mile to End the HIV Epidemic' report outlines progress in nine countries and provides an essential framework to enable targeted action. gilead.inc/3xgckpz
-
Gilead Sciences
@GileadSciences
As Gilead continues our work to help transform how cancer is treated, we’re also making investments to help our employees and their families navigate a diagnosis. Read one U.S. employee’s personal story on how he benefited from a cancer support service.
-
Gilead Sciences
@GileadSciences
We’re committed to uplifting the LGBTQ+ community in the U.S. and around the world. This Saturday, we're celebrating #pridemonth with the @SFGiants.
Oracle Park
@OracleParkSF
Pride Day at Oracle Park, #nothinglikeit! Join us on Saturday, June 15th, as we celebrate Pride Day at the ballpark. The first 20,000 fans in attendance will receive a @SFGiants Pride Long Sleeve Hooded Shirt.
More info, 🔗www.mlb.com/giants/tickets/single-game-tickets?partnerId=…
(@GileadSciences x #sfgiants) -
Gilead Sciences
@GileadSciences
“You think that you have time to have all these things happen, and you don't. Your life is put on hold and your future's put on hold and who knows if you even could have kids.”
Two women share their experiences with preserving fertility following a cancer diagnosis. Read more. -
Gilead Sciences
@GileadSciences
Learn about the unmet needs of people living with #primarybiliarycholangitis (PBC) and the advances in research that aim to improve liver health and quality of life.
-
Gilead Sciences
@GileadSciences
Gilead and @KitePharma teams raised #pridemonth flags at our campuses last week symbolizing our united support for LGBTQ+ communities globally. Our commitment to inclusion and diversity is vital to our mission and will help us create a healthier world for all people.
-
Gilead Sciences
@GileadSciences
Discover the latest advances in the diagnosis and treatment of #hepatitisd, the most severe form of viral hepatitis.
#easlcongress | #hdv -
Gilead Sciences
@GileadSciences
This #pridemonth, we’re working with other leading healthcare companies and SGM Alliance to address LGBTQ+ representation in clinical studies – an effort to remove barriers to care and ensure our medicines reflect the diverse populations we serve. Read the press release.
-
Gilead Sciences
@GileadSciences
#gileadnews: New data from our clinical trial on #hepatitisd presented at #easlcongress demonstrate undetectable #hdv ribonucleic acid after end of treatment. We’re advancing our commitment to healthier futures for people living with liver disease. gilead.inc/4c93lVM
-
Gilead Sciences
@GileadSciences
This #hltsad, learn how we’re dedicated to helping improve the quality of life and health for people aging with #hiv. gilead.inc/3X9Z3cP
-
Gilead Sciences
@GileadSciences
#gileadnews: New data presented on primary biliary cholangitis demonstrate the efficacy and safety profile of our investigational treatment and our commitment to transforming the lives of those impacted by this rare disease. #easlcongress gilead.inc/3wTo1Cx
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Emma’s persistence helped her flip the script, from feeling unseen and unheard to being an empowered advocate. We’re inspired by Emma and all who speak up to take back possibility in the face of #cancer.
#nationalcancersurvivorsmonth -
Gilead Sciences
@GileadSciences
Gilead is included in this year’s Fortune 500. Here, Daniel O’Day, Chairman and CEO, discusses the recognition and how it’s a testament to our scientific innovation, extensive portfolio and commitment to bringing transformative medicines to people around the world.
-
Gilead Sciences
@GileadSciences
Supporting and uplifting our LGBTQ+ colleagues and community starts by creating a culture in which everyone can thrive. By doing this, inclusivity becomes more than a goal - it’s a driving force toward innovation. #pridemonth
-
Gilead Sciences
@GileadSciences
#gileadnews: In partnership with @ArcusBio, we’re sharing longer-term results in metastatic upper gastrointestinal cancers from the Phase 2 EDGE-Gastric study at #asco24. gilead.inc/458v9r2
-
Gilead Sciences
@GileadSciences
#gileadnews: New update on our clinical trial in metastatic urothelial carcinoma. gilead.inc/4bJY1sj
-
Gilead Sciences
@GileadSciences
#gileadnews: We’ll share the latest data from our liver disease franchise at #easlcongress, underlining our drive for life-changing science to create healthier futures for people living with liver disease. Read more: gilead.inc/4ayTiIB
-
Gilead Sciences
@GileadSciences
#gileadnews: Gilead will share the latest data on our investigational treatment for #pbc at #ddw2024, which demonstrates improvements in markers of cholestasis, reduced inflammation and reduced pruritus. Read more: gilead.inc/4bMoViZ
-
Gilead Sciences
@GileadSciences
As we approach #heptestingday, we remain committed to increasing education and advancing community partnerships to help people with viral hepatitis get the care they need, including access to testing.
#hepatitisawarenessmonth -
Gilead Sciences
@GileadSciences
This #hepatitisawarenessmonth, we’re reinforcing the need for increased education and testing to support the @WHO's goal of eliminating viral hepatitis by 2030. Through partnerships we’ve expanded access to screening and services, supporting people most impacted by #hcv.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Living with metastatic #breastcancer is different than living with early-stage disease. Patient advocates share more about their experiences with #mbc. #esmobreast24
-
Gilead Sciences
@GileadSciences
The #bidencancermoonshot announced a series of actions organizations are taking to improve access and use of cancer screenings. We’re proud to be listed for our commitment to help increase screening rates among employees through personalized outreach. gilead.inc/4aqS42d
-
Gilead Sciences
@GileadSciences
Driven by our purpose to make the world a healthier place for all people, we’ve worked to improve health equity and advance equitable access to care. Last week, we brought together leaders, advocates and changemakers to share insights at our inaugural Global Health Equity Summit.
-
Gilead Sciences
@GileadSciences
#gileadnews: New Gilead and Kite Oncology data will showcase our ongoing commitment to developing differentiated approaches to help transform how cancer is treated. #asco24 gilead.inc/3UtJUzT
-
Gilead Sciences
@GileadSciences
We celebrate and uplift the Asian American Pacific Islander community, whose diverse traditions are woven together by the strength of the voices we amplify. Our colleagues enrich our perspectives as we continue to support the communities we serve. #aapiheritagemonth
-
Gilead Sciences
@GileadSciences
We have a decades long history addressing viral threats. Watch to learn about our research behind #covid19.
#escmidglobal2024 | #gileadinnovationspotlight -
Gilead Sciences
@GileadSciences
Today, Flavius Martin, Executive Vice President of Research, represented Gilead at the 8th Annual Stanford Drug Discovery Symposium. He showcased our innovative approach to drug discovery and shared the importance of collaborations in scientific research. #sdds2024
-
Gilead Sciences
@GileadSciences
#gileadnews: The U.S. FDA has approved an updated label for an #hiv treatment to include data on use in pregnant people with HIV who are virologically suppressed. This advances our efforts to address the needs of underrepresented communities in research. gilead.inc/3wihCQL
-
Gilead Sciences
@GileadSciences
#gileadnews: Read the press release to learn more about our financial results from last quarter. gilead.inc/3UwvGzC
-
Gilead Sciences
@GileadSciences
A Gilead grant is helping Native American women with breast cancer manage an often-complex tribal healthcare system by expanding access and removing barriers to care. Learn more about the health navigator program and how it aims to transform breast cancer care.
-
Gilead Sciences
@GileadSciences
Creating a healthier world for all people starts by protecting the health of our planet. Joydeep Ganguly, SVP of Corporate Operations, shares how we’re working across our business to reduce impact. gilead.com #earthday #gileadforgood
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
For the second year, Alex Kalomparis has been named a Top 50 Chief Communication Officer by @diversityfirst. His strategic leadership ensures we amplify the voices of the diverse communities we serve and helps advance our commitment to scientific innovation and health equity.
-
Gilead Sciences
@GileadSciences
Through innovation, growth and impact, our vision is to create a healthier world for all people. Read our 2023 ESG Impact Report and see how we’re driving positive change through every aspect of our business. www.gilead.com #gileadforgood
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Earlier this week, members of the Gilead Foundation Board were treated to a tour of @SFSU's new Science and Engineering Innovation Center. The center was made possible through a $3.5 million gift from the foundation to help advance student and faculty’s research activities.
-
Gilead Sciences
@GileadSciences
"Balance" is a word many caregivers for people with #cancer struggle to find. Laura shares her perspective and insights for those caring for both a loved one and themselves.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Creating equitable healthcare solutions is central to our work. Our Toward Health Equity grantees are working to increase representation in #clinicaltrials, from those participating to the physicians conducting them. Learn more: gilead.inc/3OTUpuh
-
Gilead Sciences
@GileadSciences
At a recent Champions of Change fireside event, we hosted meaningful conversations amongst Black women changemakers in #hiv. Kayla Quimbley shares the important role of Black women in their communities, and what prevents them from prioritizing their health and wellness.
-
Gilead Sciences
@GileadSciences
This upcoming #worldhealthday, @WHO is raising awareness for quality healthcare. At Gilead, our community partnerships help us identify barriers to care so we can expand access, address stigma and help create solutions that advance our vision of a healthier world for all people.
-
Gilead Sciences
@GileadSciences
expose-mbc.com provides real stories, like Esther's, along with a safe space for people with MBC to ask questions, share their experiences and find community and support.
Gilead Oncology
@GileadOncology
For Esther, living with metastatic #breastcancer means believing in innovations that can potentially lead to a better future. Find more real stories and helpful resources here: gilead.inc/3xd7t86
-
Gilead Sciences
@GileadSciences
We’re advancing health equity for Trans people and support organizations that do the same. Gilead grantee @BaltimoreHaven works with the Trans community to increase #hiv awareness and testing, while advocating for housing and healthcare access. gilead.inc/3PJhvo2 #tdov
-
Gilead Sciences
@GileadSciences
#gileadnews: Today we announced U.S. FDA approval for a hepatitis B treatment in children six years of age and older with compensated liver disease. This approval advances our efforts to help address unmet needs for children. gilead.inc/3TzN05a
-
Gilead Sciences
@GileadSciences
#gileadnews: Gilead and @xiliotx announce exclusive license agreement, complementing our clinical development program in difficult-to-treat cancers and expanding our focus in immuno-oncology. gilead.inc/3IXOT6G
-
Gilead Sciences
@GileadSciences
We stand firm in our commitment to the global liver community as we work together to help achieve the @WHO's goal of eliminating viral hepatitis as a public health threat by 2030.
We're sharing our latest research and knowledge at #apasl2024. -
Gilead Sciences
@GileadSciences
Gilead’s public-private partnership with the island nation of Mauritius has been transformative in helping the country deal with a surge in hepatitis C. Read more.
-
Gilead Sciences
@GileadSciences
#gileadnews: Today we officially acquired CymaBay Therapeutics, a company dedicated to developing medicines for people living with liver disease. gilead.inc/4a8VRSf
-
Gilead Sciences
@GileadSciences
Gilead’s FOCUS program is part of its efforts to support best practices in routine HIV screening in accordance with public health guidelines. Learn how the program’s model for routine screening tests and linkage to care can help remove stigma and prevent late-stage diagnoses.
-
Gilead Sciences
@GileadSciences
“I find strength in my children. I have to be here for them.”
With her children and husband by her side, LaToya finds strength to stand up to triple-negative #breastcancer and inspires others to do the same. See more stories like LaToya's on expose-mbc.com. -
Gilead Sciences
@GileadSciences
Dr. Huang, MD, Resident Physician at Taoyuan Hospital in Taiwan, was an early patient when the @WHO declared #covid19 a global pandemic. Learn how this helped him better understand patients and the role of antivirals in treatment. To watch the full video: gilead.inc/4afsyNr
-
Gilead Sciences
@GileadSciences
We believe our impact should be sustainable and enriching. Read more about @KitePharma’s focus on sustainable cell therapy manufacturing.
Kite, a Gilead Company
@KitePharma
Kite has embedded sustainability into our culture and global manufacturing operations. Our collaboration with @SustainabltyMag shares how we ensure we are having a positive impact on the communities where we live and work.
Read more: sustainabilitymag.com/magazine/sustainability-magazine-ma… -
Gilead Sciences
@GileadSciences
Women represent more than half of Gilead’s workforce, and our weighted salary ratio for women to men globally in 2023 was 99.93:100. We'll continue our efforts to champion an environment of equality and inclusion for all. #equalpayday
-
Gilead Sciences
@GileadSciences
Dale's metastatic #breastcancer diagnosis serves as a reminder that the signs and symptoms may not always be intuitive. We’re grateful to Dale and many others who inspire our work to create new possibilities for people with cancer.
-
Gilead Sciences
@GileadSciences
Healthy women are at the core of healthy communities. At Gilead, we work hard to break down barriers to promote access and equity.
#internationalwomensday | #iwd | #inspireinclusion -
Gilead Sciences
@GileadSciences
Gilead works with organizations around the globe to promote HIV prevention and treatment strategies and to remove barriers to care. We recently teamed up with organizations in Türkiye to facilitate HIV testing and help reverse the growing number of diagnoses in the country.
-
Gilead Sciences
@GileadSciences
#gileadnews: We're presenting our latest HIV treatment research at #croi2024, which includes outcomes in a diverse range of people with #hiv who also have common comorbidities. Learn more: gilead.inc/3ToZ6z1
-
Gilead Sciences
@GileadSciences
We’re presenting our latest #hiv treatment research data evaluating an investigational long-acting option at #croi2024 in collaboration with @Merck. Learn more: gilead.inc/3TnOP63
-
Gilead Sciences
@GileadSciences
#gileadnews: Today we're sharing news about a collaboration with @MerusNV to discover and develop novel trispecific antibodies in oncology. Read more: gilead.inc/437WB7G
-
Gilead Sciences
@GileadSciences
At #croi2024, we’re sharing the latest real-world data on our #covid19 antiviral, including data on #longcovid prevention. Learn more: gilead.inc/3TovbqQ
-
Gilead Sciences
@GileadSciences
#gileadnews: We’re sharing groundbreaking HIV data from our innovative #hiv treatment research pipeline at #croi2024, aiming to address unmet needs and advance public health. Learn more: gilead.inc/3V5QOND
-
Gilead Sciences
@GileadSciences
A metastatic #breastcancer diagnosis can feel isolating, but it doesn’t have to be. Explore our new hub with resources and firsthand stories to help patients and caregivers navigate the realities of life with MBC.
#tnbcday -
Gilead Sciences
@GileadSciences
This #womenshistorymonth, we celebrate the contributions of our employees and leaders who continue to drive meaningful discussions and actions that uplift women within our organization and throughout our local communities. #whm
-
Gilead Sciences
@GileadSciences
Jared Baeten, MD, PhD, Vice President, HIV Clinical Development shares his perspective on why addressing treatment resistance is an ongoing priority in our #hiv research efforts.
-
Gilead Sciences
@GileadSciences
This #hivisnotacrime Awareness Day, we’re spotlighting the @ETAForg and Lashanda Salinas – a member of their Council of Justice Leaders who is sharing her story to inspire action toward #hiv law reform across the United States. Learn more: gilead.inc/3wznk0A
-
Gilead Sciences
@GileadSciences
Gilead is proud to be a funding partner of The Robert A. Winn Diversity in Clinical Trials Award Program, designed to train early-stage investigator physicians and address the longstanding lack of diversity in clinical trials.
Learn more: gilead.inc/3uHKj9h -
Gilead Sciences
@GileadSciences
Gilead’s Setting the P.A.C.E. initiative will provide $12.6 million in grant funding to organizations working to improve the #hiv landscape for Black cisgender and Transgender women and girls in the U.S. through prevention, arts, advocacy, education and community programming.
-
Gilead Sciences
@GileadSciences
#gileadnews: The U.S. FDA has approved an expanded indication for one of our #hiv treatments to help treat people with HIV who are virologically suppressed and have a common form of HIV drug resistance. Read more: gilead.inc/4bOPBjT
-
Gilead Sciences
@GileadSciences
#gileadnews: We’re highlighting our innovative antiviral portfolio and research pipeline at #croi2024. Learn more about how Gilead researchers are propelling the next wave of person-centric biomedical innovations in virology: gilead.inc/42QeyHz
-
Gilead Sciences
@GileadSciences
We're prioritizing diverse representation in clinical trials. Our 2024 Toward Health Equity Oncology Grant supports 36 global organizations to help advance health equity and make a positive, lasting impact for people living with cancer.
Learn more: gilead.inc/3OTUpuh -
Gilead Sciences
@GileadSciences
Gilead is the second-largest biotech employer in the Bay Area and has grown considerably over the last four years. Chairman and Chief Executive Officer Daniel O’Day talks about the company’s evolution, philanthropic culture and commitment to the local community.
-
Gilead Sciences
@GileadSciences
#gileadnews: We announced today that we're acquiring @CymaBay Therapeutics, reinforcing our long-standing commitment to liver disease. Read the press release and important information: gilead.inc/48baEtP
-
Gilead Sciences
@GileadSciences
We’re proud to be on the list of #americasmostjust companies, and for being ranked #5 in our industry. We were recognized for our work helping to make the world a healthier place for all people while fulfilling our responsibilities as a good corporate citizen.
#just100 -
Gilead Sciences
@GileadSciences
This #nbhaad, we acknowledge how HIV continues to disproportionately impact the Black community.
C. Virginia Fields, President and CEO of @natlblackhealth, a Gilead grantee, shares how engagement, education and empowerment can help end the #hiv epidemic in Black communities. -
Gilead Sciences
@GileadSciences
#gileadnews: Our Q4 and Full Year 2023 Financial Results are now available. Read the press release: gilead.inc/3HNMQl9
#earnings -
Gilead Sciences
@GileadSciences
We know that there can only be true progress in scientific innovation when it's accessible to those who need it most. That's why we're working to address disparities in care for people around the world.
#worldcancerday | #closethecaregap -
Gilead Sciences
@GileadSciences
For many people living with #cancer, hearing about the experiences of others can be helpful. Dale, who is living with #breastcancer, shares her journey and point of view about how sharing information can help reduce health disparities.
#worldcancerday | #closethecaregapThis media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: Ted Love, MD, joins Gilead Sciences’ Board of Directors. gilead.inc/3UoE04A
-
Gilead Sciences
@GileadSciences
We're committed to amplifying Black voices and inspiring an inclusive culture that drives innovation. Learn more about inclusion and diversity at Gilead.
#blackhistorymonth | #bhm | #gileadlife -
Gilead Sciences
@GileadSciences
In partnership with @REvents_SustBiz, we’ve developed a white paper on how purpose-driven ESG integration can address unmet needs, ensure health equity and promote a holistic approach to healthcare.
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#kitenews: The U.S. FDA has approved a manufacturing process change resulting in a shorter manufacturing time for our #celltherapy, which is anticipated to reduce median turnaround time from 16 to 14 days in the United States.
Read more: www.kitepharma.com/news/press-releases/2024/1/kite-receiv… -
Gilead Sciences
@GileadSciences
#gileadnews: Gilead and Arcus announce amended collaboration and equity investment which provides opportunity to accelerate their anti-TIGIT program. gilead.inc/42mE1YP
-
Gilead Sciences
@GileadSciences
As Gilead marks 10 years since its curative therapies began impacting the lives of people living with hepatitis C, learn how it now has its sights on elimination by the end of the decade. gilead.inc/3UfQfAr
-
Gilead Sciences
@GileadSciences
“There are many people pushed to the margins of society where illness intertwines with social class, race, ethnicity, sexuality and poverty.”
In a recently published book, Gilead raised awareness of the stigma and marginalization often faced by people living with disease. -
Gilead Sciences
@GileadSciences
#gileadnews New update on our clinical trial in metastatic non-small cell lung cancer. www.gilead.com/news/news-details/2024/gilead-provides-upd…
-
Gilead Sciences
@GileadSciences
We continue to support initiatives to progress hepatitis D screening and path to care efforts through increased awareness and early testing of people with hepatitis B, with the aim of avoiding a delayed diagnosis for those affected.
#hbv | #hdv -
Gilead Sciences
@GileadSciences
Innovation thrives when bright and diverse minds come together. We’re proud to offer an inclusive culture that enables all people to do their best work, and we’re happy to be named one of @newsweek America’s Greatest Workplaces for Diversity. www.newsweek.com/rankings/americas-greatest-workplaces-di…
-
Gilead Sciences
@GileadSciences
People living with HIV often feel unseen, but the Dr. Peter Centre is working to change that. With Gilead's support, they're pioneering a holistic approach to #hiv treatment and care for program participants helping them to feel seen.
Learn more: gilead.inc/3zFM7iE -
Gilead Sciences
@GileadSciences
At the J.P. Morgan Healthcare Conference four years ago, we announced a bold plan to transform our company and bring 10+ transformative therapies to market by the end of 2030. This year, our team showed the world that we’re well on our way to meeting our ambitious goals. #jpm24
-
Gilead Sciences
@GileadSciences
The Gilead Foundation is inspired by the work of our inaugural Creating Possible Fund grantees. The organizations have increased social connections, fostered healthy learning environments & set students up for success in classrooms and beyond.
Learn more: gilead.inc/3pucr9Y -
Gilead Sciences
@GileadSciences
A Gilead project designed to spotlight the voices of women living with metastatic triple-negative breast cancer uses AI to convert their experiences into unique paintings. Read the story to learn about the innovative art display. #mtnbc
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Living with metastatic #breastcancer is different than living with early-stage disease. Patient advocates share more about their experiences with #mbc.
-
Gilead Sciences
@GileadSciences
At his #jpm24 presentation, Chairman and Chief Executive Officer Daniel O’Day walked through the details of our new phase of growth, including Phase 3 updates and advances in both oncology and HIV.
-
Gilead Sciences
@GileadSciences
Chairman and Chief Executive Officer Daniel O’Day joined @SquawkCNBC today to discuss how the company’s ongoing transformation has delivered real results. #jpm24
-
Gilead Sciences
@GileadSciences
2024 marks a new era for our company. We’re looking forward to innovation, continued growth and making an even greater impact as we advance our leading HIV prevention and treatment portfolio and accelerate cutting-edge treatments for cancer. #jpm24
-
Gilead Sciences
@GileadSciences
Our commitment to innovation in #hiv was recognized with The @GalienFdn's 2023 #prixgalien France Award, an honor highlighting outstanding achievements of the best research teams in healthcare.
-
Gilead Sciences
@GileadSciences
#gileadnews: Gilead and Compugen announce exclusive license agreement for novel pre-clinical immunotherapy program. gilead.inc/3thCiHo
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
For people living with metastatic #breastcancer, “quality of life” takes on new meaning. Patient advocates share what this means to them.
-
Gilead Sciences
@GileadSciences
Cara, a mother of two, likes to say that she’s not just surviving with metastatic triple-negative breast cancer – but she’s thriving. Learn about her advocacy work and how Gilead is paying tribute to her in our New Jersey office.
-
Gilead Sciences
@GileadSciences
As #cop28 comes to a close, Joydeep Ganguly, Senior Vice President, Corporate Operations and Global Head of Sustainability, talks about Gilead’s commitment to protect the environment while making the world a healthier place.
gilead.inc/3te8ueB -
Gilead Sciences
@GileadSciences
For the third consecutive year, we’ve been named to the Dow Jones Sustainability World Index, and this year also ranked on the Dow Jones Sustainability North America Index.
Learn more. gilead.inc/46XTYFw -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
The words, “clinically meaningful” can mean one thing to researchers and physicians and something different to people living with metastatic #breastcancer.
Patient advocates from around the world share what it means to them.
#sabcs23 | #bcsm -
Gilead Sciences
@GileadSciences
Collaboration. Innovation. Equity. We refuse to accept that cancer can still take the ones we love, which is why Gilead Oncology is working to transform how cancer is treated. Learn how.
#sabcs23 | #breastcancer -
Gilead Sciences
@GileadSciences
“It's an experience that I hope no one goes through, but it's an empowering experience.”
When Emma was diagnosed with #breastcancer, she felt “pushed aside” due to her age. Hear more about how she advocated for herself with the support of her family.
#bcsm | #sabcs23 -
Gilead Sciences
@GileadSciences
Emily Freeman, PhD, Senior Director, Global Medical Affairs, Patient Focused Implementation Science, shares the work Gilead is doing to differentiate what is clinically meaningful from the perspective of patients and clinicians to help with treatment decision making.
#sabcs23 -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Are you attending SABCS? Visit us at Booth 343 to learn about our commitment to the #breastcancer community and our latest research.
#sabcs23 -
Gilead Sciences
@GileadSciences
Together, we can end the HIV epidemic for everyone, everywhere. Join us for an episode of Zero Hour centered on the perspectives of two guests serving on the frontlines to help expand access for global migrant populations impacted by #hiv: gilead.inc/4a1q31X
#worldaidsday -
Gilead Sciences
@GileadSciences
We commend the #hiv community advocates and organizations working alongside us every day to drive meaningful change. Together, we continue striving to make advancements and break down barriers to end the HIV epidemic.
#worldaidsday
PhRMA
@PhRMA
"I would like nothing better than to end my career and have no one else work on HIV," says Jared Baeten, MD, PhD of @gileadsciences. Watch our full conversation with Jared and other industry leaders about the current state of HIV research: onphr.ma/4a3ocJU
-
Gilead Sciences
@GileadSciences
This #worldaidsday, we recognize the value of partnerships as we strive to improve health equity. Learn about the Gilead-supported program empowering community barbers in Cairns, Australia to have conversations about #hiv.
#gileadhivtogether -
Gilead Sciences
@GileadSciences
Gilead employees stitched together a special panel of the @aids_memorial Quilt in honor of loved ones lost to and affected by #hiv.
We’re proud to unveil it this #worldaidsday as we work toward helping end the HIV epidemic for everyone, everywhere. -
Gilead Sciences
@GileadSciences
Tomorrow is #worldaidsday. We remain steadfast in our commitment to combat all forms of stigma as a critical step toward ending the #hiv epidemic for everyone, everywhere. In this episode of Zero Hour, join us for a discussion on stigma and bias: gilead.inc/46FcDGf
-
Gilead Sciences
@GileadSciences
#gileadnews: We look forward to presenting new data in #tnbc and HR+/HER2- metastatic #breastcancer at #sabcs23. Learn more: gilead.inc/3uxQmMW
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
People living with metastatic #breastcancer drive our commitment to progress #cancer research. Vesna Zic-Côté shares the reality of mBC and reminds us why innovation is critical.
-
Gilead Sciences
@GileadSciences
Gilead’s Legal Department is working to create a future with more diverse leaders, and it has achieved Mansfield Certification Plus for its efforts. The industry program is designed to help ensure everyone in the field has a fair opportunity to advance into leadership.
-
Gilead Sciences
@GileadSciences
Anu Osinusi, MD, Vice President of Clinical Research, talked with @KevinMD about the evolving #covid19 landscape and how we’re adapting to the ongoing needs of people impacted.
Listen to the interview: gilead.inc/3QXLqIW -
Gilead Sciences
@GileadSciences
Putting our mission into action means we never stop pushing toward our goal: to create new possibilities for people with #cancer.
-
Gilead Sciences
@GileadSciences
Thank you to our panelists, @merelhennink (@LungCancerEu), Joelle Fathi (@GO2forLungCancr) and Jaymie Bowles, for sharing your invaluable perspectives with our team working to create new possibilities in #lungcancer.
#lungcancerawarenessmonth
Gilead Oncology
@GileadOncology
We’re working alongside people with #lungcancer and advocates to address the challenges currently faced by this community to make a positive impact and improve lives.
@GO2forLungCancr @LungCancerEu
#lungcancerawarenessmonth -
Gilead Sciences
@GileadSciences
As we approach #worldaidsday, we’re spotlighting global communities that are driving local work to help end the HIV epidemic. See the change happening in Paris’ Ballroom scene.
Watch the full video: gilead.inc/3zFM7iE
#gileadhivtogether -
Gilead Sciences
@GileadSciences
We’re honored to receive the 2023 Scrip Award for Community Partnership of the Year for our RADIAN partnership with @ejaf. This initiative supports grassroots efforts to address HIV in Eastern Europe and Central Asia.
-
Gilead Sciences
@GileadSciences
Caregivers experience a range of feelings – from being honored to overwhelmed. Laura channeled these by being “a voice for the voiceless” and turned her grief into action by working with the global oncology community to create possibilities for people with cancer.
#nfcm | #lcam -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
The @elliefund, a Toward Health Equity Oncology Grant recipient, allows people with #breastcancer to focus more of their time on what matters and less time on the logistics of their care. From transportation to medical appointments to grocery assistance, they help reduce stress.
-
Gilead Sciences
@GileadSciences
"If we as people - regardless of race, color, creed, origin - go to the doctor and pay more attention and advocate for ourselves more, that's how we make a change."
This #lungcancerawarenessmonth, Jaymie shares her complicated path to diagnosis.
#lcam -
Gilead Sciences
@GileadSciences
Congratulations to Deborah Telman for being named to the @PRWeekUS Health Influencer 30 list. She was included for her work promoting health equity and for raising awareness about communities that are underrepresented and disproportionately impacted by #hiv.
-
Gilead Sciences
@GileadSciences
We support several Gilead grantees who are working toward the @WHO goal to eliminate viral hepatitis by 2030.
Learn directly from community leaders working hard in this space in our four-part webinar series. gilead.inc/40ygEuB -
Gilead Sciences
@GileadSciences
Since 2010, we’ve enabled partners in the United States to conduct more than 18 million #hiv and #viralhepatitis tests through FOCUS. Learn more about our impact in Louisiana: gilead.inc/3QWKOo2
#changeinfocus | #healthequityThis media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
We congratulate the winners and finalists of the inaugural #gileadcommunityawards2023. We’re proud to celebrate the work of community organizations across Australia, Canada and Europe for their contributions to drive change at a local level.
#healthequity -
Gilead Sciences
@GileadSciences
Emma and Jaymie talk about taking back possibility when faced with #cancer and questions of #fertility.
#lungcancerawarenessmonth | #lcamThis media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
At #tlm23, we’ll join the liver community to discuss the latest strategies to reach viral hepatitis elimination by 2030.
-
Gilead Sciences
@GileadSciences
Watch today’s special #sponsored session of @AtlanticLIVE's #peoplevcancer featuring four powerful voices — and a deeply personal conversation — about gaps in cancer care and how together we can take back possibility. gilead.inc/3QPhikd
-
Gilead Sciences
@GileadSciences
#gileadnews: Q3 marks another important step in our effort to help make the world a healthier place for all people. Here are a few highlights of our progress in HIV, oncology and beyond. #earnings
-
Gilead Sciences
@GileadSciences
#gileadnews: Gilead reports Q3 2023 #earnings.
Read more: gilead.inc/3spUtdj -
Gilead Sciences
@GileadSciences
#gileadnews: At #tlm23, we look forward to sharing data that demonstrate our commitment to address the unmet medical needs of people living with liver disease.
Read more: gilead.inc/3Mp3CK3 -
Gilead Sciences
@GileadSciences
Meet the Gilead oncology grantee that's advancing health equity and addressing barriers to cancer care in Alabama’s Black Belt communities with the highest needs.
-
Gilead Sciences
@GileadSciences
For the second year, @FCAA has named us the #1 philanthropic funder of #hiv-related programs. We’re committed to empowering grassroots communities as we work together to eliminate barriers to care.
Learn more: gilead.inc/3S8m90T
#healthequity -
Gilead Sciences
@GileadSciences
There are so many ways cancer steals possibility. But together, we’re taking it back. At #esmo23, let the vulnerability, grit, strength and determination of our ambassadors spark conversations on how we can transform #cancer care as a global oncology community.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
At #eacs2023, we recognized emerging HIV investigators from around the world through our Research Scholars Program.
These awardees are incorporating new perspectives to advance scientific innovation, which are critical to helping end the HIV epidemic.
#healthequity | #hiv -
Gilead Sciences
@GileadSciences
#gileadnews: At #eacs2023, we’re presenting our latest long-acting #hiv treatment research, which includes resistance data and insights from healthcare providers and study coordinators.
Learn more: gilead.inc/3Ma14zh -
Gilead Sciences
@GileadSciences
Cancer steals possibility. At Gilead Oncology, we’re taking it back. Hear how we’re collaborating to create new possibilities for people with #cancer.
#esmo23This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
#gileadnews: We’re at #eacs2023 presenting our latest #hiv treatment data.
Learn More: gilead.inc/46XgbE2 -
Gilead Sciences
@GileadSciences
We’re working with the HIV community to bring forward new strategies to advance health equity that are informed by, and designed for, the people most impacted by HIV.
Together, we can end the epidemic for everyone, everywhere.
#eacs2023 | #hiv | #gileadinnovationspotlight -
Gilead Sciences
@GileadSciences
In Eastern Europe and Central Asia, the HIV epidemic is at a crisis with new cases increasing 49% since 2010.
Meet three community leaders working with RADIAN to address stigma, discrimination and barriers to HIV care in EECA.
#radian | #hivineeca -
Gilead Sciences
@GileadSciences
#inhsu2023 highlights why harm reduction services are critical to reach people most vulnerable to acquiring #viralhepatitis and #hiv.
Together, through our work with community-based partners, we’ll continue to address societal barriers to care and expand access for all. -
Gilead Sciences
@GileadSciences
At #ispe2023 Flavius Martin and Joydeep Ganguly discussed how research and operations can partner to ignite #innovation. From sustainable, state-of-the-art research facilities to inclusive talent STEM development programs, our teams work together to reimagine the future.
-
Gilead Sciences
@GileadSciences
For nearly a decade, the Gilead Research Scholars Program has funded early-career investigators who work to advance scientific knowledge in areas of unmet medical need for people affected by #hiv. Here’s a look at three of the scientists: gilead.inc/45I2TKU
-
Gilead Sciences
@GileadSciences
#gileadnews: Gilead and Assembly Biosciences establish partnership to develop next-generation therapeutics for serious viral diseases.
Read more: gilead.inc/45AMPdM -
Gilead Sciences
@GileadSciences
We collaborate to advance and accelerate transformative therapies for people with #cancer. For Bill Grossman, MD, SVP, Clinical Development, achieving progress isn’t just a professional goal — it’s a personal mandate.
-
Gilead Sciences
@GileadSciences
#gileadnews: Gilead and Kite Oncology will present important new data across multiple difficult-to-treat cancers at #esmo23.
gilead.inc/46xqA9V -
Gilead Sciences
@GileadSciences
#gileadnews: At #eacs2023, we look forward to sharing data that showcase our focus on person-centered innovation and health equity in #hiv.
Read more: gilead.inc/3ZYDawh -
Gilead Sciences
@GileadSciences
We’re committed to elevating the voices of Latinx communities and envision a future where health equity is a reality for all. This #nlaad, Manny Rodriguez and Oscar Mairena share what inspires them to continue advocating for positive change.
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Meet the Gilead Oncology ambassadors who inspire us. We stand together to say: cancer steals possibility, but we’re taking it back. Stay tuned to learn more about each of them and how together we’re helping to create new possibilities for people with #cancer.
-
Gilead Sciences
@GileadSciences
As the #covid19 landscape evolves, we remain committed to tackling unmet needs. With an unparalleled expertise in antivirals, we’ll continue to make progress through research and innovation.
#gileadinnovationspotlight | #idweek2023 -
Gilead Sciences
@GileadSciences
At #idweek2023, we’ll be joining industry leaders to discuss the latest in COVID-19 and how we’re working to combat the virus and other infectious diseases.
#covid19 | #infectiousdiseases -
Gilead Sciences
@GileadSciences
“It’s in our DNA to do the right thing. Part of our purpose is to introduce therapies that can benefit communities with greatest unmet medical needs.”
Read about Gilead’s long-standing commitment to addressing disease in tropical regions of the world. -
Gilead Sciences
@GileadSciences
Esther, a mother of three and career service member in the Navy, shares her experience living with HR+/HER2- metastatic #breastcancer.
Read more: gilead.inc/48IoTro
#bcsm | #breastcancerawarenessmonth -
Gilead Sciences
@GileadSciences
#gileadnews: At #idweek2023, we look forward to sharing data that demonstrate our commitment to address the unmet medical needs of people affected by #covid19 and #hiv.
Read more: gilead.inc/45y1bvz -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
We’re proud to be a national sponsor of @SusanGKomen “More Than Pink” Walks in honor of the strength, resilience and bravery of everyone impacted by #breastcancer.
#bcsm | #breastcancerawarenessmonth | #morethanpink -
Gilead Sciences
@GileadSciences
The Toward Health Equity Oncology Grant was created to help reduce discrimination and other barriers impacting cancer care. ALAS-WINGS, a 2023 grantee, empowers Latina women in the #breastcancer community with education and resources.
#healthequity | #hispanicheritagemonth
Gilead Sciences
@GileadSciences
El Toward Health Equity Oncology Grant se creó para ayudar reducir discriminación y otras barreras que afectan el tratamiento del cáncer. ALAS-WINGS, un beneficiario del 2023, empodera a las mujeres hispanas/latinas en la comunidad de #cáncerdemama con educación y recursos.
-
Gilead Sciences
@GileadSciences
We’re a proud sponsor of this week’s Reuters #esginvestment2023, where we’re hosting an Executive Roundtable on redefining the 'S' in ESG. With a focus on health equity, access and innovation, we're addressing unmet needs and making a difference for individuals and communities.
-
Gilead Sciences
@GileadSciences
We congratulate Kevin E. Lofton, Gilead’s Lead Independent Director, for being named by @NACD as one of the most influential leaders in corporate governance as part of their 2023 NACD Directorship 100™.
Read more: gilead.inc/3RHFuWw. -
Gilead Sciences
@GileadSciences
In today's #gileadinnovationspotlight, learn how we work with community partners to facilitate a holistic approach to hepatitis C.
#hepatitisc | #hepconnect -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Blood donation plays a critical role in cancer research and treatment. This #bloodcancerawarenessmonth, our colleagues joined in the @RedCross blood drive at our Foster City headquarters.
#bcam23 -
Gilead Sciences
@GileadSciences
Every year, Newsweek recognizes the greenest companies in America -- the organizations leading the charge to reduce the impact we have on our environment. This year, we’re honored to be among them.
Newsweek
@Newsweek
Newsweek is partnering with Plant-A Insights and GIST Impact to publish America's Greenest Companies 2024.
These companies have committed to working to save the Earth and its resources for future generations. ♻️
#greenestcompanies
🔗 www.newsweek.com/rankings/americas-greenest-companies-2024 -
Gilead Sciences
@GileadSciences
The Gilead COMPASS® Initiative, which is helping combat #hiv in the U.S. South, is part of our long-time work to help make the world a healthier place. We’re honored to be included on the Fortune #changetheworld list for our efforts. gilead.inc/3LDZmWO
-
Gilead Sciences
@GileadSciences
On #ngmhaad, a day to help stop HIV stigma and raise awareness of the impact of HIV on gay and bisexual men, we spoke with Alex Kalomparis, SVP of Public Affairs, to hear about his personal motivation for helping to end the HIV epidemic.
#hiv | #hivstigma -
Gilead Sciences
@GileadSciences
At the second annual Science Day in Foster City, we celebrated the depth of our research and our shared excitement about opportunities to bring new hope to patients using science.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Our bold and transformative cancer research is driving innovations that have the potential to become the next generation of life-changing medicines that may help deliver new outcomes for people living with cancer.
#worldcancerresearchday -
Gilead Sciences
@GileadSciences
In a just-published article, Sandra Patterson, Senior Vice President and Corporate Controller at Gilead, shares how her cultural values and commitment to addressing health inequities helped carve her career path.
#hispanicheritagemonth -
Gilead Sciences
@GileadSciences
Testing and treatment of #hepatitisc is critical because people can live without symptoms. The CDC recommends all adults get tested for HCV at least once, as it is the only way to detect the virus.
Get screened for HCV today. -
Gilead Sciences
@GileadSciences
Today we received a positive opinion from the #chmp of the European Medicines Agency to extend the use of our therapeutic for the treatment of #covid19 in people with mild to severe hepatic impairment.
Read more: gilead.inc/44YW4ny -
Gilead Sciences
@GileadSciences
We’re proud to support our Age Positively grantees, including @ShantiProjectSF’s “The Finely Aged Project.” This project aims to expand access to HIV services for people over the age of 50 who are living with #hiv.
Learn more. gilead.inc/3BNfX5S
#nhaad -
Gilead Sciences
@GileadSciences
At #2023uscha we focused on the Black women heroes in our lives, who are fighting for a better future for our families, communities and society. Our plenary, In Her We Trust: She is Glorious – A Celebration of Black Womanhood, honored their contributions to the #hiv movement.
-
Gilead Sciences
@GileadSciences
We’re proud to join with Latinx communities to celebrate their unique contributions and culture during #hispanicheritagemonth.
Together, we’re working to advance inclusion and belonging at Gilead as we aim to break down inequities in health worldwide.
#gileadlife -
Gilead Sciences
@GileadSciences
Advancing health equity for all, including Black women and girls, is extremely personal for Deborah Telman. Here, she highlights her experience at #uscha2023 and shares her perspective on Gilead’s commitment to supporting communities with the greatest unmet needs.
-
Gilead Sciences
@GileadSciences
At #wclc23, we’re presenting encouraging data from our open-label Phase 2 study in first-line metastatic non-small cell lung cancer. #nsclc gilead.inc/3LfZ6wR
-
Gilead Sciences
@GileadSciences
At #ers23 we’re sharing new data from our therapeutic to treat patients hospitalized with #covid19, reinforcing our commitment to the pulmonology community.
-
Gilead Sciences
@GileadSciences
Lung cancer is a complex disease that can be challenging to treat. Our goal is to reduce the burden of #lungcancer for as many people as possible. #wclc23
-
Gilead Sciences
@GileadSciences
At #2023uscha, we’re celebrating Black women leaders who have ignited change in policies, overcome inequities and educated communities.
Our new installation, “Champions of Change,” on display at the conference, features them in honor of their journeys and accomplishments. -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Today kicks off #bloodcancerawarenessmonth. Gilead and @KitePharma proudly join the efforts of the many individuals and organizations raising disease awareness, funding research and uplifting the blood cancer community.
-
Gilead Sciences
@GileadSciences
As students begin to settle into a new academic year, read how Gilead Foundation grantee @EastsideSchool is helping establish a bright future for its students.
#backtoschool #healthequity -
Gilead Sciences
@GileadSciences
The FDA approved updated guidance for use of our therapeutic for the treatment of #covid19 in people with mild to severe hepatic impairment.
Read more: gilead.inc/44if1S0 -
Gilead Sciences
@GileadSciences
We adapt to the ever-changing clinical landscape through the pursuit of innovative approaches, drug targets and combinations. Our new partnership with Tentarix helps strengthen our early pipeline. gilead.inc/458UeBC
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Clinical trials are critical to advancing the understanding and treatment of acute myeloid #leukemia. Those affected by this disease can discuss the possibility of participating in a clinical trial with their healthcare team. #aml
-
Gilead Sciences
@GileadSciences
We’re tackling #hiv in Eastern Europe and Central Asia through RADIAN. This partnership with @EJAF has met the GOLD standard in the Patient Partnership Index, a reflection of our commitment to finding innovative solutions to help end the epidemic for everyone, everywhere.
-
Gilead Sciences
@GileadSciences
Our new site in Parsippany, N.J., is one of our largest non-manufacturing investments in the U.S. outside of our Foster City HQ. This continues our transformation strategy as we deliver innovative medicines to address life-threatening conditions and attract the brightest talent.
-
Gilead Sciences
@GileadSciences
Every three minutes, someone in the U.S. receives a life-altering blood cancer diagnosis. As the National Presenting Sponsor of Celebration and Community for #lightthenight, Gilead and @KitePharma are committed to supporting @LLSusa’s mission to advance blood cancer research.
-
Gilead Sciences
@GileadSciences
In the latest video in the “5 Years, 5 Voices” series, @BeOurCOMPASS grantee, the Vision Community Foundation in Atlanta, is building a bridge between the faith community and Pride. gilead.inc/3DETsQF
-
Gilead Sciences
@GileadSciences
Stacey Ma, Executive Vice President of Pharmaceutical Development and Manufacturing, oversees a team that’s deeply involved in every stage of the process of creating a new medicine. She shares here what it takes to deliver transformative therapies as quickly as possible.
-
Gilead Sciences
@GileadSciences
To drive real change in #hivprevention, clinical trials evaluating potential #prep options must address and bridge existing gaps.
-
Gilead Sciences
@GileadSciences
Over the last quarter and beyond, Gilead has made great progress in its work to make the world a healthier place for all people. Today, Stacey Ma, EVP of Pharmaceutical Development and Manufacturing, reflected on the company’s transformation journey. #earnings
-
Gilead Sciences
@GileadSciences
Gilead stands with the LGBTQ+ community, working to reduce health inequities and break down stigma. We’re honored to be recognized with the 2023 @NAACP Pride Organization Award, a testament to the impact made by our efforts to support Black communities and advance health equity.
-
Gilead Sciences
@GileadSciences
In celebration of the @BeOurCOMPASS fifth anniversary, we are amplifying the stories of five grantees, recognizing their contributions to help end the HIV epidemic in the Southern U.S. gilead.inc/3rSu9Yz
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Lung cancer impacts millions of people globally. This World Lung Cancer Day, we're committed to building awareness to break down misconceptions and innovating to improve patient outcomes. #wlcd2023
-
Gilead Sciences
@GileadSciences
Gilead has been at the forefront of helping transform the treatment and prevention of #hiv for decades. Here, Kathryn Kersey, Executive Director, Virology Clinical Development looks at the innovative work being done to develop therapies for children.
-
Gilead Sciences
@GileadSciences
People from a variety of backgrounds are inspired to build careers at Gilead — they can see that their work makes an impact and they are valued and belong. During this year’s Inclusion and Growth Week, employees around the world explored allyship, diversity and much more.
-
Gilead Sciences
@GileadSciences
On #worldhepatitisday, we stand with the viral hepatitis community to raise awareness of the need for urgent action to accelerate the fight against viral hepatitis. By continuing to work together, we can make elimination by 2030 a reality. #hepcantwait
-
Gilead Sciences
@GileadSciences
Today we received approval in the EU for our therapy for certain people with pre-treated HR+/HER2- metastatic #breastcancer. Read more here: gilead.inc/3YaKYtU
-
Gilead Sciences
@GileadSciences
At Gilead, the work to bring about a healthier world is led by all of us, from our 2023 interns to Chairman and Chief Executive Officer Daniel O’Day. On #internappreciationday, we celebrate our future biopharma leaders — they are leading our industry in a bright direction.
-
Gilead Sciences
@GileadSciences
This year at #ias2023, with @EJAF, RADIAN convened community leaders from Eastern Europe and Central Asia to discuss urgently needed strategies to ensure no one is left behind in our efforts to end the rapidly growing HIV epidemic in the region.
-
Gilead Sciences
@GileadSciences
Underscoring our commitment to sustainability, Gilead’s state-of-the-art Virology Research Laboratories achieved Leadership in Energy and Environmental Design (LEED) Gold certification – a globally recognized environmental achievement. #esg
-
Gilead Sciences
@GileadSciences
At #ias2023 we announced our largest commitment for health equity for Australian and Canadian Indigenous communities. Alongside our partners, the program is aimed to support reducing barriers for communities impacted by #hiv and #viralhepatitis. gilead.inc/43Mf0VX
-
Gilead Sciences
@GileadSciences
It’s an honor to be named a @Forbes Best Employer for Women for the second year in a row. Women at Gilead can pursue growth and development through our employee resource groups, fostering our inclusive culture that fuels innovation.gilead.inc/3Kekn9s
-
Gilead Sciences
@GileadSciences
At #ias2023, we’re sharing new data from our person-centric HIV treatment research program. Read more: gilead.inc/3Y7BTC1
-
Gilead Sciences
@GileadSciences
With seven years left to achieve the @WHO goal of eliminating viral hepatitis as a public health threat by 2030, we’re working together with the wider hepatitis community to accelerate efforts to help make this goal a reality. #hepcantwait #worldhepatitisday
-
Gilead Sciences
@GileadSciences
In our latest #gileadinnovationspotlight, discover why long-term data on #hiv drug resistance is a research priority at Gilead. #ias2023
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
New research data presented at #ias2023 provide further insights into the treatment of HIV in diverse populations, including pregnant women and children. Read more: gilead.inc/3DK1fNj
-
Gilead Sciences
@GileadSciences
#zerohivstigmaday is intended to ignite bold and intentional action, which is the approach we’re proud to share with several community collaborators around the world like @IAPAC.
Read more about this movement and how we can all do our part to rethink #hiv. -
Gilead Sciences
@GileadSciences
We have a long tradition of partnering with organizations aiming to improve health equity and address the needs of communities disproportionally affected by disease. In this Gilead-supported program, barbers provide HIV education to an indigenous community in Australia. #ias2023
-
Gilead Sciences
@GileadSciences
Together with our partners, we are working through the #intrepidalliance to accelerate progress in the discovery and development of new antiviral therapies. Today, INTREPID is sharing recommendations to prepare for future pandemics: www.intrepidalliance.org/2023-summit-report/
-
Gilead Sciences
@GileadSciences
The new Gilead Relink grant will help bring diagnosed but untreated U.S. patients with HCV or HBV back into care. Gilead Relink builds on our longstanding commitment to addressing viral hepatitis in impacted populations. gilead.inc/3NV5J8i
-
Gilead Sciences
@GileadSciences
At #ias2023, we look forward to showcasing our work to advance people-centered innovation and community-fueled, collaborative initiatives that aim to help end the global #hiv epidemic. gilead.inc/3pSzYok
-
Gilead Sciences
@GileadSciences
What is different about hepatitis D virus (also known as hepatitis delta or HDV), compared to the other forms of viral hepatitis?
-
Gilead Sciences
@GileadSciences
Yesterday marked the 36th #aidswalksf, uniting thousands against HIV/AIDS in the Bay Area. We proudly support this cause through our community efforts and partnerships with advocates that help address stigma and discrimination.
Together, we are working to end the epidemic. -
Gilead Sciences
@GileadSciences
Healthcare is more than medicine. Gilead oncology grantees are working to reduce discrimination and other barriers to the well-being of underrepresented communities.
-
Gilead Sciences
@GileadSciences
Today we received approval from the FDA to extend the use of our therapeutic for the treatment of people with severe renal impairment who are hospitalized due to #covid19. Read more here: gilead.inc/44GQ3MG
-
Gilead Sciences
@GileadSciences
We’re proud to partner with @CHAI_health, @Penta_ID, @MonellSc and Eurofins’ Translational Cell Models Group to improve pediatric #hiv treatment access and adherence among children in low- and middle-income countries. Learn more: gilead.inc/3NKpAXI
-
Gilead Sciences
@GileadSciences
We’re proud to announce a new $3M grant program to strengthen the #hiv response in Latin America and the Caribbean by supporting NGOs to reduce HIV stigma and inequities while improving access to care. #zeroinginlac
-
Gilead Sciences
@GileadSciences
Gilead France partnered with the iconic @CentrePompidou to display an art collection exploring the victories and struggles affecting #lgbtq+ communities. We hosted more than 135 patient advocates for a tour commemorating our commitment to promote health equity and fight stigma.
-
Gilead Sciences
@GileadSciences
It’s our responsibility to be part of the climate change solution. We embed sustainability into our culture so it’s integral to everything we do. We’re holding ourselves and our suppliers accountable. Learn about our approach, centered on carbon, water, waste and product. #esg
-
Gilead Sciences
@GileadSciences
Last week at #gbef, Chairman and CEO Daniel O'Day and General Counsel Deborah Telman connected with community leaders, students and alumni at Xavier University of Louisiana, our partners in addressing the underlying determinants of health disparities.
-
Gilead Sciences
@GileadSciences
.@MomGerm with The @BornThisWay Foundation and Dr. Myeshia Price with @TrevorProject, Gilead Foundation grantees, share how they’re working to address the urgent and unmet mental health needs of LGBTQ+ youth.
-
Gilead Sciences
@GileadSciences
Gilead’s Daniel O’Day and Deborah Telman discuss our commitment to advancing health and Black equity at the @GBEF_ CEO Summit at the 2023 @essencefest. #gbef #essencefestival
-
Gilead Sciences
@GileadSciences
In celebration of the @BeOurCOMPASS fifth anniversary, we are amplifying the stories of five grantees and recognizing how they are agents of progress in helping to end the HIV epidemic in the Southern U.S. In our second video, meet Transinclusive Group from South Florida.
-
Gilead Sciences
@GileadSciences
Gilead’s Month of Service arrived in June at our Foster City campus, with employees volunteering for local organizations like Project Open Hand, National AIDS Memorial Grove, Samaritan House and more to give back to the community where we live and work.
-
Gilead Sciences
@GileadSciences
There is power in knowing your #hiv status, and the only way to know is to get tested.
Read more in @HuffPost about prioritizing HIV testing as part of routine self-care and how to take the next step no matter the result. #nhtd #hivtestingday -
Gilead Sciences
@GileadSciences
This past weekend, Gilead teams participated in #sfpride53, one of the largest LGBTQ+ celebrations in the world. We’re proud to recognize the LGBTQ+ community and create an inclusive workplace for all – this month and every month.
-
Gilead Sciences
@GileadSciences
As #easlcongress draws to a close, we feel motivated by the inspiring discussions on the latest research and innovations to continue our work together to address the unmet needs of people living with liver disease.
-
Gilead Sciences
@GileadSciences
Wayne Paul is an HIV Medical Scientist on the Australian Medical Affairs team and was recently appointed Global Co-Lead for Gilead’s PRIDE Alliance. Learn why Gilead was the first place he felt he could bring his full self to work. #pride2023
-
Gilead Sciences
@GileadSciences
Today we received a positive opinion from the #chmp of the EU medicines agency recommending marketing authorization of our therapy for certain people with pre-treated HR+/HER2- metastatic #breastcancer. Read more here: gilead.inc/3NMSeJa
-
Gilead Sciences
@GileadSciences
At #easlcongress 2023, we presented Week 96 data from the Pivotal Phase 3 trial looking at treatment options for #hdv. The data reinforce the potential of prolonged treatment for HDV. Learn more. gilead.inc/3PqnZsq
-
Gilead Sciences
@GileadSciences
We’re honored to have received the @SusanGKomen Advocacy Champion of the Year award for our efforts to raise #tnbc awareness and address health disparities in cancer care.
-
Gilead Sciences
@GileadSciences
In the age of social media, celebrities and influencers have the power to boost their brands - and use their reach to help end the HIV epidemic.
Discover how in “Power of Influence,” the newest Zero Hour episode, available on all major podcast platforms. -
Gilead Sciences
@GileadSciences
At #easlcongress, we’ll share our latest research in viral hepatitis and liver fibrosis, and connect with the liver community on the new innovations to advance research and management of liver disease.
-
Gilead Sciences
@GileadSciences
Introducing Gilead’s Setting the P.A.C.E., a 3-year, $10 million grant supporting a wide range of projects to increase HIV prevention, anti-stigma and health equity efforts for Black women and girls in the United States. gilead.inc/3Ne4AIA
-
Gilead Sciences
@GileadSciences
Father of triplets, Joel Silver credits Gilead for allowing him to be committed to both his legal work and his family. This Father’s Day, he shares the workplace perks that enabled him to earn Seramount’s Working Parent of the Year award. #fathersday
-
Gilead Sciences
@GileadSciences
This week, Gilead's GLOBE employee resource group hosted events, including our annual #juneteenth flag raising, to honor the Black experience and celebrate diversity and freedom. Together, we reflect on our shared commitment to creating a more just and equitable future.
-
Gilead Sciences
@GileadSciences
At #easl2023 Gilead will share the latest liver disease research from its #hcv, #hbv, #hdv, and #nash programs to help address the unmet needs of people living with liver disease. gilead.inc/3p4gbC4
-
Gilead Sciences
@GileadSciences
Eastern Europe and Central Asia are experiencing the world's fastest-growing #hiv epidemic. We’re working with @EJAF and our #radian grantees to change that. At #aidsimpact we're highlighting the region’s unique challenges and the community leaders helping end the HIV epidemic.
-
Gilead Sciences
@GileadSciences
We’re thrilled to be included on Seramount's annual list of Best Companies for Multicultural Women – a reflection of inclusion and diversity efforts that are essential to achieving our mission.
-
Gilead Sciences
@GileadSciences
For decades, Gilead has supported local Pride events to help empower the LGBTQ+ community. This past Saturday, we celebrated Pride month with the San Francisco Giants! We’re proud to stand beside and elevate the voices of the LGBTQ+ community in June and all year long.
Oracle Park
@OracleParkSF
Join us this Saturday as we celebrate Pride at Oracle Park. The first 20,000 fans in attendance will receive an @SFGiants Pride Jersey.
@GileadSciences | More info: sfgiants.com/pride -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
We're on a mission to give people with #bloodcancer more options. Islam Sadek, Executive Director, Global Medical Affairs, sheds light on our ongoing research. #eha23
-
Gilead Sciences
@GileadSciences
Triple-negative breast cancer (TNBC) accounts for about 15-20% of all breast cancers. When diagnosed with #tnbc, Tilly spoke up and advocated for her care.
-
Gilead Sciences
@GileadSciences
As #asco23 draws to a close, Frank Neumann, Senior Vice President, Global Head of Clinical Development at Kite, provides insight on the importance of overall survival data in cancer clinical trials.
-
Gilead Sciences
@GileadSciences
People living with #hiv are living longer, reinforcing the need for optimal holistic care. This #hltsad, we acknowledge their resilience and join the community in advocating for the aging population. Learn more: gilead.inc/3NjQhDP
-
Gilead Sciences
@GileadSciences
At #asco23, we’re presenting longer-term overall survival data from a Phase 3 study in pre-treated HR+/HER2- metastatic #breastcancer. gilead.inc/3CdAnV6
-
Gilead Sciences
@GileadSciences
At #asco23, together with Arcus Biosciences, we’re presenting updated results from our #nsclc study that includes the first Fc-silent anti-TIGIT investigational monoclonal antibody in pivotal trials. gilead.inc/43y41jC
-
Gilead Sciences
@GileadSciences
We’re on a mission to improve outcomes for people living with cancer. Luciana Preger and Amy Otto share the importance of making this goal a reality.
Gilead Oncology
@GileadOncology
At Gilead, we refuse to accept that cancer can still take the ones we love. Gilead leaders Luciana Preger and Amy Otto share the importance of improving outcomes for people living with cancer. #asco23
This media couldn't be displayed. See it on the original post. -
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
Together with @GileadOncology, we will present 17 abstracts from our industry-leading cell therapy portfolio and growing blood cancer pipeline at the upcoming 2023 @EHA_Hematology Annual Congress. #eha2023
-
Gilead Sciences
@GileadSciences
Happy #pride2023! Our Pride Alliance employee resource group raised the flag at our Foster City campus this morning, and we’ll be flying it all month long as a symbol of our support for LGBTQ+ colleagues and partners — and our work in creating an inclusive environment for all.
-
Gilead Sciences
@GileadSciences
When Joe Hawkins moved to the San Francisco Bay Area, he was surprised to learn Oakland was the only major city in California without a dedicated LGBTQ+ center. So he went on to co-found a community center to fill the gap. #pride2023
-
Gilead Sciences
@GileadSciences
We’re honored to be ranked on @Newsweek's just-released list of the 2023 Top 100 Global Most Loved Workplaces – a testament to our employees’ positive vision of Gilead’s future, a culture of inclusion and integrity, company benefits and values. #mostlovedworkplace
-
Gilead Sciences
@GileadSciences
We are extending a $3.2 million grant given in 2021 to @HRC with an additional $5 million over three years to expand their work advancing HIV and health equity programming for Black and Brown LGBTQ+ communities, making it the largest in their history. gilead.inc/3N2GMaL
-
Gilead Sciences
@GileadSciences
Bilal Piperdi, Vice President of Clinical Research in Oncology, explains why he came to Gilead and how his Oncology team is helping to bring more life to people with lung cancer.
-
Gilead Sciences
@GileadSciences
This week, Chairman and CEO Daniel O’Day had the opportunity to meet with stakeholders in Florida who are collaboratively expanding the FOCUS model in hospitals across the state.
FOCUS is centered on best practices in #hiv, #hcv and #hbv screening, diagnosis and linkage to care. -
Gilead Sciences
@GileadSciences
At several sites across the United States, we are honoring Memorial Day with “fallen comrade tables” in our campus cafes, abundant with symbolic objects for fallen, missing or imprisoned American Service Members, whose sacrifice will not be forgotten.
-
Gilead Sciences
@GileadSciences
We are pleased to have received a positive opinion from the #chmp of the EU medicines agency today to extend the use of our therapeutic for the treatment of #covid19 in people with severe renal impairment. Read more here. gilead.inc/4251kVj
-
Gilead Sciences
@GileadSciences
With only 7 years to go until the @WHO goal of eliminating #viralhep as a public health threat by 2030, we’re proud to support Asociación Madrid Positivo through a Gilead grant to provide mobile #hepatitisc screening and treatment to vulnerable populations across Madrid in Spain.
-
Gilead Sciences
@GileadSciences
Gilead’s Abbey Kim and Vicky Choi share their perspectives on cultural backgrounds intersecting with career journeys and how they’re navigating the two here. #aapiheritagemonth
-
Gilead Sciences
@GileadSciences
Our new podcast, Zero Hour, offers an in-depth look at #hiv health equity and policy, barriers to care and scientific innovation. Join the global conversation and tune into our first episode, a 35-minute exploration of bias and stigma.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
When it comes to cancer, understanding the disease can provide hope. Dr. Ted Braun, one of our #hematology Research Scholars Program grantees, shares insights on what fuels his research and hope for change in acute myeloid leukemia. #aml @OHSUNews
-
Gilead Sciences
@GileadSciences
By collaborating with community partners to tackle the world’s greatest health challenges, we’re honoring our responsibility as a corporate citizen. Gilead’s investment in communities reflects our commitment to improving the lives of patients and driving meaningful change. #esg
-
Gilead Sciences
@GileadSciences
This #nationalhepatitistestingday, we’re encouraging everyone to follow @CDCgov’s recommendation that every adult be screened at least once for #hepatitisb and #hepatitisc, as symptoms may be unnoticeable.
Find testing services near you. -
Gilead Sciences
@GileadSciences
To celebrate 5 years of @BeOurCOMPASS, we’re partnering with the @LosAngelesBlade to highlight 5 grantee voices, each serving as agents of progress in ending the HIV epidemic in the Southern U.S.
-
Gilead Sciences
@GileadSciences
The breadth of data we’ll share during #asco23 highlights our commitment to transformative science for hard-to-treat cancers. gilead.inc/4525IY1
-
Gilead Sciences
@GileadSciences
Today, we’re pleased to announce Cindy Perettie as the new Executive Vice President of Kite and a member of Gilead’s senior leadership team. gilead.inc/3WdGlhJ
-
Gilead Sciences
@GileadSciences
We continue to work with community partners to expand testing and access to #hepatitisb and #hepatitisc treatment, as 67% and 40% of Americans, respectively, are unaware of their status. This #hepatitisawarenessmonth, find local screening options: hepvu.org/services
-
Gilead Sciences
@GileadSciences
Gilead and Arcus Biosciences, Inc. announce an expanded research collaboration to include therapies for treating inflammatory diseases. This builds Gilead’s growing presence in, and broadens Arcus’ capabilities into, inflammation. gilead.inc/3pJsCmy
-
Gilead Sciences
@GileadSciences
LJ Mizzi, one of Seramount’s Working Parents of the Year, reflects on her professional journey and credits Gilead’s supportive culture as the reason she’s never had to choose between her career and her family.
-
Gilead Sciences
@GileadSciences
We’re building a diverse oncology pipeline, with aspirations to deliver the best outcomes for people with cancer.
-
Gilead Sciences
@GileadSciences
After being diagnosed with myelodysplastic syndrome, Marion vowed to not let it define her. Now treatment-free for more than 18 months, she opens up about the challenges she faced in her journey with the rare blood cancer. #mds
-
Gilead Sciences
@GileadSciences
Addressing the world’s health challenges requires people who care about making a positive impact in the world and reflect the diversity of the communities we serve. Learn about our efforts to empower people while fostering an inclusive and high-performing culture. #esg
-
Gilead Sciences
@GileadSciences
In recognition of #aapiheritagemonth, Amanda Dang shares how our focus on inclusion and diversity impacts her work and her ability to make a difference in Asian American and Pacific Islander communities.
-
Gilead Sciences
@GileadSciences
Gilead’s clinical development program is growing, and we are proud to announce the addition of early pipeline assets in oncology and inflammation. gilead.inc/44KxuI6
-
Gilead Sciences
@GileadSciences
The Gilead community yesterday celebrated the opening of our new Virology Research Laboratories on the Foster City campus. The laboratories, which will offer more than 85,000 square feet of additional space, were designed to fuel scientific innovation and collaboration.
-
Gilead Sciences
@GileadSciences
“Our goal is to magnify Gilead's legacy, to reach more patients in the future and to keep our focus.”
Today, Chairman and CEO Daniel O'Day participated in a conversation with Adam Feuerstein about Gilead’s journey at the @statnews Breakthrough Science Summit. #statbreakthrough -
Gilead Sciences
@GileadSciences
Today we announce the adoption of a positive opinion by the #chmp of the EU medicines agency @EMA_News, recommending full marketing authorization of our treatment for #hepatitis Delta virus. Read more: gilead.inc/3p7d1wX
-
Gilead Sciences
@GileadSciences
Living with #hepatitisc can be one of many hurdles people who inject drugs face, along with other social and economic challenges. Increased education and access to #hcv services are essential to achieving elimination goals.
-
Gilead Sciences
@GileadSciences
Gilead's Foundation and Pride Alliance hosted a fireside chat with @MomGerm of @BTWFoundation and @Mypreeney of @TrevorProject for #mentalhealthawarenessmonth. Together, we are building kinder and safer spaces that support colleagues, friends, families and communities.
-
Gilead Sciences reposted
STAT
@statnews
Daniel O'Day, Chairman of the Board of Directors and Chief Executive Officer at @GileadSciences
-
Gilead Sciences
@GileadSciences
We're honored to be named a top three big company for patient centricity and access in @PatientView's Corporate Reputation of Pharma survey. We’re committed to strengthening our partnerships with patient groups, working to help improve outcomes and address barriers to care.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
The awardees of our Research Scholars Program are part of the next generation of scientific progress, which we’re proud to support. Learn more about a few of our scholars from @OHSUNews, @MDAndersonNews and @TheCrick.
-
Gilead Sciences
@GileadSciences
In our first quarter, we built on the momentum we saw in 2022 and made important progress in our work to make the world a healthier place for all people. We look forward to growth and continued advancements across HIV, oncology and our other therapeutic areas. #earnings
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
People are our greatest asset. At Gilead, we strive for an environment that fosters innovation so teams can make a direct and meaningful impact.
-
Gilead Sciences
@GileadSciences
Driven by her commitment to supplier inclusion and diversity, we’re proud to share that Chief Procurement Officer Veronica Jones has been honored among the 2023 Top Blacks in Healthcare by blackdoctor.org.
-
Gilead Sciences
@GileadSciences
Today, #earthday, we join the global community in celebrating our planet and the efforts being made to safeguard it. At Gilead, we understand the connection between our climate and human health, and we're firmly committed to protecting both.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
For #amlworldawarenessday, we’re proud to partner with @BeTheMatch to help connect potential blood stem cell donors to people in need of a transplant. #knowaml
-
Gilead Sciences
@GileadSciences
Hepatitis Delta, also known as #hdv, is the most severe form of hepatitis – but how do you acquire it?
Learn more about the difference between HDV co-infection and superinfection. -
Gilead Sciences
@GileadSciences
Today, we launched our inaugural ESG Impact Report. Learn how we’re advancing our mission to create a healthier world while benefiting our people, the communities we support and our planet.
-
Gilead Sciences
@GileadSciences
We are honored to have been part of such an inspiring conference @HRInews #hr23. There is still a lot more to be done to better integrate #hiv and #hcv services within #harmreduction services. We remain committed to helping improve the care continuum for people who use drugs.
-
Gilead Sciences
@GileadSciences
The Los Angeles LGBT Center provides direct health and wellness services, including #hiv testing, to empower the transgender and gender nonbinary communities. This #nthtd, learn more about the community-led efforts supported by Gilead’s TRANScend fund.
-
Gilead Sciences
@GileadSciences
With approximately 21.5 million people living with #hepatitis B & C in Indonesia, it’s considered to be endemic across many parts of the country and Asia.
This is why, as part of the #all4liver grant program, we support Yayasan Peduli Hati Bangsa to help eliminate hepatitis B. -
Gilead Sciences
@GileadSciences
Today we announced new real-world and clinical data reinforcing the role of our antiviral treatment as the standard of care for a broad range of hospitalized patients with #covid19. Read more: gilead.inc/41dekbY #eccmid2023
-
Gilead Sciences
@GileadSciences
How can we better integrate #hiv and #hcv screening and care into existing #harmreduction services for people who use drugs? We’re excited to discuss this and share ideas with community and policy experts at the @HRInews Harm Reduction International Conference this week. #hr23
-
Gilead Sciences
@GileadSciences
“Gilead is a company that really values innovation and empowering employees. You can create a fingerprint at the company quickly.”
Jamari Brooks and Adashi Odama share the uniting force that brought them to Gilead and how strategic recruiting made a difference. #gileadlife -
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
A triple-negative breast cancer diagnosis is life-altering, but support from loved ones and the breast cancer community can make a diagnosis easier to navigate. Katja sheds light on her experience with TNBC and shares advice for others in the same situation.
-
Gilead Sciences
@GileadSciences
We are honored to be a #citeline_awards finalist for our work with @Certara around #covid19, reinforcing the role of our treatment options.
-
Gilead Sciences
@GileadSciences
Jan Christmann helps create a healthier world for all people by training colleagues in Germany and other international offices on new technologies. Learn how Gilead has enabled him to follow his passion of being the interface between people and technology.
-
Gilead Sciences
@GileadSciences
Together with AIDSVu, we’re highlighting the urgent need to raise awareness about #hiv prevention and care for youth populations – a key group affected by the HIV epidemic. Learn more: gilead.inc/3Ksw38d #nyhaad
AIDSVu
@AIDSVu
Young people accounted for 1/5 of all new HIV diagnoses in 2021, but only made up 13% of PrEP users. This #nyhaad, let’s support young people’s access the care and give them the resources they need to prevent #hiv. Learn more: aidsvu.org/national-youth-hiv-aids-awareness-day-2023/
-
Gilead Sciences
@GileadSciences
The #hepatitisb HBV-COMSAVA project, funded by a Gilead grant, works with Barcelona’s West African community to empower them to take control of their health and get tested for #hbv. Projects like this are vital to help make the goal of #viralhep elimination possible by 2030.
-
Gilead Sciences
@GileadSciences
We support Transgender people and celebrate the community’s achievements and resilience. This #tdov, we’re proud to highlight the work of Gilead grantee Tatiana Williams, who founded an organization to protect equality for all Transgender and LGBTQ+ individuals.
-
Gilead Sciences
@GileadSciences
As part of the global leadership team for Women at Gilead, Megan Kim is helping expand this employee resource group in Asia while bringing her expertise in liver disease to medical communities across the region.
-
Gilead Sciences
@GileadSciences
Approximately 5% of people living with chronic #hbv are also living with #hdv. That's 12- 60 million people who may be living with #hepd globally.
At Gilead, we are committed to helping meet the unmet needs of people living with #hepatitisdelta. -
Gilead Sciences
@GileadSciences
Johanna Mercier, Chief Commercial Officer, was a keynote speaker at Reuters’ Pharma USA today. Read her perspective on Gilead’s long legacy of working toward ensuring our therapies reach those who could benefit and our ongoing work to break down barriers to access.
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#news: Today, we announced the primary overall survival (OS) analysis results, a key secondary endpoint, of our Phase 3 study of CAR T-cell therapy for initial treatment of relapsed/refractory large B-cell lymphoma.
-
Gilead Sciences
@GileadSciences
People living with #hiv can have longer, healthier lives on treatment– but social and structural barriers still prevent many people from accessing treatment or prevention care. A group of experts examine these challenges and outline ways to achieve long-term success in HIV.
-
Gilead Sciences
@GileadSciences
As part of our Zeroing In program to help end #hiv, we’re providing $3 million in grant funding to eight organizations helping rural communities in the U.S. that are disproportionately impacted by the epidemic. gilead.inc/3LM19K3 #healthequity
-
Gilead Sciences
@GileadSciences
Gilead and @Nurix_Tx announce that Gilead has exercised its option to exclusively license Nurix’s investigational targeted protein degrader molecule, which has potential applications in the treatment of rheumatoid arthritis and other inflammatory diseases. gilead.inc/3JvBrH9
-
Gilead Sciences
@GileadSciences
This #lgbtqhealthawarenessweek, we’re focused on our core values of inclusion and health equity. We’re committed to providing access to healthcare for the LGBTQ+ community. Join us in the fight to advance disease awareness, address stigma and support front-line services and care.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Black women are two times as likely to be diagnosed with triple-negative breast cancer than white women. Leaders from @SusanGKomen, @tigerlilycares and the @CancerSupportHQ joined us to discuss addressing the inequities impacting #tnbc care. #tnbcday
-
Gilead Sciences
@GileadSciences
The Gilead Foundation awards @SFSU grant funding for their new Science and Engineering Innovation Center. This investment will provide access to cutting-edge technology and laboratories, preparing students for futures in biopharma, biotech and engineering. gilead.inc/3YTrAR3
-
Gilead Sciences
@GileadSciences
Gilead’s salary ratio for women to men globally is 99.93:100. "We're focused on prioritizing and creating an inclusive and equitable workplace,” says Jyoti Mehra, Chief Human Resources Officer. #equalpayday
-
Gilead Sciences
@GileadSciences
Three years ago, the @WHO declared COVID-19 a global pandemic. Keith Prowell was an early patient. Here he shares his experience being hospitalized and how he was inspired after participating in a clinical trial for an antiviral therapy. #nationalcovid19day
-
Gilead Sciences
@GileadSciences
Rates of #hiv in women are decreasing due to education, testing and prevention efforts, but disparities in care continue to disproportionately affect communities of color.
This #nwghaad, we encourage all women to add regular HIV screening to their care routines. -
Gilead Sciences
@GileadSciences
This week, Gilead Oncology and patient advocates came together for our inaugural Breast Cancer Advocacy Summit. We’re grateful for the opportunity to work alongside the breast cancer community as we partner to close the gaps in care and help address health inequities.
-
Gilead Sciences
@GileadSciences
“Engaging a population that doesn’t have stable housing, reliable communication and transportation is a big challenge.”
Micro-elimination programs that are tailored to meet hepatitis C patients where they are, helps remove barriers to testing, treatment and a cure. -
Gilead Sciences
@GileadSciences
Together with our grantees and partners, Gilead is committed to addressing the health inequities and discrimination experienced by communities most impacted by #hiv.
Learn how these tireless efforts help people across the globe at gileadhivtogether.com. #zerodiscriminationday -
Gilead Sciences
@GileadSciences
As we prepare for #womenshistorymonth, Sinit Mehtsun discusses the importance of Gilead's focus on empowering women and other historically underrepresented communities. Learn how this relates to her work helping to enable access to our medicines worldwide.
-
Gilead Sciences
@GileadSciences
Gilead is proud to support @ETAForg for #hivisnotacrime Awareness Day. We are helping dismantle HIV criminalization laws that drive disparities in HIV care and deter testing.
-
Gilead Sciences
@GileadSciences
After losing her father to lung cancer, Stacey Bledsoe, Gilead’s new Head of Clinical Trial Diversity and Inclusion, has made it her business to ensure clinical trials are available to everyone. Learn how her personal journey has become her professional passion.
-
Gilead Sciences
@GileadSciences
Check out the #hepcast series, where we discuss the issues faced by underserved communities at risk of #viralhepatitis.
Learn how the hepatitis community is working to address these issues as we strive for hepatitis elimination by 2030. -
Gilead Sciences
@GileadSciences
Through our RADIAN initiative, we’re proud to partner with the @EJAF to deliver HIV services and care to people in Eastern Europe and Central Asia – including those in Ukraine.
Elton John AIDS Foundation
@ejaf
On the anniversary of the invasion, we’re announcing new funding that has been awarded for the country to ensure the progress that’s been made is not lost. Read more about our commitment to Ukraine in @eltonofficial's op-ed in The @guardian 🧡🇺🇦
www.theguardian.com/commentisfree/2023/feb/23/kyiv-ukrain… -
Gilead Sciences
@GileadSciences
While #croi2023 is wrapping up, continue to follow the #gileadinnovationspotlight series for more virology updates throughout the year.
Watch today’s spotlight on the potential role of broadly neutralizing antibodies (bNAbs) in our latest #hiv treatment research. -
Gilead Sciences
@GileadSciences
The latest advances from our person-centric HIV treatment research program are featured in today’s #croi2023 press conference. gilead.inc/3kiNz5x
-
Gilead Sciences
@GileadSciences
A cure for #hiv is our ultimate goal at Gilead. Tune in to today’s #gileadinnovationspotlight on our latest advancements in cure research and the global partnerships and collaborations that help propel these efforts to transform HIV care. #croi2023
-
Gilead Sciences
@GileadSciences
Today we presented new real-world data at #croi2023, reinforcing the efficacy of our antiviral treatment in hospitalized patients with COVID-19, including those who are at high-risk for disease progression, throughout the course of the pandemic. gilead.inc/3Z43weU
-
Gilead Sciences
@GileadSciences
New data and insights at #croi2023 highlight our commitment to advancing scientific knowledge on potential pathways to achieve a cure for all people living with HIV. Read more: gilead.inc/3KpAIt5
-
Gilead Sciences
@GileadSciences
Watch today’s #gileadinnovationspotlight series on how our continuous #hiv research allows us to deliver novel treatment options that have the potential to address the evolving and diverse needs of all people with HIV. #croi2023
-
Gilead Sciences
@GileadSciences
We’re launching our #gileadinnovationspotlight series that brings to life the science and collaboration driving our research forward.
Follow along throughout #croi2023 and beyond to learn about our continuous efforts in HIV and to help eliminate existing barriers to care. -
Gilead Sciences
@GileadSciences
Today we’re presenting new data from our Phase 2 study investigating our treatment across multiple types of hard-to-treat metastatic urothelial cancer. #gu23 gilead.inc/3EfJyWg
-
Gilead Sciences
@GileadSciences
With over 30 years of experience delivering transformative medicines for liver disease globally, we support opportunities that enable an innovation and paradigm shift in hepatology, in line with the #apasl2023 theme.
-
Gilead Sciences
@GileadSciences
“Ever since the beginning of the HIV epidemic, we’ve known that the science is better when everyone has a seat at the table.”
Learn how Gilead is engaging community advisory groups to contribute to the design and execution of #hiv prevention trials. -
Gilead Sciences
@GileadSciences
E.D. Derilus leads a team that works to build community trust in Gilead and empowers people to make informed healthcare decisions.
Learn why he’s passionate about helping to advance our diverse and inclusive culture. #blackhistorymonth -
Gilead Sciences
@GileadSciences
We look forward to the Asian Pacific Association for the Study of the Liver annual congress this week to share our latest research findings and knowledge on viral hepatitis. #apasl2023
-
Gilead Sciences
@GileadSciences
Our commitment to continuous scientific discovery aimed at researching, treating and eradicating some of the most challenging viral diseases will be demonstrated at #croi2023. gilead.inc/3IkTbpg
-
Gilead Sciences
@GileadSciences
Mary Bird Perkins, a Gilead grantee, offers no-cost cancer screenings through its mobile clinics in Louisiana and Mississippi. The organization works to benefit people living in parts of the country where cancer is more likely to be diagnosed at an advanced stage.
-
Gilead Sciences
@GileadSciences
To support those impacted by Monday’s devastating earthquake in Türkiye and Syria, the Gilead Foundation is donating $1 million for on-the-ground relief efforts, divided evenly between the International Medical Corps and Direct Relief, two organizations we've long supported.
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#news: Today, we announced follow-up results from a pivotal study of #cartcell therapy in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia at the @EHA_Hematology @TheEBMT 5th European CAR T-cell Meeting. #cart23
-
Gilead Sciences
@GileadSciences
Hepatitis B continues to be the leading cause of liver cancer globally. However, many are still unaware that #hbv can develop into liver cancer.
Hear how awareness and proactivity helped make a difference to Chua Cher Joo in his battle with hepatitis B and liver cancer. -
Gilead Sciences
@GileadSciences
Gilead has a long history of developing therapies for life-threatening diseases and of supporting organizations that aim to improve health equity and access to care. Here, Chairman and CEO Daniel O’Day talks about the evolution of the company and what lies ahead.
-
Gilead Sciences
@GileadSciences
We’re proud to announce our intention to support the Getting to Zero CM Deaths program in Eswatini with the Eswatini Ministry of Health, the Mycotic Diseases Branch at the U.S. Centers for Disease Control, Integral Global Consulting and Georgetown University.
-
Gilead Sciences
@GileadSciences
Today the U.S. FDA approved our therapy for certain people with pre-treated HR+/HER2- metastatic breast cancer. gilead.inc/3jxdINJ
Gilead Sciences
@GileadSciences
Our therapy provides an important new option for certain people with pre-treated HR+/HER2- metastatic breast cancer. @hoperugo shares how this new therapy can make a difference for patients. Learn more: gilead.inc/3jxdINJ
Gilead Sciences
@GileadSciences
The metastatic #breastcancer community is in need of new treatment options. This approval represents a significant milestone. Learn more: gilead.inc/3jxdINJ
-
Gilead Sciences
@GileadSciences
This week, Gilead leaders shared ambitions for 2023. By investing in research infrastructure and remaining committed to collaboration, we're confident in what’s ahead as we work to develop and deliver the next generation of life-changing medicines. #earnings
-
Gilead Sciences
@GileadSciences
2022 was a year of great momentum for Gilead. Here are a few ways our teams worked to improve health equity and break down barriers to care, driven by the purpose of making the world a healthier place for everyone. #earnings
-
Gilead Sciences
@GileadSciences
This past year was one of transformative growth at Gilead, as we advanced clinical programs throughout our portfolio, with updates and regulatory approvals across virology and oncology. This week, we'll share how our strong momentum has shaped what's ahead for 2023. #earnings
-
Gilead Sciences
@GileadSciences
As we kick off #blackhistorymonth, Belinda Moore shares her experience balancing her Patient Support Strategy role while also helping to lead the Gilead Leadership Organization of Black Employees resource group.
Learn what inspires her about equity, inclusion and diversity. -
Gilead Sciences
@GileadSciences
Learn how NovaSalud was able to launch its Zeroing In On Youth LGBTQ+ HIV Prevention project, using social media outreach to deliver culturally competent, personalized HIV prevention services in Northern Virginia with support from Gilead’s Zeroing In initiative.
-
Gilead Sciences
@GileadSciences
Today, we commemorate when the first known person with #covid19 in the U.S. was treated with our then-investigational antiviral treatment. We remain committed to addressing the ongoing needs of the evolving pandemic.
-
Gilead Sciences
@GileadSciences
This #worldntdday, we continue to honor our decades-long commitment to helping those most vulnerable to visceral leishmaniasis (VL) receive treatment to combat one of the deadliest parasitic diseases. With @WHO, we've helped reduce VL's prevalence in India & Bangladesh.
-
Gilead Sciences
@GileadSciences
Gilead’s See Phan is all too familiar with the need for innovative new treatment options in HR+/HER2- #breastcancer. In this piece he shares the work underway at Gilead Oncology, where the vision is to help bring more life to people with cancer. gilead.inc/3HvFkfd
-
Gilead Sciences
@GileadSciences
Today we announced the European Medicines Agency validated a Marketing Authorization Application for our therapy for people with pre-treated HR+/HER2- metastatic breast cancer. gilead.inc/3QclGYu
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#news: Today, we announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has approved our CAR T-cell therapy for second-line treatment of adult patients with relapsed/refractory large B-cell lymphoma.
-
Gilead Sciences
@GileadSciences
Today, the U.S. FDA approved our first-in-class #hiv treatment option administered twice-yearly for people with limited therapy choices. gilead.inc/3BWKZIa
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#news: Announcing our intent to acquire @TmunityTx, a clinical-stage, private biotech focused on next-generation CAR T, adding additional pipeline assets, platform capabilities and a strategic research and licensing agreement with @PennMedicine to Kite’s portfolio.
-
Gilead Sciences
@GileadSciences
At the ASCO Plenary Series tomorrow, we’ll be sharing positive results from our Phase 2 trial with Arcus Biosciences in non-small cell #lungcancer. #nsclc gilead.inc/3vlUVY9
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
Sharing follow-up data from our studies of #cartcell therapy in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia and relapsed/refractory mantle cell lymphoma. #ash22
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
Today at #ash22, we’re presenting follow-up data from our studies of #cartcell therapy in adult patients with relapsed/refractory indolent non-Hodgkin lymphoma and patients with relapsed/refractory large B-cell lymphoma.
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
#news: Today, we announced new findings from our pivotal study of #cartcell therapy versus standard-of-care in patients with relapsed/refractory large B-cell lymphoma. #ash22
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
Today, we shared results from one of the largest real-world analyses of CAR T-cell therapy assessing the impact of time from leukapheresis to infusion in adult patients with relapsed/refractory large B-cell lymphoma. #ash22
-
Gilead Sciences
@GileadSciences
At #sabcs22 today, we’re sharing new data in HR+/HER2- metastatic breast cancer. gilead.inc/3Y3beWz
-
Gilead Sciences
@GileadSciences
Gilead is pleased to attend the #tlm22 in Washington, D.C., to meet and collaborate with leaders in liver disease as we work together toward the shared goal of #viralhepatitis elimination for all. #livermtg22
-
Gilead Sciences
@GileadSciences
Next month at #ash22, we’ll be sharing data from 30 abstracts alongside @KitePharma. See a preview of our #bloodcancer research at this year’s meeting, including updates in myelodysplastic syndromes #mds, acute myeloid leukemia #aml and large B-cell lymphoma #lbcl.
-
Gilead Sciences
@GileadSciences
Shadae McDaniel with the All Stars Project, a Gilead grantee, shares how the organization harnesses the power of performing to transform the lives of young people growing up in low-income neighborhoods. Learn more about its efforts to bring about social change.
-
Gilead Sciences
@GileadSciences
We are pleased to announce the @US_FDA approved our chronic #hbv treatment in pediatric patients 12 years of age and older. gilead.inc/3SS6Lm5
-
Gilead Sciences
@GileadSciences
The #lungcancer research and treatment landscape has evolved over the years. We’re committed to helping drive progress for people impacted by this disease. #lungcancerawarenessmonth
-
Gilead Sciences
@GileadSciences
At #aasld2022 Gilead will share the latest data from our broad liver disease portfolio, including data from our #hcv, #hbv, #hdv, #nash and #psc programs. We continue to strive to address the unmet needs of people living with liver disease. gilead.inc/3fmEtSZ
-
Gilead Sciences
@GileadSciences
Congratulations to Kevin Lofton, Gilead’s Lead Independent Director, on receiving the @NAHSEhq Hall of Fame Award. Throughout his career, Kevin has demonstrated a clear commitment to eliminating health disparities and creating healthier communities.
-
Gilead Sciences
@GileadSciences
In our final episode of the #hepcast, produced with @Hep_Alliance, panelists talk about how they are engaging migrant communities in healthcare and the importance of this to achieve #viralhepatitis elimination. #liverawarenessmonth
-
Gilead Sciences
@GileadSciences
In Eastern Europe and Central Asia, the #hiv epidemic is growing faster than in any other region. With the support of Gilead Sciences and #ejaf, our Radian partners are working to change that.
Find out what community leaders are doing to help end the HIV epidemic in the region. -
Gilead Sciences
@GileadSciences
Today we announced our third quarter financial results, supported by strong commercial and clinical execution. gilead.inc/3TKpQrl
-
Gilead Sciences
@GileadSciences
For team members like Jessica, work is personal. Connected to her passion for helping to make a difference for Canada’s medical oncology community, Jessica’s work in breast cancer is a meaningful part of her #gileadlife.
-
Gilead Sciences
@GileadSciences
Congratulations to Gilead’s Joel Silver and LJ Mizzi, both named 2022 @Seramount Working Parents of the Year. We’re proud to support parents like Joel and LJ who are committed to our mission, their families and communities.
-
Gilead Sciences
@GileadSciences
At #hivglasgow, we’re sharing the latest findings from our person-centered HIV treatment research program.
-
Gilead Sciences
@GileadSciences
A mother of three young daughters, LaToya lives with triple-negative breast cancer (#tnbc). She shares her experience to help others feel supported. #breastcancerawarenessmonth #meanstome
-
Gilead Sciences
@GileadSciences
Evaluating the long-term safety and efficacy data of #hiv treatments is a key focus of our research at #idweek2022. Long-term data is a critical piece of providing person-centric care and helping to end the HIV epidemic.
-
Gilead Sciences
@GileadSciences
Gilead is traveling to HBCUs to talk sexual health and breast care. HBCUs play an important role in advancing Black equity and prioritizing systemic health inequities. We're excited to visit 11 campuses over the next six weeks. #breastcancerawarenessmonth #gileadhbcuroadshow
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
Today we announced that we’ve entered into a license agreement with Refuge Biotechnologies, a synthetic biology company for cancer immunotherapy, for exclusive rights to utilize their proprietary gene expression platform to develop potential treatments for blood cancers.
-
Gilead Sciences
@GileadSciences
Jacquie was diagnosed with non-Hodgkin lymphoma when she was just 15 years old. Later in her life she received two breast cancer diagnoses. She explains why it's important to stay positive. #breastcancerawarenessmonth
-
Gilead Sciences
@GileadSciences
We are proud to support #inhsu2022 and initiatives that ensure people who inject drugs have better access to support, testing and management of #viralhepatitis. Addressing the needs of this key group is critical to achieving the WHO's goal of #viralhepatitis elimination by 2030.
-
Gilead Sciences
@GileadSciences
For more than 35 years, we’ve pursued scientific innovation to help transform #hiv. We look forward to sharing our latest progress with the scientific community at #hivglasgow. gilead.inc/3EYgrYC
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
We are pleased to announce the @EU_Commission has granted approval for our #cartcell therapy for adult patients with diffuse large B-cell lymphoma and high-grade B-cell lymphoma who do not respond to first-line treatment.
-
Gilead Sciences
@GileadSciences
José Romero is one of many advocates working to address the disproportionate burden of #hiv on the #latinx community in the U.S., beginning with access to testing, education and prevention. #nlaad
-
Gilead Sciences
@GileadSciences
Inspired by his local pharmacist while growing up, Jesse Garcia proudly works as a Senior Medical Scientist at Gilead. As Global Lead of the company’s Latino Employee Resource Group, he drives work centered around diversity, inclusion and access to care. #hispanicheritagemonth
-
Gilead Sciences
@GileadSciences
Our hallmark is dramatically improving outcomes for people facing life-threatening #infectiousdiseases. Now we’re applying this same approach and commitment to #cancer. Follow @GileadOncology for more.
-
Gilead Sciences
@GileadSciences
We're supporting #breastcancerawarenessmonth with insights from Sarah Powell, CEO of Pink Hope. Sarah shares how her own diagnosis of breast cancer has deepened her connection to helping others who are at high risk.
-
Gilead Sciences
@GileadSciences
No one told Stephanie Walker about clinical trial opportunities when she was diagnosed with metastatic breast cancer. That motivated her to become involved with MBC Alliance to discover practical ways to improve Black participation in trials.
-
Gilead Sciences
@GileadSciences
Today we announced the FDA’s acceptance of our supplemental biologics license application for our therapy in people with pre-treated HR+/HER2- metastatic breast cancer. gilead.inc/3rOcbn4
-
Gilead Sciences
@GileadSciences
Maria Rangel is part of a team that helps shape our employee experience and is a board member of our Gileados employee resource group for the Latinx community. Read how she’s been able to grow with the company across two decades at Gilead. #hispanicheritagemonth #gileadlife
-
Gilead Sciences
@GileadSciences
Join us in congratulating @KitePharma CEO Christi Shaw for being named on @Forbes' 50 Over 50 Entrepreneurs list. Christi’s inspiring leadership, at the forefront of oncology, is driven by the mission to bring potentially lifesaving therapies to the patients that need them most.
-
Gilead Sciences
@GileadSciences
“Telemedicine provides us with a variety of options and a variety of providers, but there’s nothing like that in-person connection,” says Gilead's Dr. Shanell McGoy.
Read more about @glaad's research on COVID-19's impact on HIV care and prevention. gilead.inc/3rEiRUF -
Gilead Sciences
@GileadSciences
This week, we are proud to come together at #uscha2022. During Sunday’s plenary, we will honor the art of La Brega, which demonstrates the solidarity and pride in Puerto Rico’s unwavering resolve to end the #hiv epidemic.
-
Gilead Sciences
@GileadSciences
To honor the Quilt's 35th anniversary, supporters gathered in Jackson, Miss., to “Change The Pattern,” reimagining the HIV epidemic response in the U.S. South. Each panel commemorates a person who died from AIDS-related causes and the value of community, remembrance and hope.
-
Gilead Sciences
@GileadSciences
At Gilead, we’re committed to advancing transformative science for people with cancer. Listen as Luciana explains what drives her daily commitment. #breastcancerawarenessmonth
-
Gilead Sciences
@GileadSciences
Before other #covid19 treatments or vaccines were available, our global network was able to deliver equitable global access to a new antiviral therapy in a matter of months. Learn more about how voluntary licensing partnerships speed treatment to patients worldwide.
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
We are pleased to announce the @US_FDA has approved our viral vector manufacturing facility in Southern California for commercial production, further strengthening Kite's global #celltherapy manufacturing network.
-
Gilead Sciences
@GileadSciences
Organizations serving the #hiv community in Puerto Rico are a vital link to care and need immediate support in the aftermath of Hurricane Fiona. Thank you @AIDS_United and the organizations that are serving the community in need right now.
AIDS United
@AIDSUnited
NEWS: AIDS United’s Relief, Recovery & Resilience Fund received $500,000 Monday to support hurricane recovery in Puerto Rico for organizations serving people living with HIV.
We will release a request for proposals for emergency assistance next week. aidsunited.org/aids-united-receives-500k-from-gilead-to-d… -
Gilead Sciences
@GileadSciences
Nadia Wajid shares what attracted her to @KitePharma and why keeping employees energized about the company's work for people living with blood cancer feels personally meaningful to her. #bloodcancerawarenessmonth
-
Gilead Sciences
@GileadSciences
We’re proud to support Gilead grantee Sananim, a Prague organization that advocates for #hcv testing and screening among people who use drugs. To meet the @WHO’s goal of elimination by 2030, it’s critical that we continue supporting communities most impacted by #viralhepatitis.
-
Gilead Sciences
@GileadSciences
We’re spotlighting Dr. Amelie Ramirez, a health disparities researcher with @UTHealthSA who shares her decades-long journey to help create equitable care for the Latino population. #hispanicheritagemonth
-
Gilead Sciences
@GileadSciences
The only way to know your #hiv status is to get tested. This #ngmhaad, be empowered by knowing your status and adopting HIV testing into your self-care routine. Visit hivtestnow.com to learn more, find HIV testing sites or order an at-home test.
-
Gilead Sciences
@GileadSciences
At Science Day we celebrated our culture of #innovation. Teams gathered at Gilead Park to learn about our strategies and pipelines in inflammation, oncology and virology.
-
Gilead Sciences
@GileadSciences
We are proud to announce an initiative with HAIVN, a collaboration with @BrighamWomens, @HMSPrimaryCare and @BIDMChealth, to improve #hepb and #hepc screening, diagnosis and care at primary healthcare facilities in Vietnam and the Philippines. Read more. gilead.inc/3UtOE7S
-
Gilead Sciences
@GileadSciences
We value the roles fathers have both at work and home. As a 2022 Best Company for Dads, we are proud to reinforce Gilead’s commitment to parental leave benefits, health services and career development for all employees, including our dads. gilead.inc/3RYIXx2
-
Gilead Sciences
@GileadSciences
Today, we completed our acquisition of MiroBio and its novel platform technology and pipeline. We are pleased to welcome MiroBio’s employees as we expand our inflammation portfolio. gilead.inc/3QYkdnw
-
Gilead Sciences
@GileadSciences
Gilead Foundation recently announced its inaugural Creating Possible Fund grantees. Here, learn about grantee Kingmakers of Oakland and its dedication to improving the lives of Black youth in public school systems.
-
Gilead Sciences
@GileadSciences
On #nhaad and every day, we support our Age Positively grantees – including @HealthHIV’s “Pozitively Aging.” The program aims to help improve health outcomes and overall wellbeing among people aging with HIV.
-
Gilead Sciences
@GileadSciences
Former oncology nurse Amy Dembeck, Associate Director, Public Affairs at Kite, lives with follicular lymphoma and knows how important advocacy is to raising awareness and helping patients. Hear her story. #bloodcancerawarenessmonth #fightbloodcancer #meanstome
-
Gilead Sciences
@GileadSciences
Today we are pleased to have received a positive opinion from the #chmp to extend the indication of our therapeutic for the treatment of pediatric patients with #covid19. Read more here. gilead.inc/3xsfGCA
-
Gilead Sciences
@GileadSciences
Today the @WHO announced updates to its Therapeutics and COVID-19: living guideline which conditionally recommends our antiviral treatment for use in the treatment of patients with severe COVID-19. gilead.inc/3QNfViC
-
Gilead Sciences
@GileadSciences
We are proud to welcome and congratulate the inaugural grantees of the Gilead Foundation’s Creating Possible Fund. These organizations will receive a total of $20 million in funding to advance health equity across the United States through educational efforts.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
Paris is Equal Hope’s Director of Program Operations and is working to reduce racial disparities in breast cancer mortality, in part by directing women to breast cancer screenings in the Chicagoland area.
-
Gilead Sciences
@GileadSciences
Congratulations to our corporate citizenship team, recipient of the Social Impact Team Purpose Award by #accprof! This award recognizes the team's efforts under our COMPASS Initiative, addressing the HIV epidemic in the Southern U.S. through collaborative community engagement.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
We awarded $5.7 million in grant funding to 21 organizations in the U.S. as part of our effort to help bridge the health equity gap and eliminate barriers for Black people affected by TNBC.
-
Gilead Sciences
@GileadSciences
When Kelly was diagnosed with stage 4 non-Hodgkin lymphoma it was earth shattering, but she never gave up. Watch as she shares her experience from diagnosis to various treatments, that included CAR T-cell therapy.
-
Gilead Sciences
@GileadSciences
We’re pleased to announce the launch of the Gilead Foundation’s Creating Possible Fund. Learn how this fund is supporting organizations that are advancing health through education equity and building a pipeline of Black health leaders. gilead.inc/3U1DA1L
-
Gilead Sciences
@GileadSciences
Spanish breast cancer researcher Dr. Javier Cortes explains how collective learnings presented at scientific exchanges like #esmo2022 help physicians better treat their patients. Read more in this 4 Questions on Stories@Gilead.
-
Gilead Sciences
@GileadSciences
Lai Wang Yu from Hong Kong was diagnosed with #hepatitisb by chance. Now, 30 years later, he shares his experience of how he took control of his health and explains how he now successfully manages his #hbv. gilead.inc/3AARCxM
-
Gilead Sciences
@GileadSciences
At #esmo22 we’ll present new overall survival results in pre-treated HR+/HER2- metastatic breast cancer. gilead.inc/3ezcdMh
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
Today we announced the European Commission has granted Marketing Authorization for our #cartcell therapy for the treatment of adult patients (26+) with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
-
Gilead Sciences
@GileadSciences
Chronic hepatitis delta, or #hdv, is the rarest and most severe form of viral hepatitis and can only occur in those who also have #hepatitisb. Listen as @RobertGish explains what #hdv is and how it impacts those living with this disease.
-
Gilead Sciences
@GileadSciences
At #esmo22 we'll share our latest data analysis in pre-treated HR+/HER2- metastatic breast cancer. gilead.inc/3TAHJcy
-
Gilead Sciences
@GileadSciences
We're happy to attend the #erscongress virtually. We’re joining the world’s respiratory experts to exchange the latest research and advancements in treating patients with respiratory illnesses, including #covid19.
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
No one is ever prepared for a cancer diagnosis. This #bloodcancerawarenessmonth, Roshie Moghbel, Director of Clinical Operations at Gilead, shares her family’s story of resilience when they faced a #lymphoma diagnosis. #fightbloodcancer #meanstome
-
Gilead Sciences reposted
Gilead Oncology
@GileadOncology
#esmo22 is nearly here, and we’ll be sharing #oncology research that highlights how we’re addressing decades-long gaps in treatment. Learn more about our #research development program.
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
Today we announced the expansion of Kite’s global cell therapy business with the launch of operations in Brazil, Singapore and Saudi Arabia.
-
Gilead Sciences
@GileadSciences
Today, we’re joining forces with LGBTQ+ and human rights organizations to help address the #monkeypox public health emergency. Join today’s webcast at 7-8 p.m. ET for a discussion on monkeypox and its impact on people living with HIV.
Register at gilead.inc/3wH26uT -
Gilead Sciences
@GileadSciences
Gilead Oncology is building a diverse pipeline with multiple opportunities for unique combinations, and strong potential to span tumor types and lines of therapy. gilead.inc/3Q1jS2G #esmo22
-
Gilead Sciences
@GileadSciences
As part of our Zeroing In: Ending the HIV Epidemic program, we're supporting 116 orgs in 47 countries that are advancing efforts in local communities most impacted by #hiv. Click through this map to view the locations of grantees & supported programs around the world.
-
Gilead Sciences
@GileadSciences
When Min Kyung Yoon learned he had #hepb and liver cancer, he didn’t have the information to understand his diagnosis. Hear how he took charge of his health and now he helps others with #hbv do the same.
-
Gilead Sciences
@GileadSciences
Florentin Scarlat is part of a team that interfaces with government institutions, policymakers and health officials to help improve access to Gilead’s innovative medicines. Read why this calling led him to join Gilead and relocate from France to California. #gileadlife
-
Gilead Sciences
@GileadSciences
On the heels of #shaad, we’re spotlighting Blind Angels, a docuseries on #hiv in the U.S. South honoring the grassroots activists and organizations who are working to destigmatize and raise awareness of HIV in their communities.
-
Gilead Sciences
@GileadSciences
Today, we announced the first global regulatory approval of the only twice-yearly #hiv treatment option. Learn more. gilead.inc/3AdjAjB
-
Gilead Sciences
@GileadSciences
This #shaad, we’re spotlighting our COMPASS Initiative, a 10-year commitment to organizations working to help combat the #hiv epidemic in the Southern United States. To date, COMPASS has supported 326+ organizations across the U.S.
-
Gilead Sciences
@GileadSciences
Angelina Namiba draws upon her own experience of living with HIV in her work with @4Mproject, which provides a pregnancy support system for Black migrant women in the UK. She shares her journey and the work she’s doing to help remove stigma.
-
Gilead Sciences
@GileadSciences
#hepatitisc disproportionately affects people in prisons, and more needs to be done to address this imbalance. Tune in to our latest #hepcast episode, in partnership with @Hep_Alliance, as our panel discuss eliminating #hcv. 🎧 Listen now.
-
Gilead Sciences
@GileadSciences
The COVID-19 pandemic has exacerbated inequities in #hiv care, particularly for Black communities in the U.S. South. We’re proud to collaborate with @MSMEDU’s Satcher Health Leadership Institute and @XULA1925 to help advance health equity. gilead.inc/3A2FdTA
-
Gilead Sciences
@GileadSciences
We’re happy to share the great work being done at Sustained Health Initiatives of the Philippines to help end the #hiv epidemic. See the full story at gileadhivtogether.com #togetheragainsthiv
-
Gilead Sciences
@GileadSciences
Today we announced an important update about our #covid19 treatment and the #omicron subvariants of concern, BA.4 and BA.5. gilead.inc/3pkMKZ1
-
Gilead Sciences
@GileadSciences
Today we announced an agreement with Everest Medicines to transfer all development and commercialization rights to Gilead for one of our cancer therapies in Asia. Learn more. gilead.inc/3JVXfLA
-
Gilead Sciences
@GileadSciences
We are pleased to announce new positive interim results from a Phase 3 study investigating our treatment in patients with HR+/HER2- metastatic breast cancer. Learn more. gilead.inc/3plc94M
-
Gilead Sciences
@GileadSciences
We’ve ranked No. 1 in 10 indicators in the 2021 @PatientView Corporate Reputation of Pharma Patient Perspective: Hepatitis Edition, a report on perceptions of #hepatitis patient groups. The rankings motivate us to keep striving to help address the unmet needs of the community.
-
Gilead Sciences
@GileadSciences
Senegal has had widespread #hiv prevention and treatment success over the past decade. When Fann Hospital faced its own barrier to patient care, see how one doctor — supported by Gilead — rebuilt the foundations of hope for his patients.
-
Gilead Sciences
@GileadSciences
Following #aids2022, we connected with Jared Baeten, Gilead’s Vice President of HIV Clinical Development, to discuss top highlights from the conference and ways the company is looking to transform care and improve outcomes for people affected by #hiv.
-
Gilead Sciences
@GileadSciences
We’re collaborating with @GLAAD, @HRC, @NBJCOnTheMove, @NCLRights & @NMACCommunity to address #monkeypox, which disproportionately affects the LGBTQ+ community. We're supporting education and a public policy response & creating an outbreak emergency fund: gilead.inc/3bGJOCF
-
Gilead Sciences
@GileadSciences
The @BayAreaCouncil recently released a report showing the economic impact of our work. We believe strongly in investing in our local community, and we’ll continue contributing through philanthropy, environmental sustainability and further economic investment.
-
Gilead Sciences
@GileadSciences
Organizations like @cesida_esp support people living with #hcv and #hiv and are crucial to addressing stigma and discrimination. Watch to find out more about how CESIDA is paving the way toward eliminating viral hepatitis by 2030.
-
Gilead Sciences
@GileadSciences
Eleonora never gave up while facing non-Hodgkin lymphoma, and she credits CAR T-cell therapy for helping put her cancer in remission. Watch her inspiring story to learn how she advocated for her care.
-
Gilead Sciences
@GileadSciences
The role of PrEP medicines is pivotal in helping to end the #hiv epidemic. We strive to work with partners to advance research efforts that acknowledge the needs of those disproportionately impacted by HIV and historically underrepresented in PrEP studies. #aids2022
-
Gilead Sciences
@GileadSciences
Today we announced plans to acquire MiroBio, a UK-based company focused on discovering therapies to restore immune balance in autoimmune disease. The acquisition will complement our inflammation research and development strategy.
-
Gilead Sciences
@GileadSciences
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) were recently updated for Breast Cancer. Learn more about what this means for clinicians and patients. gilead.inc/3SqIEeW
-
Gilead Sciences
@GileadSciences
Gilead is proud to sign an amicus brief supporting the continued use of race as a factor in college admissions. Diversity is hugely important for science and tech companies, and it’s essential that colleges have the tools to admit and develop diverse talent. #defenddiversity
-
Gilead Sciences
@GileadSciences
At #aids2022, we highlighted the efforts of our RADIAN community partners in Eastern Europe and Central Asia – and we’ll continue to share their inspiring stories. radianhiv.org
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Person-centric approaches are at the heart of our scientific advancements at Gilead, and we’ve been honored to share our work at #aids2022. We’re dedicated to applying real-world learnings and insights to continue driving research that addresses unmet needs of the #hiv community.
-
Gilead Sciences
@GileadSciences
We’re happy to welcome Deborah H. Telman to Gilead. She joins the company today as Executive Vice President, Corporate Affairs and General Counsel.
-
Gilead Sciences
@GileadSciences
As #aids2022 wraps up, we’re reflecting on the progress made toward the ultimate goal of finding a functional cure for #hiv. We’re working to achieve that goal through collaboration and innovation.
-
Gilead Sciences
@GileadSciences
At #aids2022, let’s talk diversity. #hiv clinical research is more impactful when everyone is included — and that's why we take a conscious, thoughtful approach to building clinical trials in which a diverse range of people who would benefit from PrEP are represented.
-
Gilead Sciences
@GileadSciences
Meet the doctors, activists and advocates from Sustained Health Initiatives of the Philippines who are working to provide access and healthcare resources to those living with #hiv. See their full story: gileadhivtogether.com #togetheragainsthiv
-
Gilead Sciences
@GileadSciences
Our RADIAN collaboration with @EJAF is working to help end the AIDS epidemic in Eastern Europe and Central Asia. Watch @eltonofficial and David Furnish highlight the impact of the RADIAN program and congratulate our new partners. #aids2022
This media couldn't be displayed. See it on the original post. -
Gilead Sciences
@GileadSciences
Our #hiv treatment research program is focused on helping people with HIV continue achieving long-term treatment success. The data at #aids2022 can help provide additional insights into redefining HIV treatment success beyond viral load suppression.
-
Gilead Sciences
@GileadSciences
At #aids2022, we're sharing new #hiv treatment research findings, including data from a landmark study evaluating the therapy responses of people with HIV/HBV coinfection. Read more: gilead.inc/3SjQPtM
-
Gilead Sciences
@GileadSciences
At Gilead, we’re committed to helping achieve the @WHO goal of hepatitis elimination by 2030. This #worldhepatitisday we stand with the hepatitis community to raise awareness of #viralhep – and together, we can make hepatitis elimination a reality. #hepcantwait
-
Gilead Sciences
@GileadSciences
FDA accepts for review the NDA for our investigational, long-acting therapy for #hiv treatment. Read more: gilead.inc/3JaZomi
-
Gilead Sciences reposted
IAC - the International AIDS Conference
@AIDS_conference
Congratulations to the 2022 Me and My Healthcare Provider Champions for delivering stigma-free #hiv services in #brazil 🇧🇷, #mexico 🇲🇽, #hongkong 🇭🇰, #taiwan 🇹🇼, #kenya 🇰🇪, #malawi 🇲🇼, #southafrica 🇿🇦 & #zambia 🇿🇲! 👏 #aids2022 @GileadSciences
-
Gilead Sciences
@GileadSciences
As we approach #internappreciationday, we thank our Gilead interns for the engagement, creativity and drive they bring to our teams. Their energy and fresh perspectives help enable our mission, and we look forward to seeing all they achieve in the future. #gileadlife
-
Gilead Sciences
@GileadSciences
We're proud to partner with the @AIDS_Memorial to preserve and display panels of the Quilt year round at our Foster City campus. Learn more about the significance of these panels and future plans for the Quilt.
-
Gilead Sciences
@GileadSciences
We’re proud to be included on @Seramount’s annual list of Top Companies for Multicultural Women – an award that recognizes companies that create and use best practices in hiring, retaining and promoting. gilead.inc/3zv24YH
-
Gilead Sciences
@GileadSciences
Only three days to go until the 14th #worldhepatitisday, which raises awareness of viral hepatitis. At Gilead, we support this year’s theme of #icantwait and continue to partner with organizations to achieve the @WHO goal of hepatitis elimination by 2030. #hepatitiscantwait
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
We are pleased to announce @EMA_News Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for our CAR T-cell therapy for the treatment of adult patients (26+) with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
-
Gilead Sciences
@GileadSciences
As our #covid19 treatment continues to retain activity against SARS-CoV-2 as it evolves, we're pleased to have received a positive opinion from the #chmp recommending the grant of full marketing authorization for our therapeutic. gilead.inc/3aVX7iq
-
Gilead Sciences
@GileadSciences
We’re a dedicated member of @BayAreaCouncil and a proud contributor to Foster City and San Mateo County. Through continued economic investment, philanthropy and environmental sustainability, we'll always work to help make the home of our corporate headquarters the best it can be.
Bay Area Council Economic Institute
@BayAreaEconomy
The #bayarea is home to some of the most innovative and fastest growing companies in the world, including
@GileadSciences. The impact of Gilead's Master Plan Expansion of their HQ in Foster City, CA is detailed in the Institute’s latest report:
www.bayareaeconomy.org/report/the-economic-impacts-of-gil… -
Gilead Sciences
@GileadSciences
A big welcome to Stacey Ma, who joined Gilead this week as our new Executive Vice President of Pharmaceutical Development and Manufacturing.
-
Gilead Sciences
@GileadSciences
Gilead recently hosted a hackathon to tap novel ways to help increase PrEP utilization. Read how the winning team is using a chatbot to engage the most vulnerable communities. #hiv
-
Gilead Sciences
@GileadSciences
We look forward to joining the global community at #aids2022 next week. We’ll be sharing an update on our scientific innovation and catalytic collaboration, which are part of our ongoing commitment to help end the #hiv epidemic for everyone, everywhere. gilead.inc/3cxv8pB
-
Gilead Sciences
@GileadSciences
Today we announced an additional $85 million contribution to the Gilead Foundation. The Foundation works to help ensure that all people have full access to educational and economic opportunities that enable them to lead healthy lives. gilead.inc/3RNxhh1
-
Gilead Sciences
@GileadSciences
We've worked hard to ensure equitable access to our treatment for #covid19. Now, in an effort to better prepare for future threats, we've signed on to @IFPMA’s Berlin Declaration, a joint solution to build equity into pandemic preparedness.
-
Gilead Sciences
@GileadSciences
We’re happy to see the launch of Equitable Breakthroughs in Medicine Development, an innovative initiative to increase clinical trial diversity. Funded by a @PhRMA grant, the work will help underrepresented patients be more involved in medicine development.
PhRMA
@PhRMA
Building trust in underserved communities means acknowledging systemic barriers and finding paths to meet patients where they are. @PhRMA is supporting these efforts with a grant for a new partnership to enhance clinical trial diversity. Learn more at phrma.org/equity
-
Gilead Sciences
@GileadSciences
#aids2022 kicks off next week, and we’re eagerly awaiting the opportunity to collaborate, learn and connect in person again as we work together to help end the #hiv epidemic for everyone, everywhere.
-
Gilead Sciences
@GileadSciences
We’ve signed a new joint procurement agreement with @EU_Commission that will help continue to enable rapid, equitable access to our #covid19 treatment authorized in Europe. Read more: gilead.inc/3PlHWhd
-
Gilead Sciences
@GileadSciences
Siobhan Daly leads a team of clinical operations experts working to adapt our innovative therapies to help meet the needs of children. Read how she approached building out her team at our new Global Pediatric Drug Development Centre of Excellence in Dublin, Ireland. #gileadlife
-
Gilead Sciences
@GileadSciences
We’re proud to be a sponsor of AIDS Walk San Francisco, which benefits dozens of #hiv/AIDS organizations in the Bay Area.
AIDS Walk San Francisco
@aidswalksf
Join us on Sunday, July 17 as AIDS Walk San Francisco makes its much-anticipated return in-person festivities in Golden Gate Park!🙌
Register today using the link in our bio! -
Gilead Sciences
@GileadSciences
.@GenderCool is appealing to people's hearts to advocate for the rights of transgender individuals. Find out how the organization’s young transgender champions are doing this through sharing their stories.
-
Gilead Sciences
@GileadSciences
Today, we spotlight The @TrevorProject, the world's largest suicide prevention and mental health organization for LGBTQ youth. Take a look back at how they increased support for young people during the start of the COVID-19 pandemic. gilead.inc/3ONAwCK #pridemonth
-
Gilead Sciences
@GileadSciences
Last weekend, our employees, family members and friends proudly participated in the @SFPride Celebration and Parade. We were happy to be back in person and to be able to show our support for the community and for organizations dedicated to LGBTQ+ rights. #sfpride52
-
Gilead Sciences
@GileadSciences
Ashley Innes leads a team of community liaisons who help provide education, resources and support to communities impacted by HIV in the Southern United States. Read about how this role has enabled her to broaden her impact on the HIV epidemic. #gileadlife gilead.inc/3OwqoyC
-
Gilead Sciences
@GileadSciences
Frank Duff leads virology clinical development efforts to address unmet needs in #hiv, #covid19, #viralhepatitis and other areas at Gilead. Learn more about his commitment to inclusion and person-centered research here. stories.gilead.com/articles/the-next-wave-of-innovation-i…
-
Gilead Sciences reposted
Kite, a Gilead Company
@KitePharma
Today we announced that the European Commission has granted marketing authorization for our CAR T-cell therapy for the treatment of adult patients with advanced relapsed/refractory follicular lymphoma.
-
Gilead Sciences
@GileadSciences
Gilead shares a regulatory update on our investigational, long-acting therapy for #hiv treatment. Read more: gilead.inc/3HZLmUe
-
Gilead Sciences
@GileadSciences
Routine #hiv testing is an important and normal part of self-care, and knowing your status empowers you with options to treat or prevent HIV. This National HIV Testing Day, visit hivtestnow.com to learn more, find HIV testing sites, or order an at-home test.
-
Gilead Sciences
@GileadSciences
We're proud to endorse the Kigali Declaration, a multi-sector partnership to control and end neglected tropical diseases. We have a long history of supporting the elimination of #ntds, and our work in this area will continue. gilead.inc/3OIqlj0 #kigalisummit #beatntds
-
Gilead Sciences
@GileadSciences
Ensuring access to medicines for all and removing barriers to care have always been core to our mission. In light of today’s U.S. Supreme Court decision, we affirm our support of women’s rights to make decisions about their own health and care. gilead.inc/3ylvlEY
-
Gilead Sciences
@GileadSciences
The European CHMP has adopted a positive opinion for our investigational, long-acting therapy for #hiv treatment. Learn more: gilead.inc/39Sia4Q
-
Gilead Sciences
@GileadSciences
At #ilc2022, we’re presenting Week 48 data from the Pivotal Phase 3 trial looking at treatment options for #hdv. The data reinforce the potential of HDV treatment to address some of the unmet medical needs of this rare disease. Learn more gilead.inc/3yd1Dlc @EASLNews
-
Gilead Sciences
@GileadSciences
Over Gilead’s 35-year history, bold ambitions were set and achieved in the company’s fight against devastating diseases. On our anniversary, watch a video featuring our commitment to help make the world a healthier place for all people. #35yearsofgilead
-
Gilead Sciences
@GileadSciences
At #ilc2022 we’ll share the latest data from our diverse liver disease programs across #hcv, #hbv, #hdv, #nash & #psc to help address the unmet needs of people living with liver disease. Learn more about recent innovations in liver disease: gilead.inc/3xKdZ2Y @EASLNews
-
Gilead Sciences
@GileadSciences
In honor of #pridemonth, we celebrate the @AIDS_Memorial #aidsquilt and @CleveJones1, human rights advocate and founder of the powerful community art piece. Learn about the history of the Quilt and how it’s been a source of healing to people who lost loved ones to the epidemic.
-
Gilead Sciences
@GileadSciences
We’re honored to have received the @BioNJ_Org Innovator Award, as well as the Heart of BioNJ Award for our contributions during the #covid-19 pandemic.
-
Gilead Sciences
@GileadSciences
“Hearing someone's story who was my age is what inspired me to advocate for other people living with hepatitis B.” In Episode 2 of the #hepcast, produced with @Hep_Alliance, hear about the importance of empowering young people to address #hbv stigma and eliminate #viralhep.
-
Gilead Sciences
@GileadSciences
We’re looking forward to being at #ilc2022, where we’ll join the global liver community to exchange the latest research and ideas. At Gilead, we remain committed to pursuing ongoing research to address the unmet needs of people living with liver disease globally.
-
Gilead Sciences
@GileadSciences
Ahead of #juneteenth, our Gilead Leadership Organization of Black Employees (GLOBE) employee resource group raised the flag on our Foster City campus in honor of the holiday. With this symbol of freedom and justice, we renew our dedication to advancing racial equity for all.
-
Gilead Sciences
@GileadSciences
In honor of #juneteenth, Gilead launches the Social Justice Experience, an interactive installation for employees that examines the experience and history of Black people in the United States.
-
Gilead Sciences
@GileadSciences
Congratulations to @Hep_Alliance on another successful #worldhepatitissummit. We'll continue supporting those who are working tirelessly to make #viralhepatitis elimination a reality by 2030. #whs22
World Hepatitis Alliance
@Hep_Alliance
What an amazing way to end #worldhepatitissummit! We're so thrilled that the 4th WHS 2024 will be in Lisbon, Portugal!👏
WHS 2024 will bring the global community together and continue to drive #hepatitis elimination.
Vemo-nos em Lisboa! 🇵🇹 -
Gilead Sciences
@GileadSciences
Daan Koper leads a team that supports the production of @KitePharma’s cell therapies at our facility in the Netherlands. Learn how he’s grown professionally while playing a key role in some of the most innovative manufacturing in biopharma. #gileadlife gilead.inc/3lIIEYN
-
Gilead Sciences
@GileadSciences
At #asco2022, we’re showcasing Gilead and @KitePharma’s diverse oncology pipeline. Our data presentations reinforce the potential of our transformative science across multiple cancers.
-
Gilead Sciences
@GileadSciences
At Gilead, 2021 was the year we moved ‘Forward and Onward Together.’ Through the promotion of inclusion and diversity, transformative science and renewed commitments to sustainability, we worked toward furthering our mission of making the world a healthier place for everyone.
-
Gilead Sciences
@GileadSciences
We’re proud to be named one of America's Best Employers for Diversity by @Forbes. Building a diverse workforce is critical to our mission of creating a better, healthier world – and we’ll continue to provide a supportive, innovative place for employees.
-
Gilead Sciences
@GileadSciences
We’re featuring Julie, a wife and mother of two from Pennsylvania who was diagnosed with large B-cell lymphoma. Here, she shares her #cartcell therapy journey.
-
Gilead Sciences
@GileadSciences
We’re proud to have three employees honored by the HBA. Congratulations to Luminary Keeley Wettan & Rising Stars Jill Gannon and @KitePharma’s Sophia Sharp-Donaldson, who were recognized for their work here and for helping advance the impact and influence of women in healthcare.
Healthcare Businesswomen’s Association (HBA)
@HBAnet
Congrats! Michelene Taptich, @EndoIntlplc; Amy Hutnik, Paula Hackl, @EVERSANAcompany; Doreen Eckert, @evoke_group; Susan Garfield, @EYnews; Keeley Wettan, Jill Gannon, Sophia Sharp-Donaldson @GileadSciences
hbanet.org/2022-rising-stars-and-luminaries
#hbawoty22 #hbaimpact #genderequality #healthcare -
Gilead Sciences
@GileadSciences
In honor of #tnbcday, we’re highlighting LaToya Bolds-Johnson, a mother of three from Maryland. She shares her journey with triple-negative breast cancer and why she's spreading awareness among women. gilead.inc/3sDAe9c
-
Gilead Sciences
@GileadSciences
Today we’re celebrating the historic accomplishments of #womeninscience and cheering on the #girlsinstem who will carry on their legacy. On this International Day of Women and Girls in Science, we look forward to their contributions and remain committed to gender equity in STEM.
-
Gilead Sciences
@GileadSciences
At Gilead, we’re survivors and supporters, storytellers and scientists – and we all have a tireless drive to help change the course of cancer. Today, we’re sharing what #worldcancerday #meanstome, and we’re here to learn.
-
Gilead Sciences
@GileadSciences
Jonathan Tsang is a process scientist dedicated to the continuous improvement of @KitePharma’s CAR T-cell therapy manufacturing processes. Learn about what makes his work so critical. #creatingpossible gilead.inc/3IZFx8f
-
Gilead Sciences
@GileadSciences
We’re pleased to be named a Best Place to Work for LGTBQ+ Equality by the @HRC Foundation. We’ve achieved a 100% rating in the Corporate Equality Index for five consecutive years, and we celebrate our diverse workforce and inclusive culture. #cei2022
-
Gilead Sciences
@GileadSciences
On Dr. Martin Luther King Jr. Day, we continue to be inspired by the indelible mark he left on the world. At Gilead, we aim to further Dr. King’s legacy through our efforts to promote equity, inclusion and diversity here and in partnership with communities we serve. #mlkday2022
-
Gilead Sciences
@GileadSciences
Sherrie Musick manages the materials needed to manufacture @KitePharma's cell therapies and helps ship engineered cells to authorized cancer treatment centers across the United States. Find out what inspired her to join the company. gilead.inc/3K16VEq #creatingpossible
-
Gilead Sciences
@GileadSciences
As the oncology community gets ready for #asco21, read the perspectives of @KitePharma clinical researcher Behzad Kharabi, and @MoffittNews clinician Bijal Shah, who discuss the need for finding new therapies in adult acute lymphoblastic #leukemia: www.gilead.com/stories
-
Gilead Sciences
@GileadSciences
Today, as #pridemonth begins, we celebrate the diverse identities of members of LGTBQ+ communities around the world. We’re committed to helping our employees, patients and partners be their authentic selves and to fostering an environment that promotes equity for all.
-
Gilead Sciences
@GileadSciences
This #asco21, we’re showcasing the collective efforts of the Gilead and @KitePharma teams to help address the unmet medical needs of people living with cancer. Here’s what we’ve been working on: www.gilead.com/news/news-details/2021/gilead-kite-oncolog…
-
Gilead Sciences
@GileadSciences
Last year was a year like no other. At Gilead, we rose to the challenge and responded to the pandemic while continuing to help advance medicines for life-threatening diseases, contribute to positive social change and grow our business sustainably: www.gilead.com/news-and-press/annual-report/year-in-revie…
-
Gilead Sciences
@GileadSciences
We stand in solidarity with our Asian-American and Pacific Islander employees. The recent attacks in Atlanta and the Bay Area are deplorable, and we condemn racism of any kind. Read more from Chairman and CEO Daniel O’Day: www.gilead.com/stories
-
Gilead Sciences
@GileadSciences
As COVID-19 began spreading across Europe last March, supply chains were severely disrupted. See how the dedicated @KitePharma logistics team worked to transport live cells and help people with cancer: www.gilead.com/stories #creatingpossible
-
Gilead Sciences
@GileadSciences
Read more about Chuck, who received #cartcell therapy to treat a form of non-Hodgkin lymphoma and now helps other patients with cancer: www.gilead.com/stories
-
Gilead Sciences
@GileadSciences
We’re logging into #croi2021 this week to share updates from our antiviral program. See how through scientific discovery we aim to eliminate #hcv globally, help alter the trajectory of the #hiv epidemic & gain insight into addressing the #covid19 pandemic: www.gilead.com/news/news-details/2021/gilead-to-present-n…
-
Gilead Sciences
@GileadSciences
On #worldcancerday, Merdad Parsey, our Chief Medical Officer, shares what’s happening in oncology at Gilead and @KitePharma: www.gilead.com/stories
-
Gilead Sciences
@GileadSciences
Gilead celebrates the historical achievements and contributions of Black leaders. On this and every day, we aim to advance Black leadership and mitigate health disparities - and we stand with those working to promote racial equity and social justice. #blackhistorymonth
-
Gilead Sciences
@GileadSciences
As #ash20 draws to a close, we’re more excited than ever about innovation in oncology – and we remain committed to working with @Kitepharma to help address some of the hardest-to-treat forms of cancer. Learn more about our work.
-
Gilead Sciences
@GileadSciences
We’re looking forward to participating in the #ashfromhome meeting and presenting our work alongside @KitePharma colleagues. #ash20
-
Gilead Sciences
@GileadSciences
Together with @KitePharma, we’re looking forward to presenting data from 16 abstracts including some of our latest scientific advances in hematologic malignancies at #ash20.
-
Gilead Sciences
@GileadSciences
.@LLSusa is pivoting to keep people living with blood cancers connected to support and services. Read more about the Gilead and Kite partner’s efforts to evolve amid the COVID-19 pandemic.
-
Gilead Sciences
@GileadSciences
This #worldlymphomaawarenessday, watch a video and read more about Shon, who received #cartcell therapy to treat his advanced blood cancer. www.gilead.com/stories #creatingpossible #wlad2020
-
Gilead Sciences
@GileadSciences
In recognition of being named a 2020 @_WorkingMother_ 100 Best Company, read about the experience of Mia Campitelli, Director of Public Affairs, balancing work and home during the pandemic. #wm100best
-
Gilead Sciences
@GileadSciences
In recognition of #bloodcancerawarenessmonth, read what motivates Jan Pineda, Cell Therapy Specialist at @KitePharma, as she works on the front lines of the CAR T manufacturing process. #creatingpossible #fightbloodcancer #bcam
-
Gilead Sciences
@GileadSciences
We are recognizing Juneteenth by encouraging our employees around the world to take today off to mark this important day. We are committed to working with our employees and partners toward a world where Black communities are free from racial injustice.
-
Gilead Sciences
@GileadSciences
Gilead stands in solidarity and empathy with our Black employees, their families and African American communities everywhere and we condemn racism of any kind.
Gilead Sciences
@GileadSciences
We will continue to listen to our Black/African American employees and community partners to better understand how we can be an ally. Read more from our Chairman and CEO Daniel O’Day: www.gilead.com/stories/articles/message-to-our-employees-….
-
Gilead Sciences
@GileadSciences
This week we’re sponsoring the first virtual @HBAnet Illuminate 2020 event in support of inspiring leaders in healthcare and life sciences. Learn more about this event and how to attend: hbanet.org/Illuminate2020 #hbailluminate #hbaimpact
-
Gilead Sciences
@GileadSciences
Today we published our Year in Review 2019, which provides an in-depth look at our efforts to develop transformative medicines, support employees, partner with communities around the world and grow our business sustainably. Read more: www.gilead.com/news-and-press/annual-report/year-in-revie….
-
Gilead Sciences
@GileadSciences
Today we launched the global Gilead CARES Grantee Fund, which will provide up to $20 million in financial support to current grantees facing hardships due to the COVID-19 pandemic.
Gilead Sciences
@GileadSciences
We are also donating $1 million each to @SMC_Strong and @MayorsFundLA to provide support for families & small businesses in California. Read more about our efforts to support organizations & individuals impacted by COVID-19: www.gilead.com/news/news-details/2020/gilead-announces-$2….
-
Gilead Sciences
@GileadSciences
The way we see it, the impossible is not impossible. It’s simply what hasn’t been achieved yet.
Come see what’s next: www.gilead.com/stories/articles/creating-possible. -
Gilead Sciences
@GileadSciences
We’re proud to have been awarded Best Biotechnology Product, along with @Novartis at this year’s @GalienFdn #prixgalien ceremony. It is an honor to have been nominated among other biomedical innovations that have made a tremendous impact on human health. #celltherapy
-
Gilead Sciences
@GileadSciences
“We welcome the development that Gilead’s once-daily #hiv prevention therapy is now available for adolescents.” – Matthew Rose, Policy & Advocacy Manager, @NMACCommunity: investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArt….












































































































































































































































































































































